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ABSTRACT 
The pathogenesis of C. jejuni in broiler chickens is still poorly understood despite 
the importance of poultry meat as a source of infection in humans. The overall objective 
of this project was to understand the role of flagella and Campylobacter invasion antigens 
in mucosal and systemic colonization, and to evaluate the vaccine potential of C. jejuni 
paralyzed flagella mutants. As a first step to track C. jejuni in vivo, a Green Fluorescent 
Protein (GFP) reporter system that is constitutively expressed was constructed. The 
system was transformed into different C. jejuni strains and isolates, and their mucosal and 
systemic spreading was studied over the period of 7 days. C. jejuni NCTC11168V1 and 
V26 share the same background but differ in their ability to colonize chickens. C. jejuni 
81-176 and K2-55 share the same genetic background but K2-55 has an insertion 
mutation in pflA gene that produced paralyzed flagella. Although the K2-55 flagella 
remained intact structurally, it did not secret Campylobacter invasion antigens (Cia). The 
reporter system was stable in all of these strains both in vitro and in vivo. Fluorescent 
bacteria were visualized successfully using fluorescent and confocal microscopes. C. 
jejuni NCTC11168V1 and 81-176 were detected in the intestinal tract and in the liver and 
spleen of more than 30% of the challenged birds, while V26 and K2-55 were only 
detected in the intestinal tract. C. jejuni 81-176 and K2-55 did not spread systemically to 
the spleen and liver of BALB/c mice challenged using the same approach, although they 
colonized the ceca.  
 A live attenuated vaccine based on C. jejuni K2-55 protected broiler chickens 
from C. jejuni 81-176 challenge in chickens following streptomycin treatment of drinking 
water. The same vaccine had no significant protection against a heterolgous C. jejuni 
NCTC11168V1 strain challenge. The vaccine was a poor stimulator of secretory IgA.  
 Macrophage-like HD11 cells inflammatory response to the presence of C. jejuni 
K2-55 was not significantly different from their response to wild-type 81-176 when 
measured by qRT-PCR. The lack of Cia secretion and motility had no effect on 
expression of IL-1β, IL-2, IL-6, IL-8, IL, IL-10, IL-12β, or TLR5. A flgK mutant 
expressing the flagella up to the hook had a significantly lower expression of these genes. 
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Chapter I: Literature review 
 
1.1. Campylobacter 
 
1.1.1 Campylobacter biology: 
 The name Campylobacter is derived from two Latin words, campylo and bacter, 
which together means curved-rod. This reflects the microscopic appearance of 
Campylobacter as a Gram-negative bacterium that is spiral in shape, 0.2-0.5 µm wide and 
0.5-5µm long, and the initial classification as a Vibrio was based on its shape. 
Campylobacter could appear spherical or coccoid if it is in the state of viable but non-
cultureable form (VBNC). Transition to this form is the result of various stress conditions 
the bacteria might encounter including old bacterial culture that is depleted of nutrients. 
The presence of uni- or bi-polar flagella makes Campylobacter motile. The flagellum is 
2.6-3.9 µm in length and ~21 nm in width (Guerry, 2007). The motility of 
Campylobacter is a great asset in colonization of the intestinal tract of its host.    
 Campylobacter is microaerophilic, growing best in 3-15% oxygen (O2), and 
capnophilic as the best carbon dioxide (CO2) concentration for their growth is 3-5%. The 
genome size of C. jejuni is 1.6-1.7 Mbp with a GC ratio of ~30% (Parkhill et al., 2000). 
A distinct feature that might be involved in C. jejuni pathogenesis and immune evasion is 
the hypervariable regions in the genome sequence (Parkhill et al., 2000). Some C. jejuni 
strains harbor extra-chromosomal elements including plasmids and bacteriophages 
(Bacon et al., 2000)  
1.1.2 Campylobacter jejuni morphology: 
 Campylobacter jejuni is generally described as spiral in shape, but a growing 
culture of C. jejuni would have different shapes that predominate over the course of time 
(Griffiths, 1993; Tangwatcharin et al., 2006), making C. jejuni pleomorphic. When the 
culture is in the exponential phase, most of C. jejuni cells assume the typical short spiral 
morphology, but as the culture reaches the mid-stationary phase, cells are almost twice 
the length of exponential phase cells (Griffiths, 1993). As the culture ages further and 
enters the late-stationary phase, cells that are coccoid in shape become predominant, and 
the remaining spiral cells are 3-4 times the length of C. jejuni cells in the exponential 
phase (Griffiths, 1993).   
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1.1.3. Epidemiology of Campylobacter: 
 Campylobacter jejuni is estimated to be responsible for 90% of 
campylobacteriosis cases in humans, and C. coli for the remaining 10% (Janssen et al., 
2008), therefore most of the data available represent C. jejuni infections. The estimated 
number of campylobacteriosis cases varies from a country to a country with a range of 
12.7 cases/100,000 in the USA to a high of 396 cases/100,000 in New Zealand (Baker et 
al., 2007). These numbers are an estimate based on the number of cases reported and 
confirmed by laboratory tests then corrected to project an estimation of unreported cases. 
This estimation is very important since most cases of C. jejuni gastroenteritis are self-
limiting and usually unreported.  
C. jejuni infection is generally sporadic and in contrast to infections caused by 
other food-borne pathogens such as Salmonella and E. coli O157, outbreaks are rarely 
reported. The reported outbreaks are usually associated with drinking contaminated/ 
untreated water (Kuusi et al., 2005)  and consumption of raw milk (Teunis et al., 2005). 
1.2. C. jejuni and poultry: 
 Although C. jejuni has been isolated from all food-producing animals and pets, 
poultry products contaminated with C. jejuni remain the main source for human infection 
(Jorgensen et al., 2002). Studies have identified the consumption of poultry or poultry 
products as a risk factor for C. jejuni infections. This includes raw or undercooked 
chicken (Hopkins et al., 1984; Istre et al., 1984), cooked chicken (Harris et al., 1986), and 
chicken consumed or prepared in a restaurant or commercial production facility (Effler et 
al., 2001). Direct evidence for the role poultry plays came from two studies. The first 
study was conducted in Belgium after the dioxin crisis during the early summer of 1999, 
when the carcinogenic substance was found in the feed of poultry. A ban was issued and 
all poultry products were withdrawn from the market. During the period of poultry 
product ban there was a 40% reduction in the number of reported C. jejuni infections 
(Vellinga and Van Loock, 2002).  
The second evidence comes from Iceland, which had a low incidence of C. jejuni 
infections prior to 1996 (Stern et al., 2003). At this time, consumers had access to frozen 
poultry only, but after 1996 fresh poultry products became available. The incidence of C. 
jejuni confirmed cases increased from only 38 cases per 100,000 to reach a peak of 116 
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cases per 100,000 in 1999. Upon investigation, it was found that 62% of broiler carcasses 
were contaminated with C. jejuni (Stern et al., 2003). As a preventive measure, birds 
from poultry flocks testing positive were frozen and only birds from C. jejuni-free flocks 
were sold fresh. As a result, fresh chicken carcasses available for consumers which were 
contaminated with C. jejuni dropped to 16%. The corresponding drop in human cases 
was significant with only 33 per 100,000 cases in 2000 (Stern et al., 2003).   
These two pieces of evidence suggest strongly that poultry products are 
responsible for a significant proportion of human infections. The data collected through a 
Campylobacter screening project in The Netherlands further supports the hypothesis that 
poultry is a risk factor for Campylobacter infection. This project estimates that 20-40% of 
laboratory confirmed C. jejuni cases are linked to poultry consumption or handling 
(Janssen et al., 2008). The source of C. jejuni in the remaining cases (up to 50% of 
confirmed cases) is largely unknown, leaving the possibility of another major risk factor 
that might be involved or the combination of other minor factors unanswered.      
1.2.1. Sources of C. jejuni on the poultry farm: 
To develop an efficient control strategy, an understanding of the sources of C. 
jejuni colonization in broiler chickens is needed. There are many studies that have 
investigated the source(s) of C. jejuni on the farm (Barrios et al., 2006; Gregory et al., 
1997; Hald et al., 2008; Van Overbeke et al., 2006). These studies are very important in 
understanding the sources of C. jejuni infection but they have relied mainly on surveys 
and questionnaires rather than making use of genetic tools necessary for identifying the 
source of the infection and clonal relationship between the different isolates on the farm.  
Given the role broiler chickens play in transmission of C. jejuni to humans, most 
of the available studies have focused on this large segment of the poultry industry, 
making available information from other segments such as layers and turkeys limited. In 
this section, the various potential sources for C. jejuni infection of the poultry flock will 
be examined. 
It is generally accepted that the main source of C. jejuni transmission from the 
environment to poultry flocks is horizontal transmission. Drinking water, houseflies and 
beetles, general farm practices such as human movement and flock thinning, the presence 
of multiple broiler houses on the same farm, pets and wild life in the immediate vicinity 
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of the farm has been identified as some of the main risk factors according to a systematic 
review conduct by Adkin and colleagues that analyzed a 159 papers that investigated 
more than 1200 flocks from United States and Europe (Adkin et al., 2006). However, it is 
important to note that the presence of C. jejuni in the rearing environment of a poultry 
flock does not indicate that the flock will necessarily be colonized (Stern et al., 2001).  
1.2.1.1. Water: 
 Water chlorination is a common practice in the poultry industry. The chlorine 
dose used for water treatment is lethal for Campylobacter and contamination of water is 
usually detected only after the flock is shedding (Jacobs-Reitsma, 1995; Shane et al., 
1985). This suggests a minor role for water in introducing C. jejuni into the farm, but a 
potential role for spreading the bacteria within the same poultry house once several birds 
start shedding. 
1.2.1.2. Insects: 
 Houseflies and darkling beetles have been implicated in C. jejuni transmission. 
Consuming a single adult or larva darkling beetle infected with C. jejuni is enough to 
infect 90% of chickens under experimental conditions (Strother et al., 2005), illustrating 
the impact this pest can have as a vector not only for Campylobacter, but Salmonella as 
well (Skov et al., 2004).  
Fly traffic in and out of a broiler house has been shown to be a risk factor for 
transmission of C. jejuni. About 8% of the flies caught outside poultry houses in 
Denmark contained C. jejuni (Hald et al., 2004), with some flies carrying the same strain 
colonizing the chickens (Hald et al., 2004). When 20 broiler houses were under strict fly 
control using extra and double fly screens during the summer season of 2007 (Hald et al., 
2007), only 15.4% of the flocks were positive, compared to the control group with 
regular fly screens that was 51.4% positive for C. jejuni (Hald et al., 2007). 
1.2.1.3. General farm practices and human movement: 
 Poor hygiene-related practices, retaining used litter in the same poultry house, and 
flock thinning (depopulation schedule) are clearly a potential source of infection. 
Campylobacter has been isolated from the water of farms’ footbath, farmer’s boots, 
external clothes, and equipment (Jacobs-Reitsma, 1997; Stern et al., 2001). A study 
ranking the sources of Campylobacter infection in the United Kingdom has considered 
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flock thinning as the major source of infection (Adkin et al., 2006). Thinning is a 
common practice in the UK, as it lowers the density of the birds and allows the producer 
to supply the market demand for certain bird sizes. It requires personnel to enter the farm 
with their equipment, which have been found to be usually contaminated with C. jejuni 
(Newell, 2001), thus contaminating Campylobacter-free flocks, (Hald et al., 2001), and 
causing Campylobacter positive birds to be sent to market.  
 Biosecurity practices vary from farm to farm and this affects the probability of a 
farm being infected. The best example is the high percentage of colonized organic or 
free-range flocks compared to conventional reared flocks (Van Overbeke et al., 2006). In 
organic broiler production, birds must have access to open space, which probably leads to 
added fly and other insect exposure, which are highly correlated with C. jejuni 
transmission (Hald et al., 2004; Hald et al., 2008). Broiler chickens raised using organic 
guidelines had a significantly higher C. jejuni in their feces than broiler chickens from the 
same hatchery, which were raised within the same geographical area using conventional 
methods (Van Overbeke et al., 2006).        
1.2.1.4. Presence of animals other than poultry on the farm: 
 The presence of other animals on the farm or on its immediate surroundings has 
been identified as a risk factor for flock contamination in several studies (Bouwknegt et 
al., 2004; Kapperud et al., 1993; van de Giessen et al., 1992). The presence of cattle has 
the greatest impact on contamination of broiler flocks with Campylobacter when 
compared to other domestic animals (Gregory et al., 1997). When genotyping of flaA was 
carried out, Campylobacter isolated from chickens had the same flaA genotype as those 
isolated from cattle on the same farm were shedding (Stern et al., 1997). In another study, 
the same C. jejuni isolate found in cattle was detected in flies, rodents, the water of the 
farm, and the feces of sparrows from surrounding urban areas (Adhikari et al., 2004). In 
Alberta, when 46 bovine and 41human C. jejuni isolates obtained from the same 
geographical area within a short period of time were compared using comparative 
genomic hybridization, a high degree of similarity was found, leading to the division of 
these isolates into 13 clusters that mostly contained both cattle and human isolates 
(Hannon et al., 2008).  
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Wildlife might play a role in spreading C. jejuni as the droppings of wild birds 
near several farms contained C. jejuni, but the strains were usually different from the 
ones found colonizing the broilers on these farms (Craven et al., 2000).  
Although these studies clearly show that Campylobacter is widely spread on 
individual farms, it does not indicate which was infected first, the chickens or the other 
animals, but it is an indication of the potential contamination that might be caused by the 
presence of these animals and insects, and the role they might play in spread of the 
organism.   
1.3. Campylobacter interaction with avian and human hosts: 
 “If it was the responsibility of laboratory scientists to determine if Campylobacter 
spp. could become a food-borne pathogen, it would be deemed the least likely candidate. 
However, not for the first time, bacteria have proved scientists wrong, and 
Campylobacter spp. continue to be a serious public health threat.”  
      -Murphy et al. (Murphy et al., 2006) 
 
 The main source for human infections is handling and consumption of 
contaminated poultry meat. Campylobacter colonizes chickens with no apparent 
symptoms. No single source is solely responsible for the contamination of chicken flocks 
with Campylobacter. Once in contact with the host, Campylobacter has to overcome 
several host defense mechanisms to establish an infection, and it uses the same 
mechanisms both in human and avian hosts but with different outcomes. It is not well 
understood why the outcomes of the interaction are different. The lack of a reproducible 
animal model that exactly mimics the human disease remains the major obstacle in 
understanding the pathogenesis of human disease (Young et al., 2007). On the other 
hand, the tools available for studying the pathogenesis of C. jejuni in chickens are rather 
limited.  
C. jejuni posses a limited repertoire of typical virulence genes that are common to 
other enteric bacteria. These include the flagella and its secreted proteins (Guerry, 2007), 
cytolethal distending toxin (CDT) (Johnson and Lior, 1988), and capsule (Bacon et al., 
2001). C. jejuni has several attributes and genes that help the bacteria to survive in both 
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the host and the environment, including adhesins, acid resistance, heat and cold stress 
resistance (Butzler, 2004).  
In the following section, the mechanisms employed by C. jejuni during its course 
of interaction with the host will be discussed, and the outcome of interaction with an 
avian or a human host will be compared.  
1.3.1. Infection: 
 The clinical presentation of C. jejuni infection in humans is acute gastroenteritis 
with a varying degree of fever, diarrhea and abdominal cramps. In some cases, fresh 
blood, pus, or mucus may appear in the stool sample (Butzler, 2004). Diarrhea caused by 
C. jejuni ceases after 3 days, but it is not unusual for the abdominal cramps to occur after 
the diarrhea had stopped. The minimum infective dose that has been established in 
clinical studies is 500-800 bacterial cells (Black et al., 1988; Robinson, 1981), and the 
incubation period is typically 3-5 days, but incubation for as long as 10 days had been 
reported. Although most cases of C. jejuni infection do not require hospitalization and are 
usually self-resolved, a condition known as Guillain–Barré syndrome (GBS) is the most 
serious long term disorder caused by C. jejuni (Rhodes and Tattersfield, 1982; Yuki, 
2001). Guillain–Barré syndrome is an autoimmune disease caused by the antibodies 
generated in an immune response to C. jejuni lipooligosaccharide (LOS) (Yuki, 2001). 
These antibodies do not distinguish between LOS and human GM1 ganglioside; so long 
after C. jejuni infection has been cleared the antibodies will destroy the peripheral nerve 
tissue, leading to paralysis (Godschalk et al., 2007; Kuijf et al., 2007). The evidence of 
the role C. jejuni play in GBS is discussed in the Animal Models section below. 
Depending on the severity of the condition, GBS patients may be hospitalized, especially 
if the respiratory muscles are involved. If managed properly, most patients recover with 
good medical care (Douglas and Winer, 2006). Not all C. jejuni serotypes are associated 
with GBS, as molecular mimicry is limited to a number of serotypes such as HS:19 
(Kuroki et al., 1993). The presence of these serotypes or others that induce antibodies that 
cross-react with gagnliosides does not necessarily lead to development of GBS 
(Nachamkin et al., 1999), indicating a multifactorial process in which both host and C. 
jejuni play a role. Other immune-mediated diseases associated with C. jejuni infection 
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include reactive arthritis (Berden et al., 1979; van de Putte et al., 1980) and urethral 
inflammation known as Reiter syndrome (Rothe and Kerdel, 1991). 
Chickens display no symptoms upon infection with C. jejuni, although up to 1010 
colony forming units (CFU) might be present per gram of feces. The ability to colonize 
chickens varies greatly from  strain to strain, but under experimental conditions as little 
as 40 CFU of chicken-passaged C. jejuni were enough to cause maximal colonization 
(Cawthraw et al., 1996). Horizontal transfer from other poultry and the environment is 
probably the main source for infection (Wagenaar et al., 2006). Under field conditions, C. 
jejuni is not detected in newly hatched chicks,  but after 2-3 weeks of placement in a 
poultry barn it is readily detected (Newell and Fearnley, 2003). Once a few birds are 
infected on the farm, the high levels of C. jejuni shed in the feces of these birds, and the 
coprophagic nature of chickens accelerates the spread of the bacteria throughout the 
flock. 
1.3.2. Acid resistance:  
To establish infection, C. jejuni has to survive the acidity of the stomach in 
humans, and crop and gizzard in chickens. To date, no single gene has been found 
responsible for acid resistance; upregulation in expression profiles of several genes that 
are involved in production of heat shock proteins, and response to oxidative stress of C. 
jejuni recovered from the stomachs of orally inoculated neonatal piglets suggests that 
they play a role in resistance of C. jejuni to acid (Adhikari et al., 2004). 
1.3.3. Interaction with intestinal surfaces: 
 
C. jejuni colonizes the small intestine in the initial stages of the infection in 
humans, then establishes itself in the colon (Black et al., 1988). In chickens, the preferred 
site for colonization is the cecum, but C. jejuni has been isolated from other parts of the 
gastrointestinal tract, including small and large intestine and cloaca. The cecum of the 
chicken and the human colon are similar in the abundance of lactic acid and short-chain 
fatty acids (Clench, 1995), which allow C. jejuni to thrive. 
 Mucus is the main defensive barrier of the gastrointestinal tract. C. jejuni 
overcome the mucus layer in both humans and chickens using its corkscrew shape and 
darting motility C. jejuni (Guerry, 2007). The shorter than usual O-sidechain of C. 
jejuni’s LOS may also reduce nonspecific binding to glycopeptides of the intestinal 
9 
 
mucin layer (McSweegan et al., 1987; McSweegan and Walker, 1986). Avian mucus 
might be an important factor in the asymptomatic nature of the infection in chickens. 
Adding avian mucus to human primary intestinal cells significantly reduced the number 
of internalized cells compared to cells covered with mucus from human origin (Byrne et 
al., 2007). Once C. jejuni has overcome the mucus barrier, it will be in direct contact with 
the intestinal epithelial cells. 
1.3.4. Body temperature: 
One of the main differences between humans and chickens is core body 
temperature. Poultry generally maintain a range of 41° to 45 °C. A temperature-sensitive 
two-component regulatory system named RacR-RacS was found to be vital for 
colonization of wild-type in chickens and growth of C. jejuni at 42 °C (Bras et al., 1999). 
When C. jejuni cultures were transferred from 37° to 42 °C, almost 20% of genes were 
either up- or down-regulated (Stintzi, 2003), including genes involved in membrane 
structure modification and protein transport.     
1.3.5. Adherence:  
 Bacterial adhesion to the host cell surface occurs mainly by adhesin-receptor 
interaction. One of the common adhesion mechanisms enteric bacteria utilize to adhere to 
intestinal epithelial cells are pilli. C. jejuni has type II and IV secretory mechanisms, 
which are the main requirement for pilus synthesis, but its genome does not contain any 
pilus genes, and the only pilus-like structure reported using electron microscopy (Dolg et 
al., 1996) was proven to be an artifact caused by the media used  (Gaynor et al., 2001). 
Several proposed C. jejuni adhesins have been studied extensively in vitro and in vivo. 
The fact that heat-killed C. jejuni binds to cultured cells at the same efficiency that live 
bacteria bind  (Konkel et al., 1992a) suggests that the crucial adhesins are constitutively 
synthesized. The outer-membrane protein (OMP) CadF binds specifically to fibronectin 
(Fn)(Konkel et al., 1997). The 37 kDa protein was found to be conserved among 38 out 
of 40 C. jejuni isolates tested (Konkel et al., 1999a). In human colonic T84 cells, CadF 
binds to fibronectin on the basolateral surface (Konkel et al., 2005), and the binding 
domain was identified to be residues of phenylalanine-arginine-leucine-serine using 
enzyme linked immunosorbent assay (ELISA) (Konkel et al., 2005). C. jejuni binding to 
INT407 cells was inhibited when pre-incubated with the identified binding domain 
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(Konkel et al., 2005). The presence of CadF was found to be essential for both invasion 
in vitro and colonization of day-old chicks (Ziprin et al., 1999). 
 Two lipoproteins are suggested to play a role in C. jejuni adhesion, JlpA and 
CapA. The lipoprotein JlpA contains a signal peptide and an N-terminus lipoprotein 
processing site. The lipoprotein is crucial for binding to HEp-2 cells, as jlpA deletion lead 
to significant reduction in adhesion, and incubation of the C. jejuni with anti-JlpA 
antibodies reduced adhesion in a dose dependent relationship (Jin et al., 2001). Pro-
inflammatory factors, nuclear factor (NF)-κB and mitogen-activated protein (MAP) 
kinase were triggered in HEp-2 cells when incubated with JlpA (Jin et al., 2003).  
The surface localization of CapA was determined using immunogold electron 
microscope (Ashgar et al., 2007). The autotransporter is important for C. jejuni binding to 
Caco-2 cells (Ashgar et al., 2007), as capA mutant had significantly lower cell adherence 
and invasion abilities. A capA mutant was undetectable two weeks after the challenge of 
day-old chicks, while chickens challenged with wild-type remained colonized (Ashgar et 
al., 2007).   
 In conclusion, the experiments outlined above demonstrate that C. jejuni has 
multiple adhesins that play an important role of binding to human cell lines, and in 
colonization of chickens’ intestinal tract.  
1.3.6. Translocation, invasion, and intracellular fate: 
 Several studies have shown clearly that C. jejuni resides in intestinal epithelial 
cells during the course of infection. Since epithelial cells are non-phagocytic by nature, 
C. jejuni must be able to induce its own uptake. In this section, C. jejuni translocation, 
invasion, and intracellular fate in cells associated with intestinal epithelium will be 
discussed.   
 Van Spreeuwel and colleagues were able to detect C. jejuni in the biopsies of 22 
human patients that were confirmed positive by culture using a combination of 
immunohistochemistry and electron microscopy (van Spreeuwel et al., 1985).  The 
invasive bacteria resided mainly in colonic submucosa without any major disruption in 
the mucosa. This demonstrates the ability of C. jejuni to cross the epithelial layer and 
reside in the submucosa.  
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 Macaca mulatta monkeys orally challenged with 2.7 X 1010 CFU of C. jejuni 
showed clinical signs of campylobacteriosis including diarrhea (Russell et al., 1993). 
When colonic samples were inspected using electron microscopy, C. jejuni were found to 
be located both extracellularly in the mucosa and submucosa, and intracellularly, either in 
a membrane-bound vacuole, or free in the cytoplasm. The researchers also noticed 
structural damage to the epithelial cells, some of which had undergone apoptosis (Russell 
et al., 1993).  
 Enterocytes obtained from the small intestine of newly born piglets have been 
used as a primary cell line to study the invasiveness of C. jejuni clinical isolates. C. jejuni 
invaded the cells at a higher rate than an E. coli control strain as judged by recovery rates 
of bacterial cells using bacterial culture (Babakhani and Joens, 1993).        
    Taken together, these three experiments demonstrate that C. jejuni has the 
potential to invade epithelial cells in vivo or in primary cell lines. However, little is 
known about the factors that induce bacterial internalization and the mechanisms that are 
used by the cell to take up the bacteria.   
The ability of C. jejuni  to translocate was studied in polarized Caco-2 as these 
cells more closely resemble the human intestine to a much better extent than other 
available cell lines (Everest et al., 1992). When 33 different C. jejuni isolates were 
studied, C. jejuni from clinical isolates were able to translocate at a much higher 
frequency (86%) than non-clinical isolates (48%) (Everest et al., 1992), indicating a 
strain-to-strain variability. 
 It is not clear which mechanism is preferably used by C. jejuni to translocate 
across the epithelial cell barrier. Translocation of C. jejuni is inhibited at 20 °C (the 
temperature that inhibits the host endocytic pathway) (Konkel et al., 1992b), and 
scanning electron microscope images show cellular pseudopods extending towards and 
enveloping the bacteria (Biswas et al., 2000), suggesting that C. jejuni can translocate 
using a trans-cellular route. C. jejuni also disrupted the epithelial barrier and induced the 
production of pro-inflammatory cytokine response in polarized T84 colonic cells (Chen 
et al., 2006),indicating the possibility of a para-cellular route as well.  
Additional in vivo strategies may be utilized by C. jejuni to translocate across the 
epithelium. Microfold cells (M cells), which are found in follicle-associated epithelium 
12 
 
and specialize in antigen sampling, have been shown to taken up C. jejuni in rabbits 
(Walker et al., 1988). The mechanism C. jejuni preferably uses to cross the intestinal 
epithelial barrier in humans remains unknown (Young et al., 2007). 
Several studies have investigated the role that some of C. jejuni components may 
play to induce internalization, but most of these factors have been studied based on the 
reduction in the ability of their corresponding mutants to colonize. Most of these 
mutations have a limited impact on C. jejuni’s invasion ability, which indicates that these 
factors are indirectly involved in colonization. In Salmonella enterica serovar 
Typhimurium, dozens of different mutations had an indirect impact on invasion ability of 
the bacteria by affecting functions that support the invasion but are not directly involved 
in it, including some Type three secretion system (T3SS) effector molecules (Coburn et 
al., 2007). Applying these findings to C. jejuni, a limited number of factors have an 
impact large enough to be considered detrimental to internalization. An example of the 
factors directly related to invasion is the flagellum, which is discussed in more detail in 
the following section. An example of factors indirectly related to invasion is the C. jejuni 
capsule, which is critical for attachment to cell lines (Bacon et al., 2001). Capsule 
mutants have reduced invasion ability, which might be a side effect for the reduction of 
attachment ability of C. jejuni (Bacon et al., 2001; Watson and Galan, 2008).     
The systemic spread of C. jejuni in humans beyond the intestinal tissues is 
limited. Based on current literature, septicemia is uncommon during campylobacteriosis 
in humans, occurring in only 0.4% of the cases (Allos and Blaser, 1995). 
In chickens, C. jejuni is believed to mainly reside in the lumen and mucus layer of 
the cecum rather than invading cells (Beery et al., 1988). The bacteria comes in close 
contact with epithelial cells with no apparent adhesion or invasion (Beery et al., 1988). 
This is intriguing since C. jejuni was found in the internal organs of broiler chickens 
(Dhillon et al., 2006) and broiler breeders (Cox et al., 2006). Clearly, C. jejuni has to 
come in close proximity and somehow be able to translocate across the intestinal 
epithelial barrier to be able to spread systemically; however, there is no direct evidence of 
which mechanism is being used for this purpose. 
Many bacterial pathogens incorporate intracellular survival mechanisms as a part 
of their pathogenesis in an attempt to manipulate the host to their advantage. Some, like 
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Listeria monocytogenes, will break out from the phagocytic vacuole where they reside 
and replicate in the cytosol (Drevets and Bronze, 2008). Others, like Mycobacterium 
tuberculosis, will prevent phago-lysosomal fusion which is a critical step in killing 
invading bacteria (Pieters, 2008). Finally, some will live in membrane-bound 
compartment, such as Legionella pneumophila, which resides in a compartment known as 
the Legionella-containing vacuole (LCV) inside the macrophage. This vacuole provides a 
safe niche where it can replicate safely until large numbers of bacteria burst out of the 
vacuole and spread the bacteria through repetitive cycles of invasion and replication 
(Shin and Roy, 2008).   
C. jejuni is capable of invading host cells, but most studies concluded that its 
intracellular fate is affected by the strain to strain variability. Using different cell lines 
and different culture methods for recovery of the bacteria, it is generally thought that C. 
jejuni is not viable after 24 hours of internalization. Using Fluorescent Cell Sorter 
Analysis (FACS) and staining for viability, Watson and Galan demonstrated that C. jejuni 
remains viable although it is not recoverable using routine laboratory culturing 
methodologies (Watson and Galan, 2008). When invasion/survival assays were 
conducted by growing C. jejuni under oxygen-limiting conditions, bacterial counts were 
not significantly reduced after 24 hours of internalization, indicating that C. jejuni can 
survive in intestinal epithelial cells for a period of 24 hours. It however, undergoes 
metabolic changes that require growth conditions that are different from those provided 
by the methods used routinely in the laboratory (Watson and Galan, 2008). This 
physiological shift probably reflects C. jejuni response to the low concentration of 
oxygen intracellularly (Watson and Galan, 2008).   
Where C. jejuni resides once it is internalized is crucial for intracellular survival. 
An early report has suggested that C. jejuni 81-176 resides within a membrane-bound 
vacuole after internalization into Caco-2 cells (Russell and Blake, 1994). A more recent 
report shows that C. jejuni deviates from the regular canonical endocytic pathway in non-
phagocytic cells to reside in a unique compartment; therefore, avoiding phago-lysosome 
fusion (Watson and Galan, 2008). The fate of C. jejuni is very different in bone marrow-
derived macrophages, as it is delivered directly to lysosomes and killed (Watson and 
Galan, 2008). In human monocytic cells, C. jejuni strain 81-176 is capable of survival 
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and even replication to increase recovered bacterial counts by 3 logs (Hickey et al., 
2005). C. jejuni survives well in chicken epithelial cell lines including primary cecal 
epithelial crypt cells (Van Deun et al., 2007) and chicken kidney cells (CKC) (Smith et 
al., 2005). C. jejuni ability to survive in avian macrophages varies from strain to strain, 
but C. jejuni is generally killed within 24 hours and could be killed within 6 hours when 
cultured with chicken peritoneal macrophages (Myszewski and Stern, 1991) 
1.4. Campylobacter flagellum:  
 The flagellum is a locomotory organelle that propels C. jejuni in a direction 
dictated by chemical signals received from the environment (Guerry, 2007). It plays a 
vital role in C. jejuni colonization, transmission from host to host, and secretion of 
various proteins. The presence of C. jejuni flagellum has consistently been linked to 
virulence; that is why it is probably the most studied structure of the organism.   
There are at least 8 proteins that share significant structure and sequence 
similarities between Type Three Secretion System (T3SS) and the flagellum (Van 
Gijsegem et al., 1995). Several studies suggest that the flagellum and T3SS share a 
common evolutionary ancestor (Kubori et al., 1998; Marlovits et al., 2004). However, it 
is not clear which is more ancient, as some studies suggest that the flagellum is more 
ancient (Liu and Ochman, 2007), while there is a considerable evidence in the literature 
that indicates that T3SS is more ancient (Journet et al., 2005). 
 In the following section, flagellar and T3SS structure, function, and the role they 
play during pathogenesis will be discussed.  
1.4.1 Flagellar structure: 
 Each flagellum is composed of a basal body, motor complex, a switch for the 
motor complex, hook, junction proteins that bind the hook to the long filament, and a 
filament cap. The motor complex generates motility by switching the flagellum from one 
side to the other. The filament is a helical, long, thin structure that extends outside the 
bacterial cell surface. Flagellar subunits (or building blocks) are called flagellin. The C. 
jejuni flagellum is composed of two flagellin subunits, FlaA, and FlaB, which makes it 
more complex than E. coli’s which is a monomer. Both FlaA and FlaB are synthesized at 
the same time, but flaA is expressed much more than flaB (Nuijten et al., 1991). 
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Regulation of flaA expression is controlled by σ28 (Nuijten et al., 1991), while flaB 
expression is regulated by σ54 (Hendrixson et al., 2001). There are two reports with 
different outcomes regarding the flaA-flaB+ mutant. In one report, the mutant had a 
truncated flagellum (Wassenaar et al., 1991), while in another, the mutant had a full-
length flagellum and was as motile as the wild-type, suggesting that a shift might occur in 
the expression to have one gene predominantly expressed at a given time (Wassenaar et 
al., 1994).        
1.4.2. Structural and functional relationship of Type Three Secretion System (T3SS) 
and flagellum: 
The C. jejuni flagellum extends from the cytoplasm to the cell exterior. The major 
extracellular component of a flagellum is a rotating filament that is connected to a basal 
body that provides rotary motor function via a small curved structure known as the hook. 
All the external proteins that are involved in the formation of the hook and the filament 
have to be exported sequentially (Macnab, 2003). C. jejuni employs a flagellar T3SS 
pathway that exports these structural proteins, and secretes virulence factors that are not a 
component of the flagellum extracellularly (Konkel et al., 1999b). Y. enterocolitica 
secretes a phospholipase (YplA) that contributes to its survival in host tissues during 
infection mainly through its flagella, and also through the other T3SS it harbors (Schmiel 
et al., 1998). Salmonella enterica serovar Typhimurium secretes two effectors SptP and 
SopE occasionally through the flagella T3SS rather than SPI1 secretion system (Lee and 
Galan, 2004). The secretion of these effectors through more than one T3SS reveals that 
these systems are not only structurally related, but they share a common protein targeting 
mechanism (Warren and Young, 2005).  
1.4.3. Proteins secreted by flagellar export apparatus: 
 C. jejuni produces three sets of proteins that are exported via flagellar T3SS and 
play a role in pathogenesis. These include Campylobacter Invasion Antigens (Cia), 
Flagella Secreted Proteins (Fsp), and FlaC. Overall, C. jejuni secretion mechanisms are 
poorly understood compared to those of other enteric bacteria. Campylobacter invasion 
antigens consist of at least 8 different proteins (CiaA-H) (Konkel et al., 1999b). The only 
Campylobacter invasion antigen with a known corresponding gene is CiaB, a 73-kDa 
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protein, is important in internalization of C. jejuni into INT407 cells (Rivera-Amill and 
Konkel, 1999) and colonization of chicken’s ceca (Ziprin et al., 2001), as a ciaB mutant 
has a reduced ability to invade INT407 cells (Rivera-Amill et al., 2001) and reduced 
ability to colonize the chicken’s ceca (Ziprin et al., 2001). Campylobacter invasion 
antigens secretion requires a stimulatory signal that can be induced in vitro by growing  
C. jejuni in the presence of INT407 cell line (Konkel et al., 1999b), adding bile salts or 
serum-free media (Rivera-Amill et al., 2001; Rivera-Amill and Konkel, 1999), chicken 
mucus (Biswas et al., 2007b), and chicken or bovine serum (Biswas et al., 2007b). 
Secretion of these proteins requires the presence of one of the two flagellar filaments, 
FlaA or FlaB (Konkel et al., 2004).  
A recent experiment conducted by Pacheco and Konkel proved that CiaB could be  
secreted through a heterologous T3SS (Pacheco and Konkel, 2008). The researchers 
transformed Yersinia enterocolitica with a vector that expresses ciaB. The bacteria had 3 
different T3SS’s, including a flagellar T3SS that could be separately induced under 
certain culture conditions.  Under conditions that induced the flagellar T3SS, CiaB was 
detected in the supernatant of the bacterial culture using polyclonal anti-CiaB serum. A Y. 
enterocolitica flagella mutant did not secrete the protein, but the cell lysate contained the 
protein, indicating that the protein was produced but not secreted. This is strong evidence 
that CiaB is secreted through the flagella, and that the flagella acts as T3SS since a 
heterologous T3SS could secrete the protein (Pacheco and Konkel, 2008).  
Flagella secreted protein A (FspA) is another C. jejuni flagella secreted protein 
(Poly et al., 2007). When 41 C. jejuni isolates were tested, FspA was detected in all of 
them, and  two variants (FspA1 and FspA2) that share only 33% similarity were found 
(Poly et al., 2007). In contrast to Cia proteins, secretion of FspA requires minimal 
flagellar structure (expression of a flagellar structure up to the hook protein), and occurs 
simply when the bacteria is grown in broth (Poly et al., 2007). The exact role that FspA 
plays during infection is unknown, but when INT407 cells were incubated with  
recombinant FspA2, the protein bound to the cells and induced apoptosis (Poly et al., 
2007). When recombinant FspA1 was given as an intranasal vaccine to BALB/c mice, 
57.8% were protected against intranasal challenge with a homologous C. jejuni 81-176 
strain (Baqar et al., 2008). A much less characterized protein, FlaC, is secreted through  
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Fig 1.1: Comparison of bacterial flagella and T3SS structures. (A) The upper schematic 
drawing illustrates the main similarities between the flagellum and T3SS, which includes 
the outer membrane and cell membrane rings, the hook in the flagellum and the rod of 
T3SS needle that extend from bacterial surface (Macnab, 2003). (B) Main flagellar 
components as seen by EM (Jones et al., 1990). (C) Electron microscope image of needle 
complexes of T3SS. The needle is 80 nm long and 13 nm wide, and it is a stiff, straight 
tube, in contrast to the flagellum, which is bent (Kubori et al., 1998). Figs A, B, and C are 
taken directly from (Macnab, 2003).    
 
 
A 
B C 
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the flagellar secretion apparatus as well (Song et al., 2004). The FlaC protein is 70% 
similar to FlaA over a stretch of 40 amino acids, but is much smaller in size.  
The secretion of FlaC requires a functional flagellar T3SS. For FlaC to be 
secreted extracellularly, the expression of the flagellum up to the hook is required (Poly 
et al., 2007). A fliG mutant (null-flagellar mutant) expressed but did not secret FlaC (Poly 
et al., 2007). A flaC insertion mutation produces a fully motile mutant but with reduced 
ability to invade HEp-2 cells (Song et al., 2004). The role FlaC might play in 
pathogenesis is unknown.          
 In conclusion, proteins secreted through Campylobacter flagellar export apparatus 
stimulate host cell signaling, internalization of bacteria, apoptosis, and are critical to 
colonization of the ceca of chickens. The role of Campylobacter invasion antigens, 
flagella secreted proteins, and FlaC are summarized in Table 1.1. To date, direct evidence 
for the injection of these proteins into the host cell is lacking.  
1.4.4. Role in pathogenesis: 
 Both flagella and T3SS play an important role in establishing the bacterial 
colonization in the host. Type III secretion system is critical for delivery of the effector 
molecules into the eukaryotic cell. The flagellum provides motility, which is a well 
established virulence factor for C. jejuni and this is critical in cell invasion (Carrillo et al., 
2004; Yao et al., 1994). Mutations that abolish motility or the complete flagellar structure 
almost completely inhibit internalization. At the same time, flagellum serves as an export 
apparatus for flagellar secreted proteins, which are involved in internalization into host 
cells as discussed above (Konkel et al., 1999c). 
 Two other unique features of C. jejuni flagellum help in evading the immune 
system. A mutation in the epitope which interacts with Toll-like receptor 5 (TLR5) that 
prevents activation of TLR5 signaling pathway (Watson and Galan, 2005). This gives the 
bacteria a major advantage early in the infection as it delays induction of the innate 
immune system.  Secondly, the glycosylation of flagellar filament creates an 
antigenically diverse population of C. jejuni that eludes the adaptive immune system as 
discussed below. 
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 Campylobacter 
Invasion 
Antigens 
Flagella Secreted 
Proteins 
Flagellin 
Proteins 
secreted 
At least 8 proteins 
Cia A-H 
FspA, with two variants: 
FspA1 and FspA2 
FlaA, FlaB, and FlaC 
Size 12.8-108 kDa 
CiaB 73 kDa 
15.5 kDa 26 kDa 
Required 
flagellar 
structure 
Fully functional 
flagellum (either 
FlaA or B) 
Minimal flagellar 
structure 
(up to the hook) 
Minimal flagellar 
structure (up to the 
hook) 
Function - Modify cell 
behavior 
- Enhance 
invasion of host 
cell 
- Induce apoptosis of  
INT407 cells 
- protection of mice 
vaccinated intranasally 
with FspA2 
FlaA, B: flagellum 
building blocks 
 
FlaC: might play a role 
in invasion 
Stimulatory 
signal 
FBS, bile salts, or 
presence of 
eukaryotic cells 
Normal growth conditions 
in broth stimulate 
secretion 
Normal growth 
conditions in broth 
stimulate secretion 
Effect of 
mutation 
-Reduced INT407 
invasion 
-Reduced cecal 
colonization 
No observed effects on 
adherence or invasion of 
INT407 
FlaC: 
- Reduced HEp-2 cells 
invasion 
- No effect on motility 
and morphology 
Table 1.1: Proteins secreted by C. jejuni flagellar T3SS. Three groups of proteins secreted 
through flagellar T3SS have been identified. Flagellin (the main structural unit of 
flagellar filament), Campylobacter invasion antigens (Cia), and Flagella Secreted 
Proteins (FSP).  
FBS: Fetal bovine serum, Cia: Campylobacter invasion antigens, Fsp: Flagella secreted 
protein, Fla: flagellin. 
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1.5. Immune response to C. jejuni infection: 
 Given the widespread presence of C. jejuni in fresh poultry and other food 
products, the number of campylobacteriosis cases would be expected to be higher than 
what is reported (Janssen et al., 2008). The role played by the host to combat infection is 
as critical as the virulence attributes of the infecting C. jejuni strain in determining the 
clinical outcome. In the following sections the role of innate and adaptive immune 
response in the light of present literature is discussed.  
1.5.1 Innate immune response to C. jejuni infection: 
 The innate immune system represents the first line of defense against pathogens. 
C. jejuni has an array of mechanisms to delay or avoid detection by immune system. Two 
unique features of the C. jejuni flagellum are directly involved in immune evasion. The 
first is an alteration in the structure of the area recognized by TLR5 that evades 
flagellum-mediated stimulation of TLR5 (Watson and Galan, 2005). The other feature is 
the heavy glycosylation of the flagella, which is thought to play a role in immune evasion 
(Szymanski et al., 1999). C. jejuni is a poor Toll-like receptor 9 stimulator, and this is due 
to its AT-rich genome that lacks the unmethylated CpG dinucleotides necessary for TLR9 
activation (Dalpke et al., 2006). Chickens contain TLR orthologues, but their stimulation 
by C. jejuni has not been studied yet.  
 C. jejuni induces the expression of several pro-inflammatory cytokines in both 
humans and chickens. Production of IL-8 results in the activation of several cellular 
immune mechanisms. C. jejuni induces IL-8 production in both human epithelial cells 
and chicken intestinal primary cell lines (Borrmann et al., 2007). Another pro-
inflammatory cytokine, IL-1β, is induced by C. jejuni in human and chicken cells (Jones 
et al., 2003). Production of IL-6, iNOS, and nitric oxide are stimulated in HD11 cells and 
CKC (Smith et al., 2005). Incubation of  either live or heat-killed C. jejuni with HeLa 
cells activated NF- κB (Jones et al., 2003). The activation process is not immediate, and 
takes a minimum of 16 hours. The activation of NF- κB by C. jejuni in human cells is not 
surprising, as gastroenteritis is the main clinical manifestation of campylobacteriosis, and 
many of the pro-inflammatory genes mentioned above are activated by NF- κB. Dendritic 
cells produce IL-1β, IL-6, IL-8, IL-10, and a high level of IL-12 after internalization of 
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live or heat-killed C. jejuni (Hu et al., 2006). The high levels of IL-12 indicates a Th1 
polarized immune response in humans (Hu et al., 2006). Although cytokines are induced 
during C. jejuni infection, the disease outcome in chickens is very different. It is possible 
that the response in chickens is local or brief, preventing any lesion formation or further 
recruitment of inflammatory cells. Another possibility is that the immune response to C. 
jejuni is somehow redirected towards tolerance. This is supported by the inability of most 
live or killed vaccines to protect chickens from colonization, but when attenuated 
Salmonella expressing C. jejuni antigen CjaA was used as a vaccine, the CFU/g of feces 
in the ceca of challenged birds were lowered by more than 6 logs, indicating a potent and 
protective immune response (Wyszynska et al., 2004).       
1.5.2. Adaptive immune response to C. jejuni infection in humans: 
 Antibodies are detected by the second week after infection in humans. These 
antibodies are directed against several major C. jejuni antigens, including LOS (Mills and 
Bradbury, 1984) , major outer-membrane protein (MOMP) (Kervella et al., 1992), and 
flagellin (Cawthraw et al., 1994). Levels of IgM, IgA and IgG  peak within 8-14 days 
post-infection (Blaser and Duncan, 1984). Activity of IgM and IgA is relatively short 
lived, as IgA returns to a basal level within 20 days, and IgM gradually decreases within 
two months to a basal level (Cawthraw et al., 2002). In contrast, IgG activity declines 
over the period of one year (Cawthraw et al., 2002). Three main observations suggest that 
antibodies might provide some protection. The first evidence is that human volunteers re-
challenged with C. jejuni had relatively milder clinical symptoms using a homologous 
challenge (Black et al., 1988). The second evidence is that breast milk with high maternal 
anti-Campylobacter IgA has been shown to be related to protection in young children 
against C. jejuni infection (Renom et al., 1992). Finally, reports of asymptomatic carriers 
in developing countries where people are constantly exposed to C. jejuni suggest that 
antibody formation might be protective (Blaser et al., 1985).    
1.5.3. Adaptive immune response to C. jejuni infection in chickens: 
 As discussed in the innate immune response section, a C. jejuni infection does not 
induce any inflammatory signs in the gut or any pathology regardless of the age at the 
time of infection despite its large numbers per gram of feces. In contrast to humans, an 
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antibody response takes a longer time to develop and IgM, IgG, and IgA antibody activity 
generally increases in the serum after two weeks of a challenge (Rice et al., 1997; Sahin 
et al., 2003). Secretory IgA level takes a longer time to increase as it is usually detected 
only after 3 weeks of an oral challenge (Myszewski and Stern, 1990; Rice et al., 1997).   
 Broiler breeders infected with C. jejuni deposit large amounts of anti-
Campylobacter antibodies into their eggs (Sahin et al., 2002; Sahin et al., 2001). When 
they hatch, day-old chicks contain maternal antibodies that can recognize several outer-
membrane proteins (Sahin et al., 2001). These maternal antibodies have bactericidal 
activity in vitro (Sahin et al., 2001), and might play a role in delaying colonization of 
day-old chicks. Colonization of chicks hatched from infected breeders was delayed by 2-
4 days compared to chicks from non-infected ones (Sahin et al., 2003).    
1.6. Preventing C. jejuni carriage by broiler chickens: 
 Several methods have been proposed to reduce or eliminate C. jejuni in the final 
poultry product available to the consumer. Epidemiological modeling predicts that the 
maximum reduction in human infections with C. jejuni could be achieved by preventing 
or lowering the infection of chickens on the poultry farm (de Zoete et al., 2007). The 
ubiquitous nature of C. jejuni, as discussed above, makes control by biosecurity alone 
very difficult. Since the biosecurity barrier could be easily breached, it is important to 
have other measures that protect chickens from being colonized. A limited number of 
preventive measures have been explored, including vaccination, competitive exclusion, 
and breeding birds that have a Campylobacter-resistant background.  
1.6.1. Campylobacter-resistant chickens: 
Naturally Campylobacter-resistant chickens have been reported in several inbred 
lines (Boyd et al., 2005). If a genetic locus that is strongly correlated with persistent 
reduction in Campylobacter colonization could be identified, chickens might be selected 
for this trait. However, it is a common observation during experimental infection of 
broiler chickens that the cecal colonization levels are different from one bird to the other 
and from one experiment to the next. More in-depth studies are needed to determine the 
efficacy and the feasibility of this approach, especially if the genetic trait encoding for 
resistance interferes with weight gain or feed conversion efficacy.  
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1.6.2. Competitive exclusion: 
Competitive exclusion is the protective effect of non-pathogenic bacterial flora in 
limiting pathogenic bacteria colonization. Competitive exclusion has been used in the 
poultry industry to control foodborne pathogens such as Salmonella with an acceptable 
level of success. Several attempts to use competitive exclusion with Campylobacter had 
different outcomes. Mead and colleagues tested two different mixtures, defined 
aerobically grown bacteria from the ceca of Campylobacter-free laying hens, and an 
undefined anaerobic mixture grown from the same source (Mead et al., 1996). The 
anaerobic bacteria mixture significantly reduced colonization with C. jejuni after oral 
challenge. Another study by Hakkinen and Schneitz showed promising results when a 
commercial competitive exclusion product that is designed to target Salmonella also 
protected against Campylobacter colonization in broiler chickens (Hakkinen and 
Schneitz, 1999). Despite the success of these experiments, other competitive exclusion 
products did not protect against Campylobacter colonization (Aho et al., 1992). The exact 
mechanism of protection against Campylobacter is not clear, but bacteriocins produced 
by other bacteria might be the main factor in protection (Stern et al., 2005). When the 
bacteriocin of Paenibacillus polymyxa was purified, microencapsulated in 
polyvinylpyrrolidone, and added to the feed of broiler chickens it prevented colonization 
by Campylobacter as the challenged group had no detectable Campylobacter in their 
cecal contents (Stern et al., 2005). The limited number of studies and the unknown 
impact of bacteriocins on chicken’s microflora are a limiting factor in recommending this 
approach, for the time being, as a solution to Campylobacter colonization of broiler 
chickens.  
1.7. Vaccination: 
A protective vaccine against C. jejuni in broiler chickens must be safe, cost 
effective, and produce protective immunity quickly and as early as possible given the 
short life span of broiler chickens. As well, it should protect against several strains, as the 
same flock will likely be colonized by more than one strain, as discussed earlier. 
Epidemiological modeling predicts that a reduction by 3 logs in the level of C. jejuni 
shedding by broilers should significantly reduce human infection (de Zoete et al., 2007). 
1.7.1. Role of antibodies in protecting against C. jejuni infection: 
24 
 
 As discussed above in the adaptive immune response section,  chickens hatched 
from a breeder infected with C. jejuni will start shedding 2-4 days after chickens hatched 
from non-infected breeders (Sahin et al., 2003). Chickens that had no maternal antibodies 
are easier to infect as the required dose for infection was 50% less than chickens with 
maternal antibodies. As proof of principle, this demonstrates that maternal antibodies 
play a role in protecting hatched chicks for the first few days in their life, and it confirms 
that an adaptive immune response induced by a vaccine might be protective. 
1.7.2. C. jejuni experimental vaccines tested to date: 
 To date, there is no licensed vaccine against C. jejuni in broiler chickens. The 
vaccines that have been studied or are being developed are whole-cell killed or live 
attenuated vaccines, flagella-based vaccine, and subunit vaccine.  
1.7.2.1 Whole-cell vaccines: 
 Whole-cell vaccines are an attractive choice for vaccination since they are 
relatively cheap and easy to produce, and are generally considered safe to use (Walker, 
2005). Unfortunately, whole-cell vaccines have had  limited success in protecting broiler 
chickens against colonization with C. jejuni. This is contrary to the results obtained with 
WCV used against other enteric pathogens (Walker, 1999, 2005).  
 Rice et. al used formalin inactivated C. jejuni whole-cell vaccine to vaccinate day-
old broiler chickens (Rice et al., 1997). Each dose contained 1x109 CFU and chickens 
were vaccinated multiple times. When chickens were challenged using a seeder model (a 
small group of infected chickens housed with non-infected ones), the maximum reduction 
in colonization in the vaccinated group compared to those non-vaccinated was 1.5 logs. 
The addition of E. coli heat-labile toxin (LT), which acts as a mucosal adjuvant, did not 
enhance the immune response (Rice et al., 1997). Billiary IgA levels did not increase 
after vaccination, but using Western blots, IgA from vaccinated chickens detected more 
C. jejuni antigens than that from non-vaccinated chickens.  
 A whole-cell vaccine made of 1x1010 formalin killed CFU in Freund’s complete 
adjuvant administered subcutaneously elicited a high antibody titer (Glunder, 1995), but 
there was no significant difference between the shedding of vaccinated and non-
vaccinated chickens challenged using a homologous strain (de Zoete et al., 2007). A high 
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antibody titer was also obtained using heat-killed C. jejuni in ovo (Noor et al., 1995). 
Embryos were vaccinated at day 16 of incubation, and 7 days post-hatch. Although IgG 
antibody titers decreased after the booster dose, which might have resulted from the 
neutralizing effect of the vaccine antigen, IgA titers in bile and intestinal scrapings had 
increased significantly (Noor et al., 1995). Immunized chickens were not challenged, 
therefore it is unknown whether these high antibody titers were protective or not.  
1.7.2.2. Subunit-based vaccines:   
 Flagella/flagellin and outer membrane proteins (OMPs) were tested as vaccine 
candidates against C. jejuni infection based on their predominant immunogenicity. It is 
assumed that an immunogenic antigen would lead to an immune response that is 
protective for chickens.  
 A vaccine made of purified flagellin or flagellin combined with heat killed C. 
jejuni administered twice intraperitoneally at days 16 and 29 of age was able to reduce 
the intestinal colonization with C. jejuni (Widders et al., 1996). The combination of 
flagellin and heat-killed C. jejuni resulted in a higher IgG and IgM in serum and a higher 
IgG in the intestine than flagellin alone.    
 Khoury and Meinersmann developed a recombinant flagellin-based vaccine 
(Khoury and Meinersmann, 1995). The flaA gene was cloned in-frame with the B subunit 
of E. coli heat labile toxin (LT-B). The protein fusion was expressed in E. coli, purified 
and administered intramuscularly and orally in different doses. Not all the birds 
responded to vaccination, with only 75% containing FlaA antibodies in their intestinal 
secretion. The researchers vaccinated a group of birds twice at 2 and 4 weeks of age and 
challenged them orally at 3 weeks of age with 2 X 108 CFU. The vaccinated group had 
27.6% of the birds colonized by the end of the experiment, while 49.3% of control birds 
remained colonized.  
  Immunization with plasmid DNA that contain the flaA gene gave results that are 
within the same range of other flagella-based vaccines (de Zoete et al., 2007). Although 
vaccinating the birds intramuscularly twice on day 2 and 18 did not induce any detectable 
antibodies, birds challenged had approximately a 2 log reduction of C. jejuni carriage in 
the intestinal tract when compared to controls. 
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 An attenuated S. enterica serovar Typhimurium strain expressing the CjaA 
protein was able to reduce C. jejuni colonization of chickens by ~ 6 logs compared to 
control. Both CjaA and CjaC are putative ABC transporter proteins that are strongly 
immunogenic (Raczko et al., 2004). When 30 clinical isolates of C. jejuni were tested 
using hybridization, the genes cjaA and cjaC were found in all of them (Pawelec et al., 
2000). The researchers selected CjaA to be constitutively expressed in Salmonella and 
vaccinated 20 chickens twice at 2 and 14 days of age. Serum IgG and mucosal IgA levels 
against both CjaA and Salmonella increased as detected by ELISA. Chickens were 
challenged at 4 weeks of age and had significant reduction with only three of the 20 
chickens shedding C. jejuni that was above the detection level (1x103 CFU/g) of the 
selective media used over the period of 12 days. The experiment lacked a third group that 
should have received a Salmonella strain with the plasmid only which expressed no CjaA 
protein. This would have determined precisely the role of Salmonella induced immune 
response in protection against C. jejuni. This vaccine has a great potential as it provide a 
significant reduction in C. jejuni cecal counts of the vaccinated birds and induces an 
immune response against Salmonella.      
 Although a flagellin-based vaccine induced an immune response, the majority of 
antibodies generated are not directed towards surface epitopes but rather the unexposed 
flagellar structure (Widders et al., 1998). The post-transcriptional modifications of C. 
jejuni flagella (Doig et al., 1996) may influence the efficiency of a flagellin-based 
vaccine as at least 16 flagellar pseudaminic acid (PseAm) residues varies in amount and 
form. Antibodies formed against these residues on one flagellum may not necessarily 
recognize PseAm residues on another (Logan et al., 2002).  
 The dampened immune response induced by whole-cell vaccines or live- 
attenuated C. jejuni vaccine might be the result of either limited exposure to the immune 
system and antigen presenting cells, as some live-attenuated strains are cleared quickly, 
or the absence of certain structures that might be necessary for a more rigorous immune 
response but are not produced under the vaccine growing conditions, such as 
Campylobacter invasion antigens and other flagella-secreted proteins. Even with natural 
infection with C. jejuni, the chicken’s immune system takes a relatively long time to 
respond and produce an adaptive immune response as discussed above. To enhance the 
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efficacy of a vaccine, a stronger and a faster immune response would be useful. This was 
achieved using the attenuated Salmonella vaccine (Wyszynska et al., 2004). Other types 
of recombinant vaccines, including genetically engineered pox virus and adenovirus, 
might be as efficient in exposing the antigens to the chicken’s immune system and 
therefore induce a better immune response, as these vaccines have protected against an 
array of poultry disease including Newcastle disease (Perozo et al., 2008a) and infectious 
bursal disease (Perozo et al., 2008b).  
1.8. Eliminating Campylobacter from infected broiler flocks: 
    An alternative approach to preventing the infection is to eliminate C. jejuni from 
the infected flock. The use of antibiotics is not an option as the life span of a broiler 
chicken is a maximum of 42 days, which means that most antibiotic treatments should 
stop 3 weeks earlier (day 21), therefore preventing their use. Also, the emergence of a C. 
jejuni strain that has antimicrobial resistance is a major public health concern.  
 The use of bacteriophage as a treatment for C. jejuni infection resulted a limited 
reduction in bacterial counts in the cecum. When a mixture of two bacteriophages was 
given to broiler chickens colonized by C. jejuni for a period of 6 days, an initial reduction 
in bacterial counts in cecal content by 3 logs compared to an untreated control group was 
observed (Wagenaar et al., 2005). After 5 days of treatment, bacterial counts increased, 
reducing the difference to only one log. The colonization level remained the same 
throughout the experiment. It is not obvious why the counts initially were lower, but it is 
possible that C. jejuni resistant to the bacteriophage became more dominant in the 
population. Bacteriophage treatment is still in an early phase of testing, and it has several 
limitations such as the rapid resistance that develops against the phages used and the 
governmental regulatory restrictions that might require the elimination of the phage from 
the final poultry product (Rees and Dodd, 2006)   
1.9. Antimicrobial resistance in C. jejuni: 
 Antibiotics are infrequently used for treatment of campylobacteriosis in humans 
as the disease is typically self-limiting and only occasionally requires hospitalization. In 
some severe cases antibiotic treatment is unavoidable. The drug of choice for C. jejuni 
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infections is erythromycin (member of the macrolide family), followed by ciprofloxacin 
(member of the fluoroquinolone family) (Nachamkin et al., 2002). 
A dramatic increase in C. jejuni resistance to fluoroquinolones since the mid-
1990s was observed in the United States of America (Nachamkin et al., 2002). During the 
period of 1982-1992, C. jejuni isolates from 142 patients had no fluoroquinolone 
resistance, and only 2% erythromycin resistance. Fluoroquinolone resistance in 47 C. 
jejuni isolates from patients in 2001 increased to 40.5% compared to isolates from the 
1980’s. A similar increase has been documented for C. jejuni isolates from the late 
1990’s. Erythromycin resistance remained low, with an increase in resistance in only 4% 
of the total isolates.   The increase in resistance in human C. jejuni fluoroquinolone 
isolates was linked to the licensing of fluoroquinolone use in poultry production (Jimenez 
et al., 1994; Khachatourians, 1998). Enrofloxacin, a fluoroquinolone, was licensed in the 
early 1990s in Europe and Asia, and soon after a high incidence of resistant C. jejuni 
isolates from animal sources was reported. In Spain, 99% C. jejuni isolated from broiler 
and pig farms were resistant to fluoroquinolones, while 72% of human isolates were 
resistant at the same time period (Saenz et al., 2000). The same trend was observed in 
Taiwan, where 92% of C. jejuni isolated from chickens were resistant to 
fluoroquinolones, and 52% of human isolates were resistant (Li et al., 1998). The 
antimicrobial resistance pattern in Australia was different to the situation in Europe and 
Asia, as fluoroquinolones were never licensed for use in poultry (Hart et al., 2004; 
Unicomb et al., 2003). The numbers of resistant isolates from humans and animals 
remained low, and no increase in resistance has been observed (Unicomb et al., 2003). 
Streptomycin, which belongs to the aminoglycoside class of drugs, is a 
bactericidal antibiotic that prevents protein synthesis initiation by binding to the 16S 
rRNA subunit. Aminoglycoside resistance in general, specifically streptomycin, is not 
common, as studies have found resistance in 0-2.76% in various C. jejuni isolates 
(Velazquez et al., 1995). C. jejuni isolates from rinses of poultry carcasses in the USA 
were sensitive to aminoglycosides, making this group of antibiotics a good marker for 
molecular techniques. Resistant C. jejuni isolates modify the antibiotic, so that it is 
unable to interact with the ribosome, through the enzyme aminoglycoside 
adenyltransferase (AAD) (Pinto-Alphandary et al., 1990). Two types of this enzyme have 
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been found in C. jejuni and they both provide streptomycin resistance; AAD (3”) which 
is encoded by aadA, and AAD(6) which is encoded by aadE gene. The majority of the 
resistant strains encodes aadA, but some streptomycin-sensitive strains encodes an aadA 
homologue on a plasmid but with no apparent resistance (Nirdnoy et al., 2005).           
1.10. Animal Models Other Than Poultry for Studying C. jejuni infection: 
A considerable amount of C. jejuni pathogenesis and colonization research was 
performed using chickens as a model. This model is of particular importance as poultry 
products are considered to be the main source for C. jejuni infections as discussed above, 
and recognizing how an immune response is generated in a chicken and the factors that 
are crucial for C. jejuni colonization of the intestinal tract of a chicken is important in 
reducing the carriage of C. jejuni in chickens, therefore reducing the chance of infection 
in humans (Doyle and Erickson, 2006). However, the lack of clinical disease in chickens 
makes this model unsuitable for studying disease pathogenesis. The wide spectrum of 
symptoms that results from C. jejuni infection in humans makes having several animal 
models necessary. The infection could occur with no apparent symptoms, mild or severe 
diarrhea, or could result a chronic sequel such as Guillain-Barré syndrome (Wassenaar 
and Blaser, 1999). In this section, mouse, pig, ferret, and rabbit animal models will be 
discussed.   
1.10.1 Mouse 
Mice are used often in studying many aspects of human diseases including 
immune responses, pathogenesis, and the factors that might affect colonization (Bacon et 
al., 2000). Under natural conditions, C. jejuni is not normally isolated from the intestinal 
tract of laboratory mice, but using various experimental settings colonization could be 
induced. Kazmi et al. injected infant mice intraperitoneally with C. jejuni (Kazmi et al., 
1987), causing a self-limiting diarrhea. The value of this model is very limited, as the 
infection is introduced through injection rather than ingestion, and the mice are too young 
to have a proper immune response. Adult athymic (nu/nu) gonobiotic mice also 
developed transit diarrhea 7-9 days after oral challenge in addition to splenomegaly 1-2 
weeks after colonization (Yrios and Balish, 1986). Chang and Miller were able to 
develop a mouse model with reproducible colonization results using wild-type C3H mice 
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that contained pre-defined microflora (Limited-flora) that included Firmicutes, 
Lactobacillus, and Acinetobacter spp. (Chang and Miller, 2006). After oral gavage with a 
C. jejuni culture, these mice remained colonized with a high level of C. jejuni (up to 108 
CFU/gram of feces). Using a dose response titration, the researchers determined that the 
ID50 was 2 X 102 CFU. Mice had a limited inflammatory reaction in their intestine and 
cleared the infection a few weeks after the challenge. When limited-flora mice that are 
immuno-deficient (SCID) were challenged with C. jejuni orally, they developed severe 
typhlocolitis in the colon and cecum. Gastritis also occurred on day 28 after the 
challenge. Inflammatory cells involved were mainly granulocytes with some 
mononuclear cells. This model might be of limited value in studying pathogenesis as the 
lesions are far more severe than typical C. jejuni infections in humans, but it might serve 
well in identifying genes involved in virulence or colonization. MacKichan and 
colleagues used SCID mice with limited-flora to show that the two-component regulatory 
system of C. jejuni (dccR-dccS) is crucial in C. jejuni colonization of the gastrointestinal 
tract (MacKichan et al., 2004), as the dccR mutant was not able to stimulate any 
inflammatory response by mice.     
 The intranasal route of infection with C. jejuni is highly artificial in humans or 
animals, but BALB/c mice that received C. jejuni intranasally developed a systemic 
infection and had  increased mortality among the challenged group (72% of the mice 
died) (Baqar et al., 1996). When killed C. jejuni was administered as a vaccine 
intranasally, it induced a strong humeral immune response and mice survived a challenge 
with a homologous strain that was lethal in the non-vaccinated group (Baqar et al., 1996). 
The researchers got different mortality ratios using different C. jejuni strains, making 
intranasal challenge more suitable for evaluation of C. jejuni virulence rather than 
studying pathogenesis and immune response. 
 Nuclear factor-κB (Nf-κB ) deficient mice were used to study pathogenesis of C. 
jejuni and the potential role for NF-κB to the resistance of the infection (Fox et al., 2004). 
These mice were found to be susceptible to Helicobacter hepaticus, an enterohepatic 
bacterium that is closely related to C. jejuni (Fox et al., 2004). H. hepaticus pathogenesis 
is caused partially by a toxin that has a pathway similar to the cytolethal destending toxin 
of C. jejuni (Chien et al., 2000). Mice that received C. jejuni 81-176 were colonized at a 
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high level (75-100%) and developed gastritis and proximal duodenitis, but the bacteria 
did not spread beyond the GIT to any of the internal organs. In the same experiment, a C. 
jejuni cdtB mutant was administered orally to NF-κB deficient mice. The mutant 
colonized at the same level as the wild-type and caused the same lesions as the wild-type 
with the exception of typhlocolitis lesions. Also, the IgG (adaptive immune response) and 
IgG2a (innate immune response indicator) levels were significantly lower than in the 
control mice. This is not surprising, as these mice cannot produce IL-1, IL-6, IL-12, and 
TNF-α, which are crucial for innate and adaptive immune responses (Fox et al., 2004).  
1.10.2. Rabbit: 
 Rabbits were used in studying C. jejuni colonization and vaccine development 
(Caldwell et al., 1983; Walker et al., 1988). A removable Intestinal Tie Adult Rabbit 
Diarrhea model (RITARD) was first used in 1983 by Caldwell et al. in an attempt to 
mimic typical campylobacteriosis in humans. The cecum was ligated, and a slip knot was 
placed at the terminal ileum, and 1 X 109 CFU of bacterial culture was injected into the 
mid-small bowel. The loose ends of the knot were left protruding through the incision, 
and four hours later the slip knot was released. Rabbits received two different strains, the 
first caused diarrhea in 52% and death of 41% of the rabbits. The other strain caused 
diarrhea in 73% and death of 65% of the rabbits in the group. None of the rabbits in the 
control group that did not receive C. jejuni died (Caldwell et al., 1983). The clinical 
symptoms caused by challenging rabbits were similar to the results obtained when the 
same two strains were given to human volunteers (Black et al., 1988), indicating that this 
model might be useful in predicting the virulence of each strain in humans. The model 
requires some surgical skills and extra time to perform surgery on each and every animal 
in the experiment, making it a more demanding challenge model and therefore a less 
attractive choice than others.     
 Rabbits were also used to demonstrate the role of C. jejuni LOS molecular 
mimicry in Guillain-Barré syndrome (GBS). The observation that the sera of patients 
with GBS had developed antibodies to minor gangliosides GM1b and GalNAc-GD1a and 
to C. jejuni lead to the assumption that GBS is caused by molecular mimicry of C. jejuni 
to the gangliosides (Ho et al., 1999). Rabbits were used to study GBS by both injection 
with gangliosides (Yuki, 2001) and injection with C. jejuni LOS (Yuki et al., 2004). 
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Using a mixture of gangliosides extracted from bovine brain to inject rabbits, Yuki was 
able to induce high anti-GM1 IgG antibodies and flaccid limb weakness (Yuki, 2001). 
Upon histopathological examination, peripheral neurons were degenerated without 
cellular infiltration but rather IgG deposits. To prove the connection with C. jejuni, 
rabbits were injected with C. jejuni LOS that had an epitope similar in structure to GM1 
(Yuki et al., 2004). Rabbits quickly developed high levels of anti-GM1 IgG and 
developed flaccid limb weakness. Researchers used E. coli and Salmonella LOS as 
controls, and none of the control animals developed GBS or GBS-like symptoms (Yuki et 
al., 2004). Through the use of rabbits, the four criteria of Koch’s postulates were fulfilled 
(Ang et al., 2004): 
• Presence of an epidemiological link between GBS and C. jejuni 
• Identified the role of anti-GM1 IgG antibodies  
• Identified C. jejuni molecules that mimic gangliosides 
• Reproduced the disease in an animal model (rabbit) 
1.10.3. Nonhuman primates: 
 Nonhuman primates have been found to be infected with Campylobacter in 
several studies over different parts of the world. Bryant and colleagues found C. jejuni in 
46% of Patas monkeys with chronic diarrhea (Bryant et al., 1983). The monkeys 
experienced muco-hemorrhagic diarrhea, and when treated with streptomycin or 
tetracycline for 10 days the diarrhea ceased. After one month, an outbreak of diarrhea 
occurred among the colony, and C. jejuni was identified as the causative agent. It is 
possible that the treatment did not completely clear the infection, and given the feco-oral 
habits of monkeys, re-infection may have occurred (Bryant et al., 1983).  In another 
colony of infant Macaca nemestrina monkeys, multiple strains of C. jejuni were found in 
animals with and without diarrhea (Russell et al., 1990). Using DNA hybridization and 
polyacrylamide gel electrophoresis protein profiles, the researchers were able to show 
that an infection with one strain lasted for 3-4 weeks (Russell et al., 1990). Fitzgeorge et 
al. infected Rhesus monkeys with a human strain of C. jejuni (Fitzgeorge et al., 1981). 
The animals shed the bacterium for a long period of time, but only had a brief period of 
bacteraemia, diarrhea and inappetence. When the animals were re-challenged with the 
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same strain, no clinical symptoms were observed, and shedding lasted for only 3 days 
post-challenge (Fitzgeorge et al., 1981). Russell et al. challenged Campylobacter-free 
monkeys with 3 X 1011 CFU of strain C. jejuni 81-176 (Russell et al., 1989). Bloody 
feces and fluid diarrhea were observed. A strong antibody response to C. jejuni occurred 
as a result of the challenge. Re-challenging the monkeys with both homologous and 
heterologous strains resulted only a mild diarrhea, indicating a partially protective 
immunity (Russell et al., 1989).    
1.10.4. Ferret: 
 Ferrets are commonly colonized by C. jejuni. In a study by Fox et al. 61% of 168 
ferrets sampled were positive for C. jejuni (Fox et al., 1983). C. jejuni has been isolated 
from weanling ferrets (kits) suffering from mucoid diarrhea (Bell and Manning, 1990). 
When ferrets were orally challenged with 108-1010 CFU C. jejuni isolated from a diarrhea 
outbreak in minks or humans; their feces became mucoid or they developed diarrhea 
(Bell and Manning, 1990). When the strain isolated from mink was administered 
intravenous the animals developed watery diarrhea. The diarrhea in both cases was self-
limiting, and was resolved in 3-8 days. Animals developed antibodies as detected by an 
agglutination test and cleared the infection in a period of 7 days. When some of the 
ferrets were re-challenged with a homologous strain, no diarrhea developed but the 
animals were colonized by C. jejuni. The researchers inoculated animals 5 times either 
orally or intra-rectally over the period of 5 weeks and they were able to induce immunity 
to both disease and infection. Kits born to dams with high antibody titer were colonized 
with C. jejuni upon infection, but they did not develop diarrhea. Bacteremia developed in 
ferrets challenged orally on days 2-5, but animals developing bacteraemia had similar 
clinical signs to the animals with no clinical signs. 
 Burr and colleagues were able to prevent development of diarrhea in 80% of 
challenged ferrets by vaccinating them orally 4 times with a C. jejuni formalin-fixed 
whole cell vaccine (Burr et al., 2005). The vaccination did not prevent colonization, but 
provided protection against disease caused by both homologous and heterologous strains. 
The addition of leukotoxin as an adjuvant or increasing of the number bacteria in the 
vaccine did not improve the protection.  
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The ferret model of infection results in clinical symptoms that resembles those 
associated with campylobacteriosis in humans, but the infective dose that has been 
reported is high, and the duration of bacterial shedding is short, limiting the ability to use 
this model for vaccine testing.        
 Animal models described above are summarized in Table 1.2. 
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 Chicken Mouse Ferret Non-human primates Rabbit 
Minimal 
infectious dose 
> 40 cfu > 2x102 CFU N/A N/A N/A 
Infection 
Symptoms 
None varies from no 
symptoms to  
diarrhea  
self-limiting 
diarrhea, moderate 
enteritis 
self-limiting diarrhea, 
some spleenomegaly 
flaccid paralysis 
Genetic 
background 
(Inbred/ outbred) 
outbred inbred outbred outbred outbred 
Main application -Colonization 
-Vaccine 
-Pathogenesis, 
-Role of specific 
genes in disease 
development 
-pathogenesis 
-onset of clinical 
symptoms 
-pathogenesis  
-clinical symptoms 
-GBS pathogenesis  
-Enteritis 
Critical findings Role of: flagella,  
motility, secreted 
proteins, and 
adhesins in 
colonization 
 
-Contrasting the 
role of innate and 
adaptive immunity 
in limiting 
infection 
-Gut microflora 
effect on 
colonization 
Role of maternal 
antibodies in 
protection against 
diarrhea  
Role of adaptive 
immunity in protection 
against future C. jejuni 
infections 
The role of C. jejuni 
in GBS  
 
Table 1.2: Various animal models used for studying C. jejuni. This table highlights animal models used in studying C. jejuni 
pathogenesis and autoimmune diseases induced by C. jejuni.  
N/A: Not available; GBS: Guillain-Barré syndrome.
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1.11. Green Fluorescent Protein: 
 Green fluorescent protein is found naturally in the Aequorea victoria jellyfish. 
Shimomura and colleagues discovered GFP while working on another chemiluminescent 
protein, aequorin (Shimomura et al., 1961). They found that the solution containing GFP 
was greenish in sunlight, yellowish under tungsten light bulb, and bright green under UV 
(Shimomura et al., 1961). Further analysis of GFP showed that the emission spectrum 
peaked at 508 nm wavelength (Johnson et al., 1961). Green fluorescent protein is a 27 
kDa monomer made up of 238 amino acid residues in a single polypeptide chain, and it 
emits its green light by converting the blue chemiluminescent of the Ca2+- sensitive 
photoprotein, aequorin, into a green light (Chalfie et al., 1994). The active chromophore 
in GFP is a cyclic tripeptide that becomes fluorescent only after it is embedded within the 
GFP peptide (Niwa et al., 1996). Wild-type GFP (WT-GFP) absorbs UV with a 
maximum peak of absorbance at 395 nm and minor peak of 470 nm (Chalfie, 1995). Its 
maximum emission of green light is at 508 nm with a shoulder of 540 nm (Chalfie, 
1995). Green fluorescent protein undergoes photochemical transformation when 
illuminated. This transformation is what enables scientists to use GFP in the various 
assays. The outcome of photochemical transformation as a result of illumination for a 
period of time is either an irreversible photobleaching, change of fluorescent excitation 
from 488 nm to 406 nm, or conversion of excitation maximum from 395 nm to 475 nm 
(Elowitz et al., 1997). When a single chromosomal copy of gfp gene was used, no 
fluorescent signal was detected (Errampalli et al., 1999). The number of molecules that 
are required to visualize a tissue cell is around 10,000 GFP molecules (Errampalli et al., 
1999). However, the commercially available variants of GFP, including the red-shifted 
GFP (RsGFP) are estimated to have a signal that is 20-35 times more intense and 
photobleach at a slower level at the same excitation peak (Cormack et al., 1996).These 
variants were generated by introducing a point mutation to the gfp sequence (Cormack et 
al., 1996)   
 Green fluorescent protein is resistant to a variety of conditions that are frequently 
used in experimental procedures, including heat, various pH conditions, and several 
commonly used chemicals. Increasing the temperature from 15 °C to 65 °C only slightly 
affected the excitation peak of the WT-GFP, and the protein retained 50% of its 
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fluorescence at 78 °C (Ward and Bokman, 1982). Green fluorescent protein is resistant to 
alkaline pH, but it could be affected by low pH, as some quenching might occur at pH 5.5 
(Patterson et al., 1997). This quenching might reduce illumination, but it does not 
eliminate it. Green fluorescent protein was proved to resist organic solvents, detergents, 
and most common proteases (Ward and Bokman, 1982). As well, GFP is resistant to 8M 
urea solution and to 1% SDS (Chalfie, 1995), which are commonly used in laboratory 
procedures.     
1.11.1. GFP applications: 
 Green fluorescent protein has become one of the most commonly used tools in 
research. GFP have been employed by environmental scientist to study the dynamics of 
gfp-tagged bacteria in soil, water, and biofilms (Errampalli et al., 1999). Moller et al. 
studied the distribution of gfp-tagged bacteria in mixed population biofilms (Moller et al., 
1998). The experiment was conducted in a flow chamber attached to a scanning confocal 
microscope that allowed for continuous monitoring of the growing biofilm. The 
researchers found that Pseudomonas putida colonized the outer parts of the biofilm, 
while Acinetobacter sp colonized the inner part only (Moller et al., 1998).  
 One of the most important applications for GFP is studying the host-pathogen 
relationship. Green fluorescent protein has been used to study internalized bacteria, genes 
expressed in vivo, and bacterial spread throughout the host. Cho and Kim were able to 
verify that an environmental isolate of S. typhi has a viable but nonculturable (VBNC) 
state using a S. typhi with a gfp gene integrated into the chromosome (Cho and Kim, 
1999). By comparing the counts of plate-grown S. typhi to the counts of fluorescent 
bacteria in their sample the researchers were able to prove that many viable S. typhi will 
not grow using routine bacterial culture conditions, and therefore even if the bacterium is 
nonculturable, it is still viable (Cho and Kim, 1999).  
 Mixter and colleagues used C. jejuni transformed with a gfp-bearing plasmid to 
track the bacteria inside the host (Mixter et al., 2003). The fluorescent bacteria were 
injected into the peritoneum (IP) of BALB/c mice, and after 4 hours the intraperitonial 
fluids were collected. The fluids were analyzed using flow cytometry analysis, which 
revealed that most of the bacteria were associated with granulocytes. Using various sets 
of markers, researchers were able to demonstrate that C. jejuni associated mainly with 
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neutrophils and macrophages (Mixter et al., 2003). Although this experiment used IP 
injection, which is not the natural route of infection, it still showed that tracking of 
fluorescent C. jejuni inside the host is possible.  
 Thone et al. used Salmonella enterica serovar Typhimurium expressing GFP to 
study the localization of bacteria in spleenocytes (Thone et al., 2007). The researchers 
had to screen over a 100 different GFP constructs to find a construct that was expressed 
strongly enough to be detected by flow cytometry and that emitted a wavelength 
differentially from the host cell autofluorescence. Using this construct they were able to 
demonstrate that only a small subset of spleenocytes were highly infected with the 
majority of the bacteria, while other spleenocytes contained only a few bacterial cells 
(Thone et al., 2007).     
 Green fluorescent protein -expressing bacteria are bright enough that they can be 
visible from outside an animal that is infected with the bacteria. Zhao et al. gavaged nude 
CD-1mice with 1 X 1011 CFU of E. coli harboring a plasmid that expresses gfp (Zhao et 
al., 2001). Using a light box illuminated by blue light fiber optics, fluorescent bacteria 
were visible during their replication and spread throughout the intestinal tract. In the 
same experiment, mice were injected via the IP route and the E. coli spread over time was 
easily tracked without the need to sacrifice the mice to be examined (Zhao et al., 2001). 
 Miller and colleagues constructed a shuttle vector that encoded the gfp gene that 
was fused to a consensus Campylobacter promoter sequence (Miller et al., 2000). C. 
jejuni was transformed with the gfp plasmid and tested on a variety of surfaces including 
plants and chicken skin, and it was also used to infect Caco-2 cells.  
 From the set of experiments discussed in this section, it can be concluded that 
GFP has a variety of applications in biological sciences and especially bacterial 
pathogenesis and interaction with host cells. 
1.12. Summary: 
 C. jejuni continues to be a global challenge that can affect humans of all ages. 
Poultry, especially broiler chickens, are the main source of human infections. The control 
of infection in broiler chickens should dramatically affect the level of campylobacteriosis 
in humans. Based on current literature, vaccination remains the most feasible approach 
for control of C. jejuni spread in chickens.   
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Although the immune system is able to limit the disease outcome, the details of 
cells and signalling molecules involved in combating C. jejuni infections are yet to be 
determined.      
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Chapter II: Hypothesis, Objectives, and Specific Aims of This Study 
 
2.1. Hypothesis:  
 
 It is our hypothesis that flagella are vital to colonization of the chicken intestine 
by C. jejuni, and this is mediated by proteins secreted by the flagellar export apparatus 
which is involved directly in colonization. 
2.2. Objective: 
 The pathogenesis of C. jejuni in broiler chickens is poorly understood. The overall 
objective of this project is to understand the role of flagella and Campylobacter invasion 
antigens in mucosal and systemic colonization, and to evaluate the vaccine potential of C. 
jejuni paralyzed flagella mutants.  
2.3. Specific aims: 
 Based on the hypothesis and objectives stated above, the specific aims of this 
study are: 
1. Determine the mucosal and systemic sites(s) of colonization of C. jejuni using 
green fluorescent protein (GFP). 
2. Evaluate the ability of C. jejuni mutants to colonize broiler chickens and BALB/c 
mice. 
3. Test the vaccine potential of a paralyzed flagella C. jejuni mutant. 
4. Evaluate chicken macrophage inflammatory response to C. jejuni flagella and 
secreted protein mutants. 
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Chapter III: General Materials and Methods 
3.1. Introduction:  
The purpose of this chapter is to describe the bacterial strains and laboratory 
methods that were common to several experiments and therefore avoid repetition.  
3.2. Campylobacter jejuni strains: 
 Strain C. jejuni NCTC11168V1 has a NCTC11168 genetic background and was 
originally isolated from a case of human enteritis in 1977 (Ahmed et al., 2002). The 
genome of this strain was fully sequenced in 2000 (Parkhill et al., 2000). This strain does 
not contain any plasmids. 
 Strain C. jejuni NCTC11168V26 has the same genetic background as 
NCTC11168V1but has been passaged for an undetermined number of times over the 
years resulting a variation in gene profile expression, lowered in vitro invasion, decreased 
ability to colonize chickens, and a limited ability to spread from an infected chicken to 
non-infected chicken (Carrillo et al., 2004).  
 Strain C. jejuni NCTC11168flgK has an NCTC11168 background and an 
insertion mutation in flgK gene, which encodes the hook-flagellin junction (Fernando et 
al., 2007). This mutation allows the expression of flagellar structure up to the hook, 
resulting in a truncated flagellum, and prevents secretion of Campylobacter invasion 
antigens (Fernando et al., 2007).  
 Strain C. jejuni 81-176 has a well studied genetic background and was originally 
isolated in 1981 from 9-year-old girl’s feces who consumed raw milk on a field trip to a 
diary farm (Black et al., 1988). Human volunteers receiving C. jejuni 81-176 passaged in 
the lab have suffered from gastroenteritis (Black et al., 1988). The genome of this strain 
has been sequenced and published (Hofreuter et al., 2006). It contains two plasmids, pVir 
and pTet (Bacon et al., 2000). This strain has been proved to be virulent in ferrets (Yao et 
al., 1997) and Rhesus macaques (Islam et al., 2006). Colostrum-deprived piglets infected 
with C. jejuni 81-176 developed a bloody diarrhea that was virulent enough to force 
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Naikare and colleagues to euthanize the animals after 3 days of challenge (Naikare et al., 
2006). Strains C. jejuni K2-37 and K2-55 have an 81-176 genetic background, but 
contain an insertion mutation in pflA gene, that allows them to express full length flagella 
that are paralyzed (Yao et al., 1994), resulting in non-motile strains.         
 Bacterial strains used in the set of experiments described in this thesis are listed in 
Table 3.1. 
3.3. Campylobacter storage and growth conditions: 
The source for C. jejuni strains NCTC11168V1, NCTC11168V26, and 81-176 
was minimally-passaged freezer stock courtesy of Dr. Brenda Allan (VIDO, 
Saskatchewan). For each strain used, 10 µl from the frozen stock was spread on 5% 
Mueller-Hinton agar supplemented with 5% sheep blood (MHA-Blood) (PML 
Microbiological, Richmond, BC) and grown for 24-48 hours under microaerophilic 
conditions (10% carbon dioxide, 5% oxygen, and 85% nitrogen) at 42 °C. The growing 
colonies were re-streaked on MHA-Blood using a sterile cotton swab and grown for 16-
18 hours to produce confluent growth. The bacteria were harvested and resuspended 
using Mueller-Hinton broth (MHB). Sterile glycerol was added to make up 25% of the 
final solution. The C. jejuni stock was stored at -70 °C until used.  
   C. jejuni strains were routinely cultured on Mueller-Hinton agar (MHA), (Difco), 
or MHA-B under microaerophilic conditions (10% carbon dioxide, 5% oxygen, and 85% 
nitrogen) at 42 °C unless otherwise stated. 
3.4. C. jejuni cultured on bi-phasic media: 
 For several laboratory experiments, C. jejuni was grown in bi-phasic culture that 
offers the nutrients and dynamics of a broth culture and the support and attachment from 
agar. C. jejuni was grown from frozen stock as described above. Each plate was 
harvested using 5 ml MHB and transferred into 5 ml sterile test tube. Bacterial harvest 
was well-suspended by pipetting several times, and 250-500 µl were transferred to an 
MHA plate covered with 2.5-3ml MHB. 
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Name Description Reference 
C. jejuni strains 
NCTC11168V1 
A variant of the sequenced NCTC11168, 
colonizes chickens efficiently although it is 
isolated from a human enteritis case.  
(Ahmed et al., 
2002; Parkhill 
et al., 2000).  
NCTC11168V26 
A variant of NCTC11168 that colonizes 
chickens poorly and has a limited expression 
of flagella and other genes. 
(Carrillo et al., 
2004). 
NCTC11168flgk 
Has an insertion mutation in flgK gene, 
expresses the flagellar structure up to the 
hook. Does not secret Campylobacter 
invasion antigens 
(Fernando et al., 
2007). 
81-176 
Isolated from a human source and caused 
gastroenteritis in human volunteers. The 
genome has been sequenced. 
(Black et al., 
1988; Hofreuter 
et al., 2006). 
K2-37 
Has an 81-176 genetic background, but 
contains an insertion mutation in pflA gene, 
expresses full length flagella but lacks 
motility. (Yao et al., 1994). 
K2-55 
Another 81-176 pflA mutant that expresses 
full length flagella but lacks motility. 
E. coli strains 
DH5α 
Laboratory strain used for hosting plasmids 
and as a helper strain in tri-parental 
transformation. 
(Miller et al., 
2000). 
EC2576 
DH5α genetic background carrying plasmid 
AF2925555 encoding gfp gene 
(Miller et al., 
2000). 
EC1690 
DH5α genetic background carrying plasmid 
pHG101 
This study 
Salmonella strains 
Salmonella enterica 
serovar Typhimurium 
strain SL1344 
A well studied strain that has been used in a 
number of studies and vaccine development. 
Used in this study as a positive control for 
TLR5 
(Gulig and 
Curtiss, 1987) 
Table 3.1: Bacterial strains used in this study. This table lists C. jejuni, E. coli, and 
Salmonella strains used in this study, with a brief description of their main 
characteristics.  
58 
 
The mixture was well-suspended by pipetting 3-5 times and the plate was incubated 
upright under microaerophilic conditions at 42 °C for 14-16 hours.  
3.5. Karmali selective medium: 
 Karmali selective medium is based on a formula described by Karmali et. al. 
(Karmali et al., 1986) The medium is blood-free, and it is developed specifically for 
isolation of C. jejuni and C. coli. The agar base contains activated charcoal, Columbia 
agar base, and a small amount of haemin.To prepare 500 ml of Karmali agar plates 21.5 g 
of Campylobacter agar base (Karmali) from Oxoid (Cat # CM0935) (Nepean, ON) were 
dissolved in ddH2O, brought to boil, and sterilized by autoclaving at 121 °C for 15 min. 
The medium was allowed to cool down to ~50 °C before the addition of 1 vial of 
Campylobacter selective supplement SR0167E (Oxoid) reconstituted in 2 ml of 1:1 
ethanol: sterile distilled water, which contains 50 mg of sodium pyruvate, 16 mg of 
cefoperazone, 10 mg of vancomycin, and 50 mg of cycloheximide. Medium was mixed 
well and then poured into Petri dishes and allowed to cool and solidify and were stored at 
4 °C until needed.     
3.6. Determination the number of C. jejuni colony-forming units (CFU) per gram of 
cecal contents: 
 Both ceca were collected aseptically from each chicken and placed in a sterile 
Petri dish (VWR) labeled with bird and group numbers. Each cecum was opened from 
the blind end and the cecal contents were emptied into a pre-weighed disposable 25 ml 
plastic tube with a flat bottom. The amount of cecal contents collected ranged from 0.2-
0.4 g. To each sample X10 the weight of fridge-cold normal saline was added and the 
contents were vortexed until well-suspended. From each sample dilutions of 101-106 were 
made in normal saline. From each dilution 25 µl were plated on 1/3 of the surface area of 
a Karmali selective agar plate yielding a total of two plates per bird. Plates were 
incubated at 42 °C for 48 hours under microaerophilic conditions. Generally dilutions 
with 5-200 colonies were counted unless less than 5 colonies grew in 101 dilution.      
3.7. Polymerase Chain Reaction (PCR) primers: 
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 Primers were designed and analyzed using Clone Manager Professional Suite for 
optimization of annealing temperature, GC content, exclusion of self-complementarily 
and primer dimers. The specificity of the designed oligonucleotides was tested by 
BLAST searches for short, nearly exact matches at http://www.ncbi.nlm.nih.gov/ 
BLAST/. All primers used were purchased from Invitrogen Canada (Burlington, ON). 
Before initial usage, primers were resuspended to a concentration of 10µM/µl. A working 
solution of 1 µM/µl was made and used in PCR and qRT-PCR reactions. All resuspended 
primers were stored at -20 °C after each use.   
3.8. Broiler Chickens: 
 All broiler chickens used in the various studies were purchased from a local 
commercial source (Lilydale hatcheries, Wynyard, SK), and were delivered to VIDO 
Animal Care facility on the morning of day of hatch. All experiments were carried out 
according to the guidelines of Canadian Council on Animal Care and University of 
Saskatchewan Committee on Animal Care and Supply. 
3.9. Preparation of C. jejuni samples for Electron Microscopy:  
 An electron microscope (EM) was used to obtain images of C. jejuni paralyzed 
flagella mutant to confirm the presence of full length flagella and the absence of any 
visible structural changes. Overnight cultures of C. jejuni 81-176, K2-37, and K2-55 were 
harvested and subcultured using bi-phasic media. To minimize viable but nonculturable 
(VBNC) form of C. jejuni, the bacteria were grown for no more than 14 hours and 5 ml 
of MHB were used instead of 3. Bacterial cells were harvested using 5 ml normal saline 
and collected into 14 ml sterile test tubes which were kept on ice. The samples were 
processed immediately. A few drops of bacterial broth were placed on the surface of a 
sterile Petri dish. A copper grid covered with Formvar film and coated with carbon (SPI-
Chem, West Chester, PA) was placed on top of the bacteria suspension and allowed to 
float freely for 3-5 minutes to allow for the bacteria to adhere. The grids were stained 
with 1% (w/v) ammonium molybdate for 1 min and were allowed to dry before 
examination with a Philips-410 electron microscope.  
3.10. Preparation of tissue samples for EM: 
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Freshly collected tissues from liver, spleen, and ceca were immediately placed in 
1.5% glutaraldehyde (SEGMA, Oakville, Ontario) to avoid drying out. Samples were cut 
into small pieces using a surgical carbon steel blade (VWR, Mississauga, ON), with each 
piece less than 1 mm thick allowing for complete penetration by fixative. Samples were 
fixed using 1.5% glutaraldehyde in 0.1M sodium cacodylate buffer for 3 hours at 4 °C, 
and washed 3 times (once every hour) following fixation using 0.1M sodium cacodylate 
buffer. Postfixing of samples was achieved by incubation in 1% OsO4 in 1.25% sodium 
bicarbonate buffer for 1 hour at room temperature. Samples were dehydrated and stained 
at the same time with a series of steps that started with 50% ethanol for 5 min, 70% 
ethanol saturated with uranyl acetate for 1 hour, 70% ethanol only for 5 min, 95% ethanol 
for 5 min, and finally 3 washes with 100% ethanol for 5 min each. Samples were 
submitted to the EM laboratory (Veterinary Biomedical Sciences Department, Western 
College of Veterinary Medicine) for molding and trimming. Samples were examined 
using a Philips-410 electron microscope.     
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Chapter IV: Colonization of Campylobacter jejuni in Broiler Chickens 
4.1. Introduction 
 Poultry-borne transmission of C. jejuni remains a major public health concern in 
Canada (Thomas et al., 2008a),  The United States of America (Cardinale et al., 2003), 
and The European Union (Wagenaar et al., 2006). C. jejuni infections are not limited to 
the developed world, as campylobacteriosis is widespread in developing countries with a 
significant contribution to mortality in infants and diarrhea in adults (Coker et al., 2002).  
The number of confirmed C. jejuni cases has increased steadily since the establishment of 
laboratory techniques to isolate the bacteria from clinical samples (WHO, 2001) and 
reached an estimated 400 million infections each year worldwide (Girard et al., 2006). 
The main clinical manifestation of C. jejuni is a varying degree of diarrhea and 
abdominal cramps that usually ceases after 3 days, but it is not unusual for the abdominal 
cramps to occur after the diarrhea had stopped. Although most cases of C. jejuni infection 
do not require hospitalization and are usually self-resolved, an autoimmune disease 
known as Guillain–Barré syndrome (GBS) is the most serious sequel caused by C. jejuni 
(Rhodes and Tattersfield, 1982; Yuki, 2001). The disease manifests itself as descending 
or ascending paralysis and depending on the severity of the condition, GBS patients 
might be hospitalized, especially if the respiratory muscles are involved. If managed 
properly, most patients recover under good medical supervision (Douglas and Winer, 
2006). 
 Broiler chickens display no clinical signs when they are colonized with C. jejuni 
despite the heavy carriage of the bacteria in their ceca (up to 1010 CFU per gram of cecal 
content). The ability of the organism to colonize chickens varies greatly from strain to 
strain, with as little as 40 CFU of chicken-passaged C. jejuni  able to cause maximal 
colonization under experimental conditions (Cawthraw et al., 1996).  Other studies have 
reported 5 X 104 CFU are required for two-week old broiler chickens to be colonized 
(Ringoir et al., 2007). Under field conditions, C. jejuni is not detected in newly hatched 
chicks,  and is only detected after 2-3 weeks of placement in a poultry barn (Newell and 
Fearnley, 2003). Horizontal transfer from other poultry and the environment is probably 
the main source for infection (Wagenaar et al., 2006). 
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Epidemiological studies have projected that reducing the shedding of C. jejuni by 
broiler chickens will reduce the occurrence of disease in humans, and the most effective 
approach is vaccination (Wagenaar et al., 2006). A basic understanding of C. jejuni 
interaction with its host is required to identify the best vaccine candidates and 
mechanisms of immunity required for protection. Studies conducted in chickens have 
mainly focused on colonization of the intestinal tract with limited investigation of 
systemic spread. These studies have identified some of the antigens that are involved in 
intestinal tract colonization process including CadF (Ziprin et al., 2001) and flagellin 
(Fernando et al., 2007). It has been established that C. jejuni is mainly associated with 
intestinal mucus layer, does not adhere to the intestinal cells, and have a limited systemic 
spread (Beery et al., 1988). Cox et al. found that C. jejuni spreads quickly to several 
lymphoid organs but was not detected by culture after 1 day of infection (Cox et al., 
2006).  
Negative results using standard procedures for isolation of Campylobacter from 
clinical samples does not necessarily prove that the sample was Campylobacter free, as 
these procedures have a minimal detection level that could be as high as 102 CFU/ml of 
intestinal content (Beery et al., 1988). The physiological changes that C. jejuni undergoes 
might be significant in the ability to recover the bacteria, as Watson and Galan were able 
to recover C. jejuni from samples that were negative using standard laboratory 
microaerophilic conditions by incubating the culture under oxygen-limiting conditions 
(Watson and Galan, 2008). Researchers postulate that the intracellular conditions C. 
jejuni encounters during its infection might lead to this physiological shift of the bacteria.  
The objective of experiments described in this chapter was to study the mucosal 
and systemic sites of C. jejuni colonization. To achieve this objective, an alternative 
method for standard laboratory culture to study C. jejuni pathogenesis in broiler chicken 
was introduced. Transformation of a plasmid expressing Green Fluorescent Protein 
(GFP) into C. jejuni enabled in vivo visualization of the bacteria in various tissues under 
the fluorescent microscope.          
4.2. Materials and Methods: 
4.2.1. Bacterial strains: 
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 C. jejuni NCTC1168V1and C. jejuni NCTC1168V26 have been described in 
General Material and Methods (chapter III). Two E. coli strains were used in this study: 
DH5α, a laboratory strain that does not contain any plasmids and strain EC2576 (DH5α 
background) which contains plasmid AF2925555 that expresses the gfp reporter system 
(described below). 
4.2.2. Bacterial growth conditions: 
E. coli strains were stored in Luria-Bertani (LB) broth containing 25% glycerol at  
-70 ̊C. Prior to use, 50 µl of frozen stock were inoculated into the appropiate broth and 
grown overnight with shaking at 37 °C. To determine bacterial counts in the overnight 
culture, duplicate 1ml aliqouts of the broth were diluted 10-fold from 10-1 to 10-6  and 
plated on LB agar and incubated overnight at 37 °C. Colony counts on plates with 30-300 
colonies were used to calculate the bacterial concentration.     
4.2.3. Plasmids: 
 Plasmid AF292555 was a generous gift from Dr. William W. Miller (U.S. 
Department of Agriculture, Albany, California) (Miller et al., 2000). This plasmid 
contained the Campylobacter plasmid mobility element (mob), Campylobacter plasmid 
origin of replication, ColE1 origin of replication, and Campylobacter kanamycin 
resistance gene (antibiotic marker), and promoter site that were used in constructing the 
gfp reporter system (pHG101). 
4.2.4. Plasmid purification and storage: 
 Plasmids were purified using Qiagen QIAprep Miniprep kit (Cat# 27104 Qiagen 
Inc, Mississauga, ON) according to the manufacturer instructions using an Eppendorf 
5417C tabletop centrifuge. Plasmid DNA was eluted in 50 µl of RNase-DNase-free water 
distilled water. To determine DNA purity and integrity, a 2 µl sample was analyzed using 
1% agarose gel electrophoresis. DNA concentration in the sample was determined using 
spectrophotometric analyses (UltraSpec 3000, Pharmacia Biotech, Sweden). Samples 
were diluted 1:100, and for samples with OD260/OD280 ranging between 1.8-2.0 and DNA 
concentration was determined using the formula OD260 = OD X 50 ng/µl X dilution 
factor. Purified DNA was stored at -70 °C until used.  
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4.2.5. Polymerase Chain Reaction (PCR):     
 The PCR mixture consisted of 170 µl of sterile water, 5 µl of each of the four 
dNTP’s (Fermentas, Burlington, ON), 10X reaction buffer (supplied with dNTP’s and 
contains 750 mM Tris-HCl (pH 8.8 at 25 °C), 200 mM (NH4)2SO4 and 0.1% (v/v) Tween 
20), and 5U of Taq polymerase (Fermentas). Each individual reaction contained 43 µl of 
reaction mixture, 2.5 µl of each primer (at 10 pmoles/µl), and 2 µl DNA were dispensed 
into a sterile PCR tube. Tubes were placed in Applied BioSystems 2720 thermal cycler 
(Applied BioSystems , Streetsville, ON), and parameters were set as described in General 
Materials and Methods chapter. Primers were designed and prepared as described in 
General Materials and Methods chapter and are listed in Table 4.1.      
 4.2.6. DNA digestion and ligation: 
 DNA digestion enzymes were purchased from New England BioLabs (Pickering, 
ON). Up to 1 µg of DNA was digested per reaction. The reaction mixture contained 7.5 
µl of dd H2O, 1 µl of DNA, 1 µl of reaction buffer (supplied with the enzyme), and up to 
1 µl of digesting enzyme. Reactions were incubated at 37 °C for 2-4 hours. Cleavage of 
the DNA substrate with two enzymes simultaneously was also performed using the same 
reaction conditions, but including two compatible enzymes.   
 DNA was ligated using Rapid DNA ligation Kit (Fermentas). Each ligation 
mixture contained 3:1 ratio of vector:insert DNA, rapid ligation buffer, water and T4 
DNA ligase. The mixture was spun and allowed to sit at room temperature for 5 minutes.  
For each transformation 2 µl were used, and the rest of ligation mixture was stored at -20 
°C for future use. 
4.2.7. Preparation of chemically competent cells and heat-shock transformation: 
    A stock of frozen chemically competent E. coli DH5α cells was prepared by 
plating a loopful of the bacteria on an LB plate which was incubated overnight at 37 °C. 
A single colony was then picked and inoculated in 2 ml of LB broth overnight with 
shaking at 200 rpm/minute. The culture was transferred into 500 ml 2X YT broth in a 2 
liter flask and incubated at 37 °C with shaking until a 0.5 absorbance at 600 nm 
wavelength (O.D.600 =  0.5) was obtained. The culture was transferred into pre-chilled 
250 ml sterile centrifuge tubes and were placed on ice for 10 minutes. Cells were pelleted 
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at 2000 X g at 4 °C for 10 minutes. The supernatant was removed completely and 80 ml 
of sterile RF-I solution (100 mM KCl, 50 mM MnCl2, 30 mM Potassium acetate, 10 mM 
calcium chloride and 15% glycerol ) were added and pellet was resuspended and allowed 
to incubate on ice for 30 minutes. The cells were centrifuged as above for 10 minutes, 
and the supernatant was removed. The pellet was resuspended in 4 ml of sterile RF-II 
solution (10 mM MOPS, 10 mM KCl, 75 mM CaCl2, and 15% glycerol at pH 6.8) and 
was incubated on ice for 15 minutes. Aliqouts of 100 µl were dispensed into pre-chilled 
1.5 ml Eppendorf tubes and stored at -70 °C until used. 
 For transformation, one Eppendorf tube containing frozen cells was thawed on 
ice, and ligation mixture prepared as described above was added. The mix was incubated 
on ice for 5 minutes then transferred to a water bath set at 42 °C for 1 minute. The tube 
was then incubated on ice for 3 minutes. A 100 µl of LB broth was added, and 15 µl were 
spread on an LB plate supplemented with kanamycin (LB-KM) at a concentration of 
200μl/ml. Plates were incubated at 37 °C O/N and observed for any colony growth. 
Colonies that grew were analyzed using whole-cell PCR or miniprep to confirm the 
transformation of the plasmid.  
4.2.8. Whole-cell PCR: 
 This technique was used to confirm the presence of gfp gene sequence in the 
colonies growing on LB-KM plates. The side of the colony of interest was picked using a 
sterile toothpick. The bacteria carried on a toothpick were transferred to 100 µl of sterile 
RNase/DNase-free water (SIGMA, Oakville, ON) in 1.5 ml Eppendorf tube. The water 
was boiled for 5 min in Thermolyne Dri bath (Dubuque, Iowa), followed by incubation 
on ice for 3 minutes. Two µl of boiled bacteria were transferred to a PCR mix prepared as 
described above. Primers used in the reaction are described in Table 1. The PCR reaction 
was carried out as follows: hot denaturation at 96 °C for 1 minute, then 25 cycles of 
denaturation for 30 sec at 95 °C, annealing for 30 sec at 60 °C, and extension for one 
minute and fifity seconds at 68 °C. A final extension step lasted 5 minutes at 68 °C 
4.2.9. Screening for spontaneous Streptomycin-resistant C. jejuni mutants: 
 To obtain a streptomycin-resistant isolate, a freshly grown C. jejuni was harvested 
in 5 ml MHB. The harvested bacteria were centrifuged at 2500 X g and resuspended to a 
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concentration of 108-109 CFU/ml C. jejuni, plated on MHA-SM plates and incubated at 
42 °C for 24-48 hours. Colonies growing were restreaked twice to confirm streptomycin 
resistance of the isolate.  
4.2.10. Construction of gfp reporter system: 
 A fragment containing a Campylobacter plasmid origin of replication, ColE1 
origin of replication, Campylobacter plasmid mobility element (mob), and 
Campylobacter kanamycin resistance  gene was obtained from plasmid AF292555 
(Fig1). To obtain a gfp gene that is constitutively expressed, a primer containing 
Campylobacter consensus promoter sequence described by Wosten et al (Wosten et al., 
1998) (Table 1), ribosomal binding site sequence (Miller et al., 2000), and 18 bp 
necessary to amplify gfp from plasmid pQBI-25(GFP) from Quantum Biotechnologies 
(Montreal, QC). Reaction conditions used were the same as described above with the 
exception of that the annealing temperature was 42 °C. The PCR products amplified with 
the primers were analyzed using agarose gel electrophoresis to confirm band size and 
purity. To purify the PCR product, 3µl of amplified PCR products were separated on 1% 
agarose gel and purified using UltraClean 15 kit (MO Bio Labs, Montreal, QC) silica 
binding particle method according to the manufacturer instructions.     
  To construct the final plasmid that was transformed into E. coli, purified plasmid 
AF292555 and purified PCR product were digested with enzymes EcoRI and AatII as 
described above. The reaction mixture was separated on 1% agarose and purified with 
UltraClean 15 cleaning kit. The resulting two DNA fragments were ligated and 
transformed into E. coli DH5α as described above. The transformation mixture was 
plated on LB-KM plates and incubated at 37 °C for 24 hours. Colonies were screened by 
whole-cell PCR. Colonies that contained the correct size PCR band were selected for 
sequencing for confirmation. Primers used for sequencing are listed in Table 4.1 and 
maps of plasmids AF292555 and pQBI-25 are illustrated in Fig 4.1. A frozen stock was 
made for future studies as described above. The isolate used for the remaining 
experiments was called EC1690.   
4.2.11. Transformation of C. jejuni NCTC11168V1 and V26 with plasmid pHG101: 
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 This protocol has been modified from Miller et al. (Miller et al., 2000). Three 
strains were involved in the process of transformation: C. jejuni (streptomycin-resistant), 
DH5α (helper, containing no plasmids), and EC1690 (containing plasmid pHG101). C. 
jejuni was freshly grown from frozen as described above, restreaked on MHA 
supplemented with streptomycin and allowed to grow for 9 hours. E. coli DH5α and 
EC1690 were grown in a 5 ml broth overnight. Strains were mixed in a 1:1:10 ratio 
(donor:helper:recipient) in a sterile 1.5 ml Eppendorf tube and spotted in 10µl mating 
spots on blood agar. Mating spots were harvested after 24 hours. E. coli cells were 
removed by centrifugation for 40 seconds at 3000 X g. Supernatant was plated on MHA 
plates amended with kanamycin and streptomycin. Plates were incubated for 24-48 hours. 
Fluorescent C. jejuni colonies were detected by UV light. Colonies were restreaked on 
MHA supplemented with streptomycin and kanamycin. Frozen stock was prepared as 
described above. The plasmid was extracted by miniprep extraction and complete 
transformation of plasmid was confirmed by digestion with enzymes EcoRI and AatII, 
and by sequencing using primers listed in Table 4.1. The isolate selected for future 
experiments was named C. jejuni NCTC11168V1G.       
4.2.12. Electro-transformation of C. jejuni with pHG101: 
 One plate of C. jejuni was grown overnight from frozen stock. Growing bacteria 
were restreaked onto 3 blood agar plates with a sterile cotton swab to obtain confluent 
growth. Plates were incubated overnight and bacteria were harvested with 800 µl 
electroporation buffer (15% glycerol /9% sucrose) and centrifuged for 1.5 min at 9000 X 
g. Supernatant was decanted and cells were resuspended in 800 µl of the same buffer and 
centrifuged again. Supernatant was decanted and pellet was resuspended in 125 µl of the 
same buffer and kept on ice. For every 40 µl of cells 1 µg of plasmid DNA was added 
and mixed. The mix was transferred into a pre-chilled electroporation cuvette and cells 
were pulsed with 1.25 kV with a constant range of 4-6 mS in Gene Pulser xcell (BioRad) 
electroporater. Immediately 500 µl of SOC media was added to the cuvette and mixed 
well. Cells were plated on MHA-KM and incubated at 37 °C. Transformation of the 
bacteria was confirmed by whole-cell PCR, enzyme digestion, and sequencing.       
4.2.13. Stability of transformed pHG101 in C. jejuni in vitro: 
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Table 4.1. Primers used for amplification, colony PCR, and sequencing of plasmid 
pHG101. GFP-FWD and GFP-Rev are the sequences of primers used for amplification of 
gfp gene from pQBI-25(GFP). The forward primer contained a ribosome binding site 
sequence and the starting sequence of gfp gene and overhanging site for AatII restriction 
enzyme. The reverse primer contained the necessary sequence for amplification at low 
annealing temperature and overhang sequence for digestion enzyme EcoRI. The rest of 
the primers in the table were used for sequencing of pHG101. Primers were designed to 
span a terminal part of the gene and the vector. 
FWD: forward, Rev: reverse, GFP: green fluorescent protein. 
 
 
 
 
 
 
 
 
Primer Sequence (5’→ 3’) 
GFP-Fwd 
AATTGAATTCGGCTTATTCCCTAACTAACTAAAGATTAACTTTATA
AGGAGGAAAAACATGGCTAGCAAAGGAGAAGAACTCTTCACTGG 
 
GFP-Rev ACGTGACGTCAGTTGTACAGTTCATCCATGCCATGTGT 
1 FWD AAGCTTGCATGCCTGCAGGTCG 
1 REV CAAGGAAGATGGCAACATTCTG 
2 FWD ACAAATAGGGGTTCCGCGCACA 
2 REV GAATGTTGCCATCTTCCTTGAA 
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To determine the stability of plasmid pHG101 in the absence of selective 
antibiotic pressure, freshly grown NCTC11168V1G and NCTC11168V26G were 
restreaked on Karmali selective agar plates and Karmali agar plates supplemented with 
kanamycin. Agar plates were incubated for 24 hours before bacteria were harvested in 
PBS and centrifuged at 9000 X g for 5 minutes. The pellet was resuspended to an 
absorbance of 0.1 at O.D600, and 25 µl were subcultured on corresponding plates and 
incubated for 24 hours. The ratio of fluorescent C. jejuni growing on antibiotic free 
Karmali agar plates to kanamycin-supplemented Karmali plates was determined. The 
same process was repeated for 10 consecutive subcultures. A ratio of one would indicate 
that the plasmid is stable.  
4.2.14. Stability of transformed pHG101 in NCTC11168V1G and NCTC11168V26G 
in vivo: 
The stability of plasmid pHG101 is critical in detecting C. jejuni in vivo using 
fluorescence microscopy since the bacterium that loses the plasmid will not be detected 
using fluorescence microscopy. In vivo stability of plasmid pHG101 was tested by 
challenging 21-day old broiler chickens orally and testing for fluorescent bacteria in 
chickens. Two groups of 21-day old broiler chickens, each consisting of 12 birds, 
received a dose of 1 X 109 CFU/0.5 ml of C. jejuni. Group one received 
NCTC11168V1G, and group two received NCTC11168V26G. Cloacal swabs were 
collected on daily bases for the duration of the experiment. On day 7, chickens were 
euthanized and cecal contents were collected aseptically. Samples were serially diluted as 
described in General Materials and Methods chapter, and duplicate 25 µl were plated 
from each dilution on Karmali and Karmali agar supplemented with kanamycin. Plates 
were incubated for 48 hours at 42 °C under microaerophilic conditions. The ratio of C. 
jejuni growing in the absence of antibiotic to the ratio of C. jejuni growing in the 
presence of antibiotic was determined by dividing colony counts of respective dilutions. 
A ratio of 1 indicated that the plasmid is stable in vivo.             
4.2.15. Colonization of C. jejuni NCTC11168V1G and NCTC11168V26G in broiler 
chickens: 
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 To study colonization and systemic spread of C. jejuni in broiler chickens, two 
groups of 14 chickens were housed in VIDO animal care. Birds were C. jejuni-free when 
tested upon arrival for presence of C. jejuni using cloacal swabs. On day 21, each bird in 
group one received 1 X 109 CFU of C. jejuni NCTC11168V1G suspended in 0.5 ml 
0.85% NaCl orally, while birds in group two received 1 X 109 CFU/0.5 ml C. jejuni 
NCTC11168V26G. After 24 hours 2 birds from each group were euthanized by cervical 
dislocation, and tissue samples were collected aseptically from crop, gizzard, small 
intestine, large intestine, cecum, liver, and spleen. Each sample was placed in a separate 
sterile Petri dish and immediately processed. Tissues were cut using a surgical carbon 
steel blade (VWR, Mississauga, ON) to produce small pieces of 1-3 mM X 3-5 mM 
thickness and were placed in an individual Cryomold (VWR) that had a thin film of 
Sakura Finetek Tissue-Tek Optimal Cutting Temperature media (OCT) (VWR) covering 
the bottom, and were covered completely with OCT and placed immediately either in 
liquid nitrogen for 90 second or -80 °C freezer for 20 minutes. A cloacal swab was 
dipped into the cecal contents and streaked on Karmali agar plate to confirm the presence 
of C. jejuni by culture.  The same sampling procedure was repeated every 24 hours for 
the remaining birds. All samples were stored at -20 °C until processed.  
 Tissue sections were cut in a cryostat (Microm HM505E, Thermo Scientific, 
Nepean, ON) at 5-10 μm thickness depending on tissue type. The optimal cutting 
temperature varied depending on tissue type, generally liver, spleen, crop, and gizzard 
were cut at -12 °C and the remainder of the tissues were cut at -20 °C. Tissue sections 
were transferred to room-temperature SuperFrost Excell adhesion microscopic slides 
(VWR). Each slide contained 2-3 sections. From each tissue sample 9 sections in total 
were made. Slides were air-dried for 15 minutes, washed by dipping in PBS (+4 °C) for 3 
times, air-dried for additional 10 minutes, and fixed in acetone at 4 °C for 1 hr. Tissues 
were either covered directly by cover slip and sealed with nail polish, or mounted using 
Fluoromount (Pleaston, CA) or Cytoseal 60 low viscosity mounting medium (Richard-
Allan Scientific, Kalamazoo, MI) that does not interfere with fluorescence. Slides were 
stored in a closed box at -20 °C until inspected with fluorescent microscope.  
 Slides were studied using fluorescent microscope (Carl Zeiss Inc) using light 
transmission and fluorescein isothiocyanate (FITC) filters. Each tissue section was 
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visualized using 4X, 20X, 40X, and 100 X magnifications. If any section contained 
fluorescent C. jejuni, the sample was considered positive. If C. jejuni was not found in 
any of the 9 sections, the sample was considered negative (Tables 2 and 3). 
 Tissue samples collected from four 14-day old C. jejuni-free broiler chickens 
were used as negative controls. For positive controls, cecal contents collected from 
broiler chickens positive for C. jejuni NCTC11168V1G by culture were resuspended in 
normal saline 2 X weight, embedded in OCT media, frozen, and treated as tissue samples.    
4.2.16. Confocal microscopy: 
 Samples for confocal microscopy (Leica Microsystems) were prepared as per 
fluorescence microscopy, only Fluoromount mounting media was used for slide 
preparation to avoid any distortion in image sharpness (Mathiesen, 1973).  
4.2.17. Electron Microscopy: 
 Tissue samples collected on day 4 from a bird challenged with C. jejuni 
NCTC11168V1G and another challenged with C. jejuni NCTC11168V26G were 
processed for electron microscope imaging in addition to fluorescence microscopy. 
Selected tissues from the cecum, spleen, and liver were processed as described in General 
Materials and Methods chapter and visualized using electron microscopy. 
4.2.18. Immunohistochemistry (IHC):  
 
 To confirm the presence of C. jejuni in positive tissues, and to verify that negative 
tissues did not contain non-fluorescent C. jejuni, IHC was performed on several tissue 
samples from birds sampled on different days that were either positive or negative for 
presence of C. jejuni by culture. Biotinylated secondary antibody (Vectastain Elite ABC 
kit, VectorLabs, QC) was used to detect the attachment of an anti- C. jejuni 
NCTC11168V1 polyclonal antibody (primary antibody) generated in rabbits (a generous 
gift from Dr. Brenda Allan, VIDO) to C. jejuni in tissues. Tissues to be tested were 
sectioned at 10 μm thickness, mounted on microscopic slides, and allowed to air dry for 
15 minutes then immediately fixed in acetone at 4 °C for 1 hour. Sections were rinsed for 
5 minutes in 0.1 M PBS, and treated with 3% hydrogen peroxide for 3 minutes to quench 
any endogenous peroxidase activity. Slides were washed with a gentle stream of PBS 
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from a wash bottle, and incubated in PBS that contained 2% normal goat serum to 
eliminate any background staining. Sections were incubated with rabbit anti-C. jejuni 
NCTC11168V1 polyclonal antibody that was diluted 1:100 for 4 hours at 4 °C. Samples 
were washed with PBS and incubated for 10 minutes with biotinylated secondary 
antibody followed by a wash with buffer. Sections were incubated with VectaStain ABC 
reagent for 5 minutes and washed with PBS. Peroxidase substrate 3, 3'-diaminobenzidine 
(DAB) was prepared according to the manufacturer instructions (VectorLabs, QC) and 
incubated with sections for 4 minutes to allow for color development. C. jejuni appeared 
brownish in color if present in the section.  
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4.3. Results: 
4.3.1. Construction of gfp reporter system (pHG101): 
 Construction of a plasmid containing gfp gene was a critical step for C. jejuni 
visualization in vivo. The gfp gene was amplified using primers listed in Table 4.1, 
digested with AaTII and EcoRI and ligated to the plasmid backbone derived from 
plasmid AF292555 that was digested with the same restriction enzymes. The constructed 
plasmid contained a strong constitutively expressed promoter (Pc), Campylobacter repB 
gene required for plasmid replication, mob genes required for plasmid mobility, and 
Campylobacter KM resistance gene (aphA) (Fig 4.1). After ligation, plasmid pHG101 
was transformed into E. coli DH5α using electroporation. Transformation was confirmed 
by whole-cell PCR (Fig 4.2), restriction enzyme digestion (Fig 4.2), and sequencing.  
 Streptomycin-resistant C. jejuni NCTC11168V1 and C. jejuni NCTC11168V26 
were obtained by screening for spontaneous resistant mutants using minimally passaged 
colonies. Once streptomycin-resistant isolates were obtained, the resistance was 
confirmed by subculturing two times on MHA supplemented with streptomycin.  
 The plasmid was transferred into streptomycin-resistant C. jejuni 11168V1 by a 
tri-parental mating using 1:1:10 donor:helper:recipient ratio. Colonies growing on MHA 
supplemented with streptomycin and kanamycin after 48 hours of incubation were tested 
for fluorescence directly under a UV lamp, and the presence of the desired plasmid was 
confirmed using whole-cell PCR, restriction enzyme digestion, and sequencing.  Colonies 
growing on MHA supplemented with streptomycin-kanamycin were green-creamy in 
color under room light and fluorescent under UV illumination. Some of the C. jejuni 
colonies became fluorescent only after subculture for one time on MHA supplemented 
with streptomycin and kanamycin. Most of the colonies were found to contain the 
complete plasmid pHG101 as confirmed by sequencing.     
 Plasmid pHG101 was purified from C. jejuni NCTC11168V1G and electro-
transformed into streptomycin-resistant C. jejuni NCTC11168V26. Colonies were 
confirmed to contain pHG101 using whole-cell PCR, restriction enzyme digestion, and 
sequencing (Fig 4.2).  
C. jejuni NCTC11168V1G and C. jejuni NCTC11168V26G showed various 
shapes and forms when viewed using fluorescent and electron microscopy (Fig 4.3). Both 
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strains showed the typical C. jejuni spiral shape, and the viable but not-culturable form. 
Both strains were fluorescent regardless of their form. C. jejuni fluorescence faded 
gradually when the cells were exposed to UV illumination for more than 10 minutes. This 
process is known as photobleaching (Cormack et al., 1996).  
4.3.2. Stability of pHG101 in vitro: 
 To determine the stability of plasmid pHG101 in the absence of antibiotic 
selective pressure, the ratio of fluorescent C. jejuni NCTC11168V1G and C. jejuni 
NCTC1168V26G colonies growing on Karmali agar to fluorescent colonies growing on 
Karmali agar supplemented with kanamycin was calculated. Both strains had a ratio of ~1 
after 10 subcultures (Fig 4.4), indicating the stability of pHG101in the absence of 
kanamycin, and the suitability of the plasmid for the in vivo experiment.  
4.3.3. Stability of pHG101 in vivo: 
  One of the main objectives of this study was to develop a reliable system for 
tracking C. jejuni in vivo. The stability of plasmid pHG101in C. jejuni NCTC11168V1G 
and C. jejuni NCTC11168V26G was tested in broiler chickens. C. jejuni colonies 
cultured from cloacal swabs and cecal contents on Karmali agar plates were green in 
color when examined directly under room light and fluorescent under UV illumination. 
The level of C. jejuni NCTC11168V1G and C. jejuni NCTC11168V26G detected in the 
ceca after euthanization were similar to levels reported previously in the literature for the 
parent strains C. jejuni 11168V1 and V26 (Fig 4.5 and 4.6) (Carrillo et al., 2004). The 
ratio of colonies growing on Karmali agar to colonies growing on Karmali agar 
supplemented with kanamycin was approximately one (Fig 4.5), indicating that the 
plasmid is stable in both strains in vivo.    
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Fig 4.1. Plasmids used in construction of pHG101 (A) Map of pQBI-25 GFP plasmid, the 
source for gfp gene used in the final construct. A forward primer containing 
Campylobacter consensus sequence and 18 bp of gfp sequence was used to amplify the 
gfp gene. The reverse primer only amplified gfp gene. No other elements from this 
plasmid were amplified. (B) Structural map of plasmid AF292555 (8.9 kb). Plasmid 
contained Campylobacter mobility element (mob), repB gene required for plasmid 
replication, constitutively expressed promoter attached to gfp gene, and kanamycin 
resistance gene (aphA).  
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Fig 4.2. Confirmation of pHG101 size using restriction enzyme digestion. The final 
plasmid pHG101 was obtained by ligation of two DNA segments, the backbone from 
plasmid AF292555 was digested using EcoRI and AatII (lane 2). The gfp gene was 
amplified using primers listed in Table 4.1, extracted from agarose gel, and digested with 
the same restriction enzymes (lane 3). Growing colonies were screened for pHG101 and 
confirmation of the correct plasmid size was obtained by restriction analysis (lane 1). 
DrigestIII DNA marker was used to determine band size (lane 4)   
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Fig 4.3. Various shapes and forms of C. jejuni visualized by microscopy. All samples 
were prepared from a culture grown overnight except (D) which was prepared form 48 
hours old culture. (A) C. jejuni NCTC11168V1G 1,000x, (B) Wet-mount preparation of 
NCTC11168V1G under fluorescent microscope 630x, (C) non-typical NCTC11168V1G 
in the same sample 630x, (D) NCTC11168V1G in an aging bacterial culture 1000x, (E) 
typical NCTC11168V1G as seen under TEM 18,000x, (F) and (G) non-typical 
appearance of NCTC11168V1 from the same sample of (E), (G) is similar in appearance 
to (C) 18,000x, (H) NCTC11168V26G expressing a unipolar flagellum.  
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Fig 4.4. Stability of plasmid pHG101 in C. jejuni NCTC11168V1G and C. jejuni 
NCTC11168V26G in vitro. (A) Ratio of C. jejuni NCTC11168V1G and C. jejuni 
NCTC11168V26G growing on Karmali agar to the same strains growing on Karmali agar 
supplemented with kanamycin after subculture. Subculture 0 is the ratio of cells growing 
on Karmali agar. Bacterial growth was not affected by the presence or absence of 
antibiotic as growth ratio was ~1 after 10 subcultures. (B) Plasmid stability was 
determined by dividing the ratio of fluorescent C. jejuni growing on antibiotic free 
Karmali agar plates to Karmali agar plates supplemented with kanamycin. Each set of 
subcultures was repeated twice. Both strains maintained a fluorescence ratio above 94%. 
The same process was repeated for 10 consecutive subcultures. V1G: C. jejuni 
NCTC11168V1G, V26G: C. jejuni NCTC11168V26G. 
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Fig 4.5. Stability of plasmid pHG101 in vivo. To determine stability of pHG101 two 
groups of 21-day old broiler chickens, each consisting of 12 birds, received a dose of 1 X 
109 CFU/0.5ml in 0.85% NaCl of C. jejuni NCTC11168V1G or NCTC11168V26G 
orally. On day 7 post-challenge, chickens were euthanized and cecal contents were 
collected aseptically from ceca. Samples were serially diluted and duplicates of 25 µl 
were plated from each dilution on Karmali and Karmali-KM. Plates were incubated for 
48 hours at 42 °C under microaerophilic conditions. The ratio of C. jejuni growing in the 
presence of antibiotic to the ratio of C. jejuni growing in the absence of antibiotic was 
determined by dividing colony counts of respective dilutions. A ratio of 1 indicated that 
the plasmid is stable in vivo. All the ceca of birds challenged with C. jejuni 
NCTC11168V1G were colonized, while only 5 birds were colonized with C. jejuni 
NCTC11168 V26G. Birds that had no C. jejuni detected by culture were assigned a value 
of 400.          
V1G: C. jejuni NCTC11168V1G growing on Karmali agar plates, V26G: C. jejuni 
NCTC11168V26G growing on Karmali agar plates, V1G-KM: growth on Karmali agar 
plates supplemented with kanamycin, V26G-KM: growth on Karmali agar plates 
supplemented with kanamycin.    
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Fig 4.6. Colonization of broiler chickens by C. jejuni NCTC11168V1G and C. jejuni 
NCTC11168V26G. Two groups of 14 broiler chickens were challenged with 1 X 109 
CFU suspended in 0.5 ml 0.85% NaCl of either C. jejuni NCTC11168V1G or C. jejuni 
NCTC11168V26G at day 21 of age. Every 24 hours following the infection two birds 
from each group were euthanized and tissue samples were collected aseptically including 
the ceca. Cecal contents were processed as described in the text and samples were plated 
on Karmali selective agar plates. All the ceca of birds challenged with C. jejuni 
NCTC11168V1G were colonized, while only 3 birds were colonized with C. jejuni 
NCTC11168V26G. Birds not shedding C. jejuni were assigned the lowest detection level 
possible (400).    
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4.3.4. Colonization of C. jejuni NCTC11168V1G and NCTC11168V26G in broiler 
chickens: 
 To detect the systemic dissemination of C. jejuni NCTC11168V1G and C. jejuni 
NCTC11168V26G in broiler chickens tissues samples were collected from crop, gizzard, 
small and large intestine, ceca, spleen, and liver every 24 hours after the challenge. 
Samples were preserved by freezing in OCT embedding media and studied using 
fluorescent microscope, confocal microscope, and electron microscope. All the ceca of 
chickens challenged with C. jejuni NCTC11168V1G were colonized for the duration of 
the experiment as detected by culture of cloacal swabs and tissue sections (Table 4.2), 
while only the ceca of 3 chickens were colonized by C. jejuni NCTC11168V26G (Fig 4.6 
and Table 4.3). Fluorescent C. jejuni NCTC11168V1G and C. jejuni NCTC11168V26G 
were visible in the ceca of chickens sampled 24 hours after challenge (Table 4.2 and 4.3), 
and resided in close proximity with the intestinal surface. No bacteria were detected in 
layers beneath the mucosal surface. The large intestine of the same 3 birds that had C. 
jejuni NCTC11168V26G visible in the ceca contained the fluorescent bacteria, which 
appeared as early as 24 hours post-challenge. C. jejuni NCTC11168V26G was not 
detected in any crop, gizzard, spleen, liver, or small intestine of the challenged chickens 
for the duration of the experiment (Table 4.2 and Fig 4.7).   
C. jejuni NCTC11168V1G was detected in the small intestine, liver, and spleen 
only 3 days post-challenge (Table 4.2), but only in 29%, 35.7%, 42.9% of the total 
samples respectively. Large intestines were colonized in 64.3% of the samples and were 
colonized as early as 24 hours post-challenge. Bacteria were found either in the crypts or 
the lumen of the small and large intestine, but not in any layers beneath the mucosal 
surface. In the liver and spleen, bacteria appeared to be mainly intracellular, which was 
confirmed using IHC (Fig 4.8).         
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 Crop Gizzard Small intestine Large intestine Cecum Liver Spleen Swab
Day 1 
 
        
        
Bird 1 - - - + + - - + 
Bird 2 - - - - + - - + 
         
Day 2 
 
        
        
Bird 3 - - - - + - - + 
Bird 4 - - - + + - - + 
         
Day 3         
         
Bird 5 - - + - + + + + 
Bird 6 - - + + + - + + 
         
Day 4         
         
Bird 7 - - + + + + + + 
Bird 8 - - - - + + - + 
         
Day 5         
         
Bird 9 - - - + + + + + 
Bird 10 - - - + + - + + 
         
Day 6         
         
Bird 11 - - - - + - - + 
Bird 12 - - + + + + + + 
         
Day 7         
         
Bird 13 - - - + + - - + 
Bird 14 - - - + + - - + 
Table 4.2. Colonization of C. jejuni NCTC11168V1G in various tissues of broiler 
chickens over the period of 7 days. A total of 14 birds were challenged with 1 X 109 CFU 
orally. Tissue samples were collected from gizzard, crop, small and large intestine, ceca, 
liver, and spleen from two birds every 24 hours following the challenge. Bacteria were 
detected using fluorescent microscope. Tissues were embedded in OCT frozen section 
media and sectioned at 3-5 μm thickness. (-) No fluorescent bacteria detected in any of 
the 9 sections made from the tissue sample, (+) bacteria detected in any of the 9 sections 
made from the tissue sample. No bacteria were detected in Crop or gizzard for 7 days or 
in small intestine on days 1, 2, 5, and 7. Ceca and large intestine were colonized from day 
one, while spleen and liver were colonized as of day 3.  
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  Crop  Gizzard  Large 
intestine 
Small 
intestine 
Cecum  Liver  Spleen  Swab 
Day 1                 
Bird 1  ‐  ‐  +  ‐  +  ‐  ‐  + 
Bird 2  ‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
                 
Day 2                 
Bird 3  ‐  ‐  +  ‐  +  ‐  ‐  + 
Bird 4  ‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
                 
Day 3                 
Bird 5  ‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
Bird 6  ‐  ‐  +  ‐  +  ‐  ‐  + 
                 
Day 4                 
Bird 7  ‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
Bird 8  ‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
                 
Day 5                 
Bird 9  ‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
Bird 
10 
‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
                 
Day 6                 
Bird 
11 
‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
Bird 
12 
‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
                 
Day 7                 
Bird 
13 
‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
Bird 
14 
‐  ‐  ‐  ‐  ‐  ‐  ‐  ‐ 
Table 4.3. Colonization of C. jejuni NCTC11168V26G in tissues of broiler chickens over 
the period of 7 days. A total of 14 birds were challenged with 1 X 109 CFU orally. Tissue 
samples were collected from Gizzard, crop, small and large intestine, ceca, liver, and 
spleen from two birds every 24 hours following the challenge. C. jejuni was detected 
using fluorescent microscope. Tissues were embedded in OCT frozen section media and 
sectioned at 3-5 μm thickness. (-) No fluorescent bacteria detected in any of the 9 
sections made from the tissue sample, (+) bacteria detected in any of the 9 sections made 
from the tissue sample. No bacteria were detected in Crop, gizzard, small intestine, 
spleen. No fluorescent bacteria were detected in ceca sampled on day 4 onward.  
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Fig 4.7. Systemic spread of C. jejuni NCTC11168V1G and C. jejuni NCTC11168V26G 
in broiler chickens. Two groups each conssiting of 14 birds were challenged with 1 X 109 
CFU orally with either of the strains. Tissue samples were collected from Gizzard, crop, 
small and large intestine, ceca, liver, and spleen from two birds every 24 hours following 
the challenge. Bacteria were detected using fluorescent microscope. C. jejuni was absent 
from crop and gizzard of birds challenged with both strains, and from the spleen, liver, 
and small intestine of C. jejuni NCTC11168V26G-challenged birds. All the ceca of C. 
jejuni NCTC11168V1G-challenged birds were colonized, while only 64.3%, 42.9%, and 
35.7% of large intestine, spleen, and liver were colonized respectively.  
 
11168V1G: C. jejuni NCTC11168V1G, 11168V26G: C. jejuni NCTC11168V26G 
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Fig 4.8. Presence of fluorescent C. jejuni in the ceca of broiler chickens. (A) Fluorescent 
C. jejuni NCTC11168V1G in the cecum of a broiler chicken 3 days post-challenge 
detected using fluorescent microscope. Bacteria were associated with mucus layer and 
floating in the lumen 1000x. (B) Another section from the same tissue sample used in (A) 
visualized using light transmission, the bacteria appears to be swimming freely in the 
lumen and not attaching to the surface 1000x. (C) C. jejuni NCTC11168V26G (arrow) in 
the cecum of a broiler chicken 3 days post-challenge as detected by transmission electron 
microscope 18,000x. Bacteria were associated mainly with the mucus.    
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Fig 4.9. Fluorescent C. jejuni NCTC11168V1G in the spleen of broiler chickens. (A) C. 
jejuni in the spleen of a broiler chicken 5 days post-challenge. Bacteria appeared to be 
mainly intra-cellular, with some spleenocytes or macrophages containing more than 
bacterium 630X. (B) Immunohistochemical detection of C. jejuni using polyclonal 
antibody generated in rabbits 1000X (C) Light transmission microscope of a another 
section of tissue sample in (A) with some of the bacteria visible 1000X. (D) Laser 
scanning confocal microscope of another section from the same tissue sample used in 
(A). Background has been completely eliminated and the fluorescent spots present are C. 
jejuni NCTC11168V1G. 
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4.4. Discussion: 
 Despite the important role broiler chickens play in transmitting disease to humans, 
little is known about C. jejuni colonization and systemic spread. Early studies have 
focused mainly on the gastrointestinal tract and detected no presence in the liver or a 
limited presence in the spleen (Beery et al., 1988). Other studies that have used standard 
bacterial culture detected the systemic spread of C. jejuni beyond the gastrointestinal tract 
(Cox et al., 2006; Van Deun et al., 2008). Some of the findings in these studies were 
controversial, as C. jejuni was detected in the thymus, ceca, spleen, liver, intestine, and 
bursa of fabricius only 1 hour post oral challenge with 105-106 CFU (Cox et al., 2006). 
This is highly unlikely, as the bacteria have to disseminate systemically and reach 
lymphoid organs in numbers high enough to be detected using traditional bacterial culture 
within 1 hour. 
Theunique autofluorescence characteristic green fluorescent protein using only 
ultra violet light without any requirement for an exogenous substrate makes it an ideal 
tool for detection of C. jejuni in vitro and in vivo. The presence of a strong promoter (Pc) 
that is insensitive to regulatory signals and constitutively expressed  when fused to the 
gfp gene resulted in very brightly fluorescent C. jejuni cells both in vitro (Fig 4.4) and in 
vivo (Fig 4.8). The Pc sequence has been predicted by Wosten and colleagues (Wosten et 
al., 1998) and has been used successfully by Miller et al to detect C. jejuni on several 
plant and skin surfaces and in Caco-2 cells (Miller et al., 2000). The plasmid pHG101 
was very stable both in vitro after several passages, and in vivo 7 days post-challenge. 
This level of stability made plasmid pHG101 ideal for tracking the bacteria in vivo over 
the course of several days. The absence of kanamycin did not affect stability (Fig 4.5), 
and this allowed for an experimental design that does not require the treatment of birds 
with antibiotics that might alter the intestinal microflora. Miller et al. reported that a 
plasmid that encoded a gfp gene was very stable in vitro in several C. jejuni strains, but 
no data were presented regarding stability in animals except that C. jejuni isolated from 
the ceca of challenged birds was fluorescent (Miller et al., 2000). Green fluorescent 
protein has been used successfully to detect intestinal colonization of Lactobacillus 
delbrueckii ssp. lactis D17 (Yu et al., 2007). The plasmid carrying the gfp gene were 
stable in vitro after 10 subcultures and GFP was fully expressed, while the fluorescent 
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bacteria was present in high numbers (up to 1 X 107 CFU/g of cecal contents) in vivo 
after 72 hours of the challenge (Yu et al., 2007). Yu and colleagues were able to detect 
fluorescent Lactobacillus in tissue sections of gastrointestinal tract, but unable to detect 
any in spleen or liver using fluorescent microscope (Yu et al., 2007). C. jejuni 
NCTC11168V1G and C. jejuni NCTC11168V26G fluorescence was not affected by 
tissue processing procedures or depletion of nutrients from the growth medium. Using the 
same protocol intended for tissues collected for histopathology, including freezing, 
fixation with acetone, and mounting; the two strains remained fluorescent at the end of 
the process (Fig 4.3, 4.8, and 4.7). Taken together, the stability of the plasmid and the 
fluorescence were adequate for using this system to track C. jejuni in vivo.          
In this study, C. jejuni NCTC11168V1G was detected in the ceca and large 
intestine 24 hours post-challenge, but was not detected in the liver or spleen samples 
collected at 24 or 48 hours post-challenge (Table 4.1). C. jejuni NCTC11168V26G was 
not detected in the liver, spleen, or small intestine of any of the birds sampled (Table 4.2). 
This might be a direct result of the reduced ability to colonize the ceca and large 
intestine, as C. jejuni NCTC1168V26G was detected only in 21.4% of ceca and large 
intestine sampled (Fig 4.7), while C. jejuni NCTC1168V1G colonized 100% of the ceca 
of challenged birds. Birds colonized with C. jejuni NCTC11168V26G had a 1.5 X 107 
CFU/g of cecal contents recovered, while birds colonized with C. jejuni 
NCTC11168V1G had a slightly higher mean of 8 X 107 CFU/g of cecal contents.  These 
finding are linked to previous reports in literature that wild-type C. jejuni 
NCTC11168V26 required a high dose (108 CFU) to colonize day-old chicks, and had a 
poor bird-to-bird transmission rate that did not exceed 5% (Carrillo et al., 2004), which 
demonstrates an overall reduced virulence compared to C. jejuni NCTC11168V1 and C. 
jejuni NCTC11168V1G.          
 In this study C. jejuni preferably colonized the lumen and mucus layer of ceca and 
large intestine. Most the fluorescent bacteria detected in the intestinal tract of challenged 
birds were either in the lumen or closely associated with the mucus layer, with no direct 
observation of fluorescent bacteria in the submucusal layers. Some bacteria were closely 
associated with the mucosal surface (Fig 4.8), which is an important step in establishing 
infection and crossing intestinal barrier to establish systemic infection. It is difficult to 
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rule-out that C. jejuni crosses the intestinal barrier since the bacteria have been detected 
in spleen and liver in this study and other reports in the literature (Barot et al., 1983; 
Fernandez and Pison, 1996; Forbes et al., 2009; Whyte et al., 2006). This systemic 
spreading is likely to be initiated in the ceca or large intestine where C. jejuni colonizes 
in larger numbers. Other researchers have also found that C. jejuni colonization of the 
intestine is mainly associated with mucosal layer and could be rarely detected in the 
deeper mucosal layers (Beery et al., 1988; Smith et al., 2008; Van Deun et al., 2008). 
 C. jejuni NCTC11168V1G spreads systemically beyond the gastrointestinal tract 
as it was detected in both spleen and liver of 42.9% and 35.7% of the samples examined 
respectively. All of the birds that had C. jejuni in the liver or spleen had their ceca 
colonized but not necessarily their large intestine (Tables 4.2 and 4.3), which emphasizes 
the role the ceca are playing as a foothold in establishing C. jejuni infection. Almost all of 
the birds that have C. jejuni positive livers also had the bacteria in their spleen, with the 
exception of one bird. The detection of systemic spreading of C. jejuni using the system 
developed in this study is generally in agreement with studies that used bacterial culture 
to detect the presence of C. jejuni in liver and spleen. Meade and colleagues were not 
able to detect any C. jejuni in spleen and liver samples collected at 6 hours post-infection 
with 1 X 1010 CFU using bacterial cultures (Meade et al., 2009). Only one bird had 
detectable C. jejuni in liver and spleen 20 hours post infection (Meade et al., 2009). After 
48 hours, 62.5% of birds challenged had C. jejuni in their liver, and only 25% in their 
spleen (Meade et al., 2009). The systemic spread of C. jejuni is probably facilitated by 
cells that can carry it to a secondary lymphoid organ. The spleen in poultry has limited 
hematopoietic functions and consists mainly of lymphoid aggregations (macrophages and 
heterophils) (Jeurissen, 1991). It is considered a secondary lymphoid organ to which the 
local lymphatic system drains. The cecal tonsils consist of lymphoid aggregations that 
play a role in antigen sampling and antimicrobial peptide secretion (Akbari et al., 2008; 
Haghighi et al., 2008), and are located at the proximal part of the cecum. The continuous 
presence of C. jejuni in this area increases the chances of interaction with macrophages 
present in the cecal tonsils, which might be transferring the bacteria to the spleen.  
 Another possibility for how C. jejuni spread arises from a recent observation by 
Smith and colleagues who observed an influx of heterophils in the ceca of birds infected 
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with C. jejuni without any signs of pathology (Smith et al., 2008). C. jejuni might be able 
to use any of the cells attracted to the site of infection as a vehicle to spread systemically. 
These cells will home to a secondary lymphoid organ, which is probably the spleen, 
given the high percentage of birds that contained C. jejuni in their spleens. 
 This study has demonstrated that GFP is appropriate for studying C. jejuni 
localization in various tissues if the gene is carried on a stable plasmid. Tissue processing 
and microscopy require more labor and special equipment compared to traditional 
culture, but fluorescent tags are particularly useful in pathogenesis and co-infection 
studies (wild-type vs. mutant), as different fluorescence tags can be used to track each 
bacteria. Another disadvantage for GFP use is that tissue sections exposed to UV light 
will photobleach, and eventually lose their fluorescence, limiting the ability to archive the 
sections. Our study has demonstrated that the GFP-encoding plasmid prepared did not 
interfere with colonization or invasion and systemic spreading, which confirms the 
finding by Clark and colleagues who demonstrated that the expression of GFP itself does 
not affect the invasiveness of Salmonella but it is the architecture of the reporter system 
itself (Clark et al., 2009). This study also showed that C. jejuni NCTC111618V1 and C. 
jejuni NCTC111618V26 have a different colonization pattern. It also demonstrated that 
the colonization of the bird’s ceca is directly correlated to colonization of other organs. 
The process of systemic spread required at least 48 hours of initial colonization in the 
ceca before C. jejuni was detected in the spleen.    
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Chapter V: Colonization of Chickens and BALB/c mice by Wild-type and Paralyzed 
Campylobacter jejuni Mutants  
5.1. Introduction: 
Gastro-intestinal infection with Campylobacter jejuni remains the leading cause 
of diarrhea in humans (Ailes et al., 2008; Gillespie et al., 2008; Kubota et al., 2008; 
Thomas et al., 2008b; Yang et al., 2008). The number of C. jejuni cases per community in 
Canada ranges from 23-49 cases (Thomas et al., 2008b). The exact cost of 
campylobacteriosis is not known in Canada, but the economical burden from acute 
gastroenteritis illness caused by C. jejuni, E. coli O157, and Salmonella is $115 CAD per 
capita (Thomas et al., 2008b). In the United States, up to 4 million cases of 
campylobacteriosis are estimated to occur every year leading to an estimated 400 deaths 
caused by the bacteria or its immune-mediated sequel; Guillain-Barré Syndrome (CDC, 
2009). C. jejuni is a problem among younger population in developing countries. The 
incidence of campylobacteriosis is estimated to be as high as 40,000/100,000 cases in 
children under the age of 5 according to World Health Organization estimates (Rao et al., 
2001), in comparison to 300/100,000 for the same age group in developed countries 
(Janssen et al., 2008).   
 Handling poultry and poultry meat products is the main cause of 
campylobacteriosis, and despite the importance of this source, the pathogenesis of C. 
jejuni in broiler chickens, the major carrier, is poorly explored. Broiler chickens are 
asymptomatically infected with C. jejuni although they carry up to 1010 colony forming 
units per gram of cecal contents (Dhillon et al., 2006).  
Despite the limited understanding of C. jejuni pathogenesis in broiler chickens, 
several factors involved in colonization of the cecum and invasion of cell lines have been 
characterized. Campylobacter invasion antigens (Cia), play a role in invasion and 
internalization of C. jejuni into human intestinal cells (Rivera-Amill and Konkel, 1999), 
and deletion of the ciaB gene, and thus the only characterized Cia protein, reduces the 
ability of the mutant to colonize broiler chickens upon oral infection  (Ziprin et al., 
2002a). 
C. jejuni flagella is probably the most studied component of this bacterium. The 
fast darting motility facilitated by this structure (Guerry, 2007), and the suggested role of 
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Campylobacter invasion antigens, flagella secreted proteins, and FlaC, that are secreted 
through the flagellum in cecal colonization  (Konkel et al., 2004; Poly et al., 2007), have 
led many researchers to consider the C. jejuni flagellum the main virulence factor for this 
bacterium. Researchers have studied the effect of various mutations on the expression of 
the flagellum and the ability to colonize chickens and mice. Mutations in the flaA gene 
which encodes flagellin A, the main flagellar subunit, produced a truncated flagellum that 
is non-motile and has a reduced ability to invade human intestinal cells in vitro 
(Wassenaar et al., 1991). A C. jejuni flaA mutant did not secrete Campylobacter invasion 
antigens, while a flaB mutant , the minor flagellin subunit, secrete Cia (Konkel et al., 
2004). A flaA mutant colonized chickens efficiently (Wassenaar et al., 1993), while a 
mutation in flaB enhanced the ability to colonize chickens’ cecum (Wassenaar et al., 
1994). 
Mice are used often in studying many aspects of human diseases including 
immune response and pathogenesis. They are also used to study C. jejuni mutations that 
might affect colonization (Bacon et al., 2000). Under natural conditions, C. jejuni is not 
normally isolated from the intestinal tract of laboratory mice (Diker et al., 1992; 
Jesudason et al., 1989; Newell et al., 1985), but using various experimental settings 
colonization could be induced. Establishing a reproducible challenge model and 
understanding the pathogenesis of C. jejuni in mice will allow the utilization of genetic 
and immunological tools available. Indeed, mice have already been used to study the role 
of MyD88 (Watson et al., 2007) and NF-κB (Fox et al., 2004) in the immune response 
induced by C. jejuni.  
The role Campylobacter invasion antigens play in mucosal and systemic spread of 
C. jejuni in broiler chickens and mice is unknown. In addition, to date, no published 
study has investigated the impact of flagellar paralysis on pathogenesis of C. jejuni in 
broiler chickens and mice. In this study, the role of motility in pathogenesis of C. jejuni is 
studied using paralyzed flagella mutants that express a full-length flagellum, but are 
motility impaired (Yao et al., 1994). This paralysis is a result of an insertion mutation in 
the pflA gene, the function of which is still unknown in C. jejuni, but it is common to C. 
jejuni strains sequenced to date (Gaynor et al., 2004; Parkhill et al., 2000).    
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In this study, mucosal and systemic spread of C. jejuni is studied in broiler 
chickens and BALB/c mice. C. jejuni transformed with green fluorescent protein (GFP) 
was tracked using fluorescence microscopy. The Campylobacter invasion antigens 
secretion profile of these bacteria is also determined, and the impact these proteins might 
have on colonization is determined.      
5.2. Materials and Methods: 
5.2.1. Bacterial strains: 
 Four C. jejuni strains were used in this study. The wild-type strain C. jejuni 81-
176 is described in detail in General Materials and Methods chapter.  Strains C. jejuni 
K2-37 and K2-55 were a generous gift from Dr. Patricia Guerry (Naval Medical Research 
Center, Silver Spring, Maryland), and they are isogenic mutants of wild-type strain C. 
jejuni 81-176. The mutation was generated by an insertion mutation of kanamycin-
resistance cassette into pflA gene (Yao et al., 1994). The mutants expressed full-length 
flagella that were completely paralyzed. The ability of K2-37 and K2-55 to adhere to 
INT407 cells was not significantly affected, but their ability to invade cells was reduced 
(Yao et al., 1994). Strain NCTC11168V1G was used only in BALB/c mice and is 
described in detail in General Materials and Methods chapter. 
5.2.2. Screening for spontaneous streptomycin-resistant C. jejuni: 
 To obtain a streptomycin-resistant isolate, the same procedure described in 
Chapter IV was followed. Briefly, freshly grown C. jejuni culture was harvested in 5 ml 
MHB. The harvested bacteria were centrifuged at 2500 X g and resuspended to a 
concentration of 108-109 CFU/ml. C. jejuni was plated on MHA plates supplemented with 
100 μg/ml streptomycin and incubated at 42 °C for 24-48 hours. Colonies growing were 
restreaked twice to confirm streptomycin resistance.  
 5.2.3. Construction of Green Fluorescent Protein (GFP) plasmid and bacterial 
transformation: 
 Plasmid pHG101 was constructed as described in chapter IV. The plasmid 
contained a GFP reporter system, a Campylobacter kanamycin resistance gene, a 
mobility gene (mob), and Campylobacter origin of replication (repB), E. coli ColE1 
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origin of replication, consensus primer (Pc), and translation initiation region (TIR) 
(Miller et al., 2000). Plasmid pHG101 was purified from C. jejuni NCTC 11168V1G and 
transformed by electroporation into the three strains used in this study as described in 
chapter IV. The presence of the plasmid in the strains was confirmed by whole-cell PCR, 
enzyme digestion, and sequencing. 
5.2.4. Motility test of C. jejuni 81-176, C. jejuni K2-37, and C. jejuni K2-55: 
 To establish the motility pattern of C. jejuni 81-176, C. jejuni K2-37, and C. 
jejuni K2-55, bacteria freshly grown on MHA supplemented with 5% blood at 42 °C for 
24 hours were harvested using 0.85% NaCl and diluted to an absorbance of 0.1 at 600 nm 
wavelength (O.D600). Using a sterile inoculating needle (VWR), approximately 2 μl of the 
suspension were stabbed into the side of an 0.4% MHA and incubated at 37 °C under 
microaerophilic conditions for 48 hours. The radius of the ring of growth formed by the 
mutant was compared to that of the wild-type to determine relative motility. Wild-type 
was grown on each plate to rule out plate-to-plate variation. The experiment was repeated 
3 separate times. 
5.2.5. Transformation of plasmid pHG101: 
 The plasmid was transferred into wild-type C. jejuni 81-176, K2-37, and K2-55 
using electroporation. The experiment was conducted as described in chapter IV using 
electroporation buffer (15% glycerol /9% sucrose). For every 40 µl of cells, 1 µg of 
plasmid DNA was added and mixed. The mix was transferred into pre-chilled 
electroporation cuvettes and cells were pulsed with 1.25 kV and constant range of 4-6 mS 
in a Gene Pulser xcell (BioRad) electroporater. The resulting transformants were named 
C. jejuni 81-176G, K2-37G, and K2-55G. 
5.2.6. Electron microscope examination of flagella: 
 After transformation with pHG101, the three strains used in this study were 
negatively stained and examined using transmission electron microscopy to confirm 
flagellar expression. Samples were prepared as described in General Materials and 
Methods chapter.  
5.2.7. C. jejuni protein secretion assay:       
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 The secretion assay described by Konkel and colleagues (Konkel et al., 1999c; 
Rivera-Amill and Konkel, 1999) was used to determine if Campylobacter invasion 
antigens were secreted by the strains used in this study. C. jejuni strains were grown 
overnight on MHA supplemented with 0.1% (w/v) sodium deoxycholate at 37 °C under 
microaerophilic conditions. C. jejuni growing on each plate was harvested into 5 ml 
Eagle minimum essential medium (EMEM, ICN Biomedicals, Solon, OH). The bacterial 
suspension was centrifuged at 3,000 X g, and the supernatant was decanted. The pellet 
was resuspended in 5ml EMEM and the procedure repeated. The resulting pellet was 
resuspended in EMEM supplemented with 0.5% fetal bovine serum to an absorbance of 
0.3 at 590 nm wavelength (O.D590). Fetal bovine serum used was filtered with Amicon 
Ultra centrifugal filter (MW 30K; Millipore) to avoid gel distortions. To label secreted 
proteins, [35S] methionine (Amersham Biosiences, Baie d'Urfé, QC) was added to the 
culture medium at a final concentration of 25 μCi/ml. The mixture was transferred to a 25 
ml tissue culture flask (Corning) and incubated at 37 °C for 3 hours. After incubation, 
flask contents were centrifuged at 6,000 X g for 15 minutes and the supernatant filtered 
through 0.2 μm sterile filter (Nalgene). Equal volumes of the samples were loaded in the 
wells of a 12.5% sodium dodecyl sulfate-polyacrylamide gel. Proteins were resolved by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a 
discontinuous buffer system described by Laemmli (Laemmli, 1970). Gels were treated 
with Amplify (Amersham Life Sciences) according to the manufacturer's instructions, 
and autoradiography was performed with Kodak BioMax MR film (SIGMA). Strain C. 
jejuni NCTC11168V1 was used as a positive control, and C. jejuni NCTC11168V1flgK 
mutant was used as a negative control (Fernando et al., 2007). The secretion assays were 
repeated twice.  
5.2.8. Stability of plasmid pHG101 in C. jejuni 81-176G and K2-55G in vitro: 
To determine the stability of plasmid pHG101 in the absence of selective 
antibiotic pressure, freshly grown C. jejuni 81-176G or K2-55G were restreaked on 
Karmali agar plates supplemented with 200 μg/ml kanamycin. Agar plates were 
incubated for 24 hours, bacteria were harvested in PBS, centrifuged at 9000 X g for 5 
minutes, resuspended to an absorbance of 0.1 at 600 nm wavelength (O.D600) , and 25 µl 
were subcultured on Karmali agar plates and Karmali agar plates supplemented with 
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kanamycin and incubated for 24 hours at 42 °C. The ratio of C. jejuni growing on 
antibiotic free Karmali agar plates to Karmali agar plates supplemented with kanamycin 
was determined. The same process was repeated for 10 consecutive subcultures using the 
bacteria growing on Karmali agar plates. Each set of subcultures was repeated twice. A 
ratio of one indicates that the plasmid is stable. The number of fluorescent colonies was 
determined by counting colonies illuminated by a UV lamp.  
5.2.9. Dose titration of C. jejuni 81-176G and K2-55G in day-old chicks: 
 The ability of strains C. jejuni 81-176G and K2-55G to colonize day-old chicks 
was determined by challenging 90 birds divided into 6 groups each consisting of 15 
chickens with the doses listed in Table 5.1. The challenge dose was suspended in 0.5 ml 
0.85% NaCl and delivered orally. Cecal contents were collected 7 days post challenge 
and colonization level  represented by colony forming units/g (CFU/g) of feces were 
determined using the procedure described in General Materials and Methods chapter.     
 5.2.10. Sites of colonization of C. jejuni 81-176G and K2-55G in broiler chickens: 
 To study mucosal and systemic spread of C. jejuni 81-176G wild-type and 
paralyzed flagella mutant C. jejuni K2-55G in broiler chickens, two groups of 16 
chickens were housed at VIDO animal care. Birds were C. jejuni-free when tested upon 
arrival for presence of C. jejuni using cloacal swabs.  To confirm that the birds remained 
Campylobacter-free until challenged, cloacal swabs were collected on days 1, 7, 14 and 
21 of the experiment and plated on Karmali selective agar. On day 21, each bird in group 
one received 1 X 109 CFU C. jejuni 81-176G suspended in 0.5ml 0.85% NaCl orally, 
while birds in group two received 1 X 109 CFU/0.5 ml C. jejuni K2-55G by the same 
route. After 24 hours, 2 birds from each group were euthanized by cervical dislocation, 
and tissue samples were collected aseptically from small intestine, large intestine, cecum, 
liver, spleen, crop, and gizzard. Each sample was placed in a separate sterile Petri dish 
and immediately processed. Tissues were cut using a surgical carbon steel blade (VWR, 
Mississauga, ON) to produce small pieces of 1-3 mm X 3-5 mm thickness and were 
placed in individual Cryomold (VWR) that had a thin film of Sakura Finetek Tissue-Tek 
Optimal Cutting Temperature media (OCT) (VWR) covering the bottom, and were 
covered completely with OCT and placed immediately either in liquid nitrogen for 90  
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Group Challenge dose (CFU) Strain 
1 1.5 X 104 K2-55G 
2 2 X 103 81-176G 
3 2 X 106 K2-55G 
4 1.8 X 106 81-176G 
5 2 X 108 K2-55G 
6 1.5 X 108 81-176G 
Table 5.1. Dose titration of C. jejuni 81-176G and K2-55G in day-old chicks. The ability 
of strains C. jejuni 81-176G and C. jejuni K2-55G to colonize day-old chicks was 
determined by challenging 90 birds divided into 6 groups each consisting of 15 chickens. 
Challenge dose was suspended in 0.5 ml saline and delivered orally. Cecal contents were 
collected 7 days post challenge. 
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second or -80 °C freezer for 20 minutes. A cloacal swab was dipped into the cecal 
contents and streaked on Karmali agar plate to confirm the presence of C. jejuni by 
culture.  The same sampling procedure was repeated every 24 hours for the remaining 
birds. All samples were stored at -20 °C until processed. 
Tissues were processed as described in Chapter IV to obtain sections. From each 
tissue sample 9 sections in total were made. Slides were air-dried for 15 minutes, washed 
by dipping in PBS (+4 °C temperature) for 3 times, air-dried for additional 10 minutes, 
and fixed in acetone at 4 °C for 1 hr. Tissues were either covered directly by  
cover slip and sealed with nail polish, or mount using Fluoromount (Pleaston, CA) or 
Cytoseal 60 low viscosity mounting medium (Richard-Allan Scientific, Kalamazoo, MI). 
Slides were stored in a closed box at -20 °C until inspected with fluorescent microscope.  
 Slides were studied using fluorescent microscopy (Carl Zeiss Inc) with light 
transmission and fluorescein isothiocyanate (FITC) filters. Each tissue section was 
visualized using 4X, 20X, 40X, and 100 X magnifications. If any section contained 
fluorescent C. jejuni, the sample was considered positive. If C. jejuni was not found in 
any of the 9 sections, the sample was considered negative. 
 Tissue samples collected from four 14-day old C. jejuni-free broiler chickens 
were used as negative controls. For positive controls, cecal contents collected from 
broiler chickens positive for C. jejuni 11168V1G by culture were resuspended in normal 
saline 2 X weight, embedded in OCT media, frozen, and treated as tissue samples.    
5.2.11. Sites of colonization of C. jejuni NCTC11168V1G in BALB/c mice: 
 To establish a reliable challenge model in BALB/c mice, a pilot study was 
conducted using 5 mice housed at the VIDO animal care. Mice were treated with 
streptomycin in drinking water (3g/L) for 3 days (Wadolkowski et al., 1990). On day 4, 
each mouse orally received 1 X 1010 CFU of C. jejuni NCTC11168V1G suspended in 0.5 
ml 0.85% NaCl. Fecal samples were collected on days 1, 5, 6, 7, 9, 11, and 14 from 
individual mice using a sterile Eppendorf. Fecal material was spread on Karmali selective 
agar to determine the level of C. jejuni colonization.    
 To study mucosal and systemic colonization of C. jejuni NCTC11168V1G in the 
mouse, a group of 10 BALB/c mice were challenged with 1 X 109 CFU using the same 
protocol in the pilot study. Starting 24 hours after the challenge, two mice were 
euthanized daily and tissue samples were collected from liver, spleen, small intestine, 
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large intestine, and cecum. Fecal samples were collected from cecum to confirm shedding 
of C. jejuni from the sampled animal. Tissue samples were treated as described in 
chicken studies, and the same controls were used.  
5.2.12. Sites of colonization of C. jejuni 81-176G and K2-55G in BALB/c mice: 
 Mucosal and systemic colonization of C. jejuni 81-176G and K2-55G in BALB/c 
mice was studied using two groups of 15 mice. Each mouse received 1 X 109 CFU/0.5 ml 
0.85% NaCl orally after 3 days of streptomycin treatment as described for the pilot study. 
On days 1, 3, and 6 post challenge 5 animals from each group were euthanized and tissue 
samples collected from liver, spleen, small and large intestine, and cecum. Tissues were 
treated following the same protocol described for chicken’s tissues. All samples were 
stored at -20 °C until processed.  
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5.3. Results: 
5.3.1. Plasmid pHG101 transformation and stability in vitro: 
 The plasmid pHG101 containing GFP reporter system was transformed using 
electroporation, into a streptomycin-resistant isolate of C. jejuni 81-176 and K2-55. The 
transformed isolates were named C. jejuni 81-176G and K2-55G. The presence of the 
plasmid was confirmed using whole-cell PCR, enzyme restriction digestion, and 
sequencing (Fig 5.1).  
5.3.2. Stability of plasmid pHG101 in C. jejuni 81-176G and K2-55G in vitro: 
 To determine the stability of plasmid pHG101 in transformed strains, the ratio of 
C. jejuni 81-176G or K2-55G growing on antibiotic-free Karmali agar plates to Karmali 
agar plates supplemented with kanamycin was approximately 1 after 10 subcultures, 
indicating a very stable plasmid in these strains (Fig 5.2-A). The percentage of 
fluorescent C. jejuni 81-176G and K2-55G cells was almost always above 95% of CFU 
(Fig 5.2-B)  
5.3.3. Motility tests: 
 Motility test were performed to determine if strains C. jejuni K2-37 and K2-55 
remained paralyzed after screening for streptomycin resistance, transformation with 
pHG101, and challenging chickens.  The motility test confirmed that both strains C. 
jejuni K2-37 and K2-55 had an impaired motility. It also confirmed that the bacteria 
remained paralyzed in samples recovered from cecal contents of broiler chickens and 
mice (Fig 5.4).  
5.3.4. Electron Microscopy: 
 In order to confirm the expression of full-length flagella in strains C. jejuni 81-
176G, K2-37G, and K2-55G, samples of these strains were visualized using electron 
microscopy. Strains C. jejuni 81-176G, K2-37G, and K2-55G expressed full-length intact 
flagella upon examination with transmission electron microscope (Fig 5.3). No visible 
differences were observed among the three strains.  
 The presence of C. jejuni K2-55G in the ceca was also confirmed by electron 
microscopy (Fig 5.3). 
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5.3.5. Proteins secreted by C. jejuni: 
 A protein secretion assay using radioactively-labeled methionine detected 
Campylobacter invasion antigens secretion by strain C. jejuni 81-176, while strains K2-
37, and K2-55 had no detectable secreted proteins (Fig 5.4). Strain C. jejuni 
NCTC11168V1 was used as a positive control, and C. jejuni NCTC11168V1flgK mutant 
was used as a negative control (Fernando et al., 2007). 
5.3.6. Dose titration of C. jejuni 81-176G and K2-55G in day-old chicks: 
 The ability of strains C. jejuni 81-176G and K2-55G to colonize day-old chicks 
was determined by orally challenging 90 birds divided into 6 groups each consisting of 
15 chickens (Table 5.1). All birds that received 1 X 108 CFU/0.5 ml challenge dose in 
Groups 5 and 6 of either C. jejuni 81-176G or K2-55G respectively were colonized when 
sampled (Fig 5.5). All birds that were challenged with 1X 105 CFU/0.5 ml of C. jejuni 
81-176G were colonized, while 14 birds challenged with C. jejuni K2-55G were 
colonized when sampled on day 7 (Fig 5.5). Group two challenged with 1X 103 CFU/0.5 
ml C. jejuni 81-176G had 6 birds that were colonized, while Group one that received an 
actual dose of 1.5 X104 C. jejuni K2-55G had 8 colonized birds (Fig 5.5). This suggests a 
limited effect of motility on colonization of day-old broiler chickens over the period of 7 
days.  
 5.3.7. Sites of colonization of C. jejuni 81-176G and K2-55G in broiler chickens: 
 Mucosal and systemic presence of C. jejuni 81-176G and K2-55G in broiler 
chickens was determined by examining tissue sections, collected from broiler chickens, 
using fluorescence microscopy. C. jejuni K2-55G was not detected in any tissue sections 
of crop, gizzard, liver or spleen examined (Tables 5.2 and 5.3). C. jejuni 81-176G was 
not detected in any crop or gizzard tissue sections. Both strains were detected in cecal 
tissue sections, as C. jejuni 81-176G was present in 100% of samples, while C. jejuni K2-
55G was present in 81% of the sampled birds. C. jejuni 81-176G was present in 62% of 
large intestine samples, while C. jejuni K2-55G was present in only 43% of the samples. 
Only 25% of the small intestine of birds challenged with K2-55G had detectable bacteria, 
while 43% challenged with C. jejuni 81-176G had detectable bacteria (Fig 5.6).  
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5.3.8. Sites of colonization of C. jejuni NCTC11168V1G in BALB/c mice: 
 To determine the sites of colonization of C. jejuni NCTC11168V in BALB/c 
mice, a group of 10 mice were challenged with 1 X 109 CFU orally. Starting 24 hours 
after the challenge, two mice were euthanized daily and tissue samples were collected. 
Although all the ceca of the mice challenged had detectable C. jejuni, no C. jejuni was 
detected in the liver or spleen of any of the samples, while only two mice had detectable 
C. jejuni in their small intestine, and 6 mice had the bacteria in their large intestine (Table 
5.4 and Fig 5.7). 
5.3.9. Sites of colonization of C. jejuni 81-176G and K2-55G in BALB/c mice: 
 To determine mucosal and systemic spread of C. jejuni 81-176G and K2-55G in 
BALB/c mice, two groups consisting of 15 mice each were challenged with either strain. 
Neither C. jejuni 81-176G and K2-55G were detected in any of the spleen or liver tissue 
sections of BALB/c. C. jejuni was present in 66.6% of the ceca , 33% of large intestine, 
and 20% of small intestine of the mice challenged. C. jejuni K2-55G was present in only 
53.3% of ceca sampled, 20% of large intestine tissue sections, and in none of the small 
intestine examined ( Tables 5.5 and 5.6 Fig 5.8).   
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Fig 5.1.Confirmation of the presence of pHG101 in C. jejuni 81-176G. The plasmid size 
was confirmed using restriction enzyme digestion. The final plasmid pHG101 was 
obtained by ligation of two DNA segments, the backbone from plasmid AF292555 was 
digested using EcoRI and AatII (lane 2). The gfp gene was amplified using primers listed 
in Table 4.1, extracted from agarose gel, and digested with the same restriction enzymes 
(lane 3). Growing colonies were screened for pHG101 and confirmation of the correct 
plasmid size was obtained by restriction analysis (lane 1). DrigestIII DNA marker was 
used to determine band size (lane 4)   
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Fig 5.2. Stability of plasmid pHG101 in C. jejuni 81-176G and K2-55G in vitro. (A) 
Ratio of C. jejuni 81-176G or K2-55G growing on Karmali agar to the same strains 
growing on Karmali agar supplemented with kanamycin after subculture. Subculture 0 is 
the ratio of cells growing on Karmali agar  Bacterial growth was not affected by the 
presence or absence of antibiotic as growth ratio was ~1 after 10 subcultures. (B) Plasmid 
stability was determined by dividing the ratio of fluorescent C. jejuni growing on 
antibiotic free Karmali agar plates to Karmali agar plates supplemented with kanamycin. 
Each set of subcultures was repeated twice. Both strains maintained a fluorescence ratio 
above 94%. The same process was repeated for 10 consecutive subcultures. 
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Fig 5.3. Electron and fluorescence microscopy images of C. jejuni 81-176G and K2-55G. 
(A): Scanning EM of C. jejuni 81-176G with bi-polar flagellum. (B): Scanning EM of 
K2-55G expressing fully length but paralyzed bi-polar flagellum (14,000x). (C) and (D) 
are fluorescence microscopy images of C. jejuni 81-176G and K2-55G (respectively) 
suspended in water (1000x). (E) Fluorescence microscopy image of a cross section of the 
cecum of a BALB/c mouse 3 days post-challenge with C. jejuni 81-176G. Bacteria are 
closely associated with the mucosal surface or freely in the lumen but are not found in the 
submucosal layers. (F) Fluorescent microscope image of a cross section of the cecum of a 
BALB/c mouse 2 days post-challenge with C. jejuni K2-55G.    
A B
C D
E F
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Fig 5.4. Characterization of C. jejuni K2-37 and K2-55 motility and secreted patterns. (A) 
Proteins secreted through C. jejuni flagella (Cia) were labeled using [35S] methionine as 
described in materials and methods section and resolved using 12.5% SDS-PAGE. Lane 
1: negative control (flgK mutant), lane 2: K2-37, Lane 3: K2-55, lane 4: C. jejuni 81-176, 
and lane 5: C. jejuni NCTC1168V1. Strains K2-37 and K2-55 had no detectable 
secretions in the supernatant of the culture when co-incubated with FBS. Wild-type 81-
176 had a secretion profile comparable to the positive control (Fernando et al., 2007). (B) 
Motility pattern of K2-37 and (C) K2-55 compared to the wild-type 81-176. Freshly 
grown bacteria were diluted to an absorbance of 0.1at 600 nm wavelength (O.D600). 
Using a sterile inoculating needle (VWR), approximately 2 μl of the suspension were 
stabbed into 0.4% MHA and incubated at 37 °C under microaerophilic conditions for 48 
hours. The radius of the ring formed by mutant swarm was compared to that of the wild-
type to determine motility. Wild-type was grown on each plate to rule out plate-to-plate 
variation. The experiment was repeated 3 separate times. Both strains showed an 
impaired motility compared to the wild-type.  
 
WT: wild-type, MT: mutant.   
 
B C 
A 
WT MT 
WT MT 
110 
 
4
K2
-55
G 
1.5
 X 
10
3
81
-17
6G
 2.
0 X
 10
6
K2
-55
G 
2.0
 X 
10
6
81
-17
6G
 1.
8 X
 10
8
K2
-55
G 
2.0
 X 
10
8
81
-17
6G
 1.
5 X
 10
101
102
103
104
105
106
107
108
109
1010
1011
Challenge Dose
cf
u/
g 
of
 c
ec
al
 c
on
te
nt
 
Fig 5.5. Dose titration of C. jejuni 81-176G and K2-55G in day-old chicks. To determine 
the ability of both strains to colonize day-old broiler, six groups each consisting of 15 
birds were challenged as following: Group 1: 1.5 X 104 K2-55G, Group 2: 2 X 103 81-
176G, Group 3: 2 X 106 K2-55G, Group 4: 1.8 X 106 81-176, Group 5: 2 X 108 K2-55G, 
and Group 6: 1.5 X 108 CFU/ 0.5 ml. Challenge dose was suspended in 0.85% NaCl and 
was administered orally. Birds were euthanized and cecal contents were collected on day 
7. All birds in groups 4, 5, and 6 had detectable C. jejuni in their ceca. Birds with no 
detectable C. jejuni in cecal contents were assigned the minimum detection level value of 
400. Only one bird in Group 3 had no detectable C. jejuni, while 9 birds in Group 2 and 5 
birds in Group 1 had no detectable C. jejuni in their cecal contents.  
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 Crop Gizzard Large intestine 
Small 
intestine Cecum Liver Spleen 
Cloacal 
swab 
Day 1         
Chicken 1 - - - - + - - + 
Chicken 2 - - - - + - - + 
         
Day 2         
Chicken 3 - - + + + - - + 
Chicken 4 - - + - + - - + 
         
Day 3         
Chicken 5 - - + - + + - + 
Chicken 6 - - + - + - - + 
         
Day 4         
Chicken 7 - - + + + + + + 
Chicken 8 - - - + + + - + 
         
Day 5         
Chicken 9 - - - - + - + + 
Chicken 
10 - - - + + + + 
+ 
         
Day 6         
Chicken 
11 - - + + + - - 
+ 
Chicken 
12 - - + - + - - 
+ 
         
Day 7         
Chicken 
13 - - + - + - - 
+ 
Chicken 
14 - - - - + + + 
+ 
         
Day 8         
Chicken 
15 - - + + + + + 
+ 
Chicken 
16 - - + + + - - 
+ 
 
Table 5.2: Sites of colonization of C. jejuni 81-176G in broiler chickens. A group of 16 
birds were challenged with 1 X 109 CFU C. jejuni 81-176G suspended in 0.5ml 0.85% 
NaCl orally on day 0. Every 24 hours after the challenge two birds were euthanized and 
tissue samples were collected from crop, gizzard, small and large intestine, ceca, liver, 
and spleen. Samples were frozen and processed for examination by fluorescence 
microscopy. All birds had detectable C. jejuni in their ceca, and none in the crop or 
gizzard, while 10 birds had C. jejuni in their large intestine, seven in small intestine, six 
in the liver, and 5 in the spleen. 
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 Crop Gizzard Large intestine 
Small 
intestine Cecum Liver Spleen 
Cloacal 
swab 
Day 1         
Chicken 1 - - + - + - - + 
Chicken 2 - - - - + - - + 
         
Day 2         
Chicken 3 - - - - + - - + 
Chicken 4 - - + + + - - + 
         
Day 3         
         
Chicken 5 - - - - + - - + 
Chicken 6 - - - - - - - - 
Day 4         
         
Chicken 7 - - + + + - - + 
Chicken 8 - - - - + - - + 
Day 5         
         
Chicken 9 - - - - + - - + 
Chicken 
10 - - + - + - - 
+ 
Day 6         
         
Chicken 
11 - - - - - - - 
- 
Chicken 
12 - - + + + - - 
+ 
Day 7         
         
Chicken 
13 - - + - + - - 
+ 
Chicken 
14 - - - - + - - 
+ 
Day 8         
Chicken 
15 - - - + + - - 
+ 
Chicken 
16 - - + + + - - 
+ 
 
Table 5.3. Sites of colonization of C. jejuni K2-55G in broiler chickens. A group of 16 
birds were challenged with 1 X 109 CFU C. jejuni K2-55G suspended in 0.5ml 0.85% 
NaCl orally on day 0. Every 24 hours after the challenge two birds were euthanized and 
tissue samples were collected from crop, gizzard, small and large intestine, ceca, liver, 
and spleen. Samples were frozen and processed as described in materials and methods 
section. C. jejuni was detected in the ceca of 13 birds, seven large intestines, five small 
intestines, and none of the crops, gizzards, spleens, or livers sampled.   
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Fig 5.6. Comparison of sites of colonization of C. jejuni 81-176G and K2-55G in broiler 
chickens. Two groups of 16 birds each were challenged with 1 X 109 CFU of either C. 
jejuni 81-176G or K2-55G suspended in 0.5ml 0.85% NaCl orally. Every 24 hours after 
the challenge two birds from each group were euthanized and tissue samples were 
collected from crop, gizzard, small and large intestine, ceca, liver, and spleen. Samples 
were frozen and processed for examination by fluorescence microscopy. Neither of the 
two strains were detected in the crop or gizzard, while C. jejuni K2-55 G was not 
detected in the liver or spleen. C. jejuni 81-176 was detected in 37.5% of liver and 31% 
of spleen samples examined. All the ceca of chickens challenged with C. jejuni 81-176G 
were colonized, while only 81% of the ceca of chickens challenged with C. jejuni K2-
55G were colonized.  Large intestine of 62% and 43% of the birds, and small intestine of 
43% and 25% of birds were colonized with C. jejuni 81-176G and K2-55G respectively.  
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 Large intestine Small intestine Cecum Liver Spleen Swab 
Day 1       
Mouse 1 - - + - - + 
Mouse 2 - - + - - + 
       
Day 2       
Mouse 3 + + + - - + 
Mouse 4 + - + - - + 
       
Day 3       
Mouse 5 + - + - - + 
Mouse 6 + - + - - + 
       
Day 4       
Mouse 7 + + + - - + 
Mouse 8 - - + - - + 
       
Day 5       
Mouse 9 - - + - - + 
Mouse 10 + - + - - + 
       
 
Table 5.4. Sites of colonization of C. jejuni NCTC11168V1G in BALB/c mice. Mice 
were treated with streptomycin in drinking water (3g/L) for 3 days. On day 0, each mouse 
orally received 1 X 109 CFU of C. jejuni NCTC11168V1G in 0.5 ml 0.85% NaCl. 
Starting 24 hours after the challenge, two mice were euthanized daily and tissue samples 
were collected from liver, spleen, small intestine, large intestine, and cecum. Fecal 
samples were collected from cecum to confirm shedding of C. jejuni the sampled mice. 
Tissue samples were treated as described in chickens studies, and the same controls were 
used. Although all the ceca of the mice challenged had detectable C. jejuni, no C. jejuni 
was detected in the liver or spleen of any of the samples, while only two mice had 
detectable C. jejuni in their small intestine, and 6 mice had the bacteria in their large 
intestine. 
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Fig 5.7. Colonization of C. jejuni NCTC11168V1G in BALB/c mice. Mice were treated 
with streptomycin in drinking water (3g/L) for 3 days. On day 0, each mouse orally 
received 1 X 109 CFU of C. jejuni NCTC11168V1G in 0.5 ml 0.85% NaCl. Starting 24 
hours after the challenge, two mice were euthanized daily and tissue samples were 
collected from liver, spleen, small intestine, large intestine, and cecum. Fluorescent C. 
jejuni NCTC11168V1G was detected in 100% of the ceca, but in none of the livers or 
spleens examined. C. jejuni was detected in 60% of the large intestine and only 20% of 
the small intestine examined.  
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 Small intestine Large intestine Cecum Liver Spleen Swab 
       
Day 1  
Mouse 1 - - + - - + 
Mouse 2 - + + - - + 
Mouse 3 - - - - - - 
Mouse 4 - - + - - + 
Mouse 5 - + + - - + 
       
Day 3  
Mouse 6 - - - - - - 
Mouse 7 - - + - - + 
Mouse 8 + + + - - + 
Mouse 9 - - - - - - 
Mouse 10 - - - - - - 
       
Day 6  
Mouse 11 + + + - - + 
Mouse 12 - - + - - - 
Mouse 13 - - + - - + 
Mouse 14 - - - - - - 
Mouse 15 - + + - - + 
 
Table 5.5. Sites of colonization of C. jejuni 81-176G in BALB/c mice. Mice were treated 
with streptomycin in drinking water (3g/L) for 3 days. On day 0, each mouse orally 
received 1 X 109 CFU of C. jejuni 81-176G in 0.5 ml 0.85% NaCl. On days 1, 3, and 6 
after the challenge, 5 mice were euthanized and tissue samples were collected from liver, 
spleen, small intestine, large intestine, and cecum. Fecal samples were collected from 
cecum to confirm the presence of C. jejuni in the in feces of sampled mice. Tissue 
samples were treated as described in chickens studies, and the same controls were used. 
No C. jejuni was detected in the liver or spleen of any of the samples, while only two 
mice had detectable C. jejuni in their small intestine, and 5 mice had the bacteria in their 
large intestine.  
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 Small intestine 
Large 
intestine Cecum Liver Spleen Swab 
       
Day 1  
Mouse 1 - - - - - - 
Mouse 2 - + + - - + 
Mouse 3 - - + - - + 
Mouse 4 - - - - - - 
Mouse 5 - - + - - + 
       
Day 3  
Mouse 6 - - + - - + 
Mouse 7 - - - - - - 
Mouse 8 - - - - - - 
Mouse 9 - + + - - + 
Mouse 10 - - - - - - 
       
Day 6  
Mouse 11 - + + - - + 
Mouse 12 - - + - - + 
Mouse 13 - - - - - - 
Mouse 14 - - + - - + 
Mouse 15 - - - - - - 
 
Table 5.6. Sites of colonization of C. jejuni K2-55G in BALB/c mice. Mice were treated 
with streptomycin in drinking water (3g/L) for 3 days. On day 0, each mouse orally 
received 1 X 109 CFU of C. jejuni K2-55G in 0.5 ml 0.85% NaCl. On days 1, 3, and 6 
after the challenge, five mice were euthanized and tissue samples were collected from 
liver, spleen, small intestine, large intestine, and cecum. Fecal samples were collected 
from cecum to confirm the presence of C. jejuni in the in feces of sampled animal. Tissue 
samples were treated as described in chickens studies, and same controls were used. No 
bacteria were detected in the spleen, liver, or small intestine of any of the mice sampled. 
The bacteria were found in 3 of large intestine samples, and 8 ceca.   
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Fig 5.8. Comparison of sites of colonization of C. jejuni 81-176G and K2-55G in 
BALB/c. Two groups of 15 mice each were treated with streptomycin in drinking water 
(3g/L) for 3 days. On day 0, each mouse orally received 1 X 109 CFU of C. jejuni 81-
176G in 0.5 ml 0.85% NaCl. On days 1, 3, and 6 after the challenge, five mice were 
euthanized and tissue samples were collected from liver, spleen, small intestine, large 
intestine, and cecum. Both strains were not detected in any of liver or spleen samples. C. 
jejuni 81-176G was detected in only 20% of small intestinal samples, while C. jejuni K2-
55G was not detected in any of the small intestine samples. Strain C. jejuni 81-176G was 
detected in 66.6% of sampled ceca while C. jejuni K2-55G was detected in only 53.3% of 
sampled ceca.  
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5.4. Discussion: 
 Campylobacter jejuni pathogenesis in poultry is still poorly understood when 
compared to the pathogenesis of other enteric bacteria. Although there has been an 
increase in published studies investigating C. jejuni, the main focus has been the 
epidemiology and mechanisms of survival in the environment, and only a limited number 
of studies investigated pathogenesis.  From this limited knowledge, flagella have been 
identified as a major contributor to C. jejuni’s pathogenesis (Guerry, 2007). Flagella are 
not only a motility organelle, but also serve as a secretion system that exports several sets 
of proteins (Konkel et al., 1999c; Poly et al., 2007). The lack of appropriate tools for 
studying the pathogenesis of this unique organism has contributed to low number of these 
studies. In this study we used a green fluorescent protein reporter system to detect the 
mucosal and systemic presence of C. jejuni 81-176 and its paralyzed flagella mutant at 
various time points in broiler chickens and BALB/c mice. Two earlier studies have 
utilized C. jejuni that harbored a GFP reporter system; a study by Miller and colleagues 
that mainly investigated the stability of a plasmid carrying a GFP reporter system. Miller 
and colleagues, although they did not investigate C. jejuni’s pathogenesis, have reported 
the use of a constitutively expressed Campylobacter promoter, which enabled the 
detection of the fluorescent bacteria without any external substrates or induction and 
under a variety of environmental conditions (Miller et al., 2000).The study by Konkel and 
colleagues investigated the cells associated with intraperitoneal infection of mice with C. 
jejuni expressing GFP (Mixter et al., 2003). In our study, the promoter identified by 
Wosten and colleagues was used (Wosten et al., 1998), along with other elements from 
the same plasmid used by Miller et al. (Miller et al., 2000). The plasmid pHG101 was 
very stable in vitro after 10 subcultures with and without selective antibiotic pressure in 
both strains C. jejuni 81-176 and K2-55. The plasmid was also very stable in vivo based 
on the results obtained from the various animal trials conducted in broiler chickens and 
BALB/c mice. The study by Konkel and colleagues drew its conclusions though 
intraperitoneal administration of the bacteria and collecting peritoneal fluids a few hours 
later (Konkel et al., 2004), which is a highly artificial challenge method, as the bacteria 
are introduced to an environment in which they do not exist in under natural infection 
conditions. The model used in this study uses an oral challenge route that mimics the 
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natural infection and allows the monitoring of C. jejuni dissemination into the various 
organs of the bird or mouse providing possibly more relevant information.  
 C. jejuni K2-55 and K2-37 expressed a full-length uni- or bipolar flagella that 
appeared to be intact, but were paralyzed in both strains, resulting in a very limited 
motility. Both strains did not secret any Campylobacter invasion antigens that were 
detectable in secretion assays, which allowed us to investigate the importance of these 
proteins in pathogenesis of C. jejuni. The most noticeable difference was the detection of 
the wild-type C. jejuni 81-176 in liver and spleen, while C. jejuni K2-55 was not 
detectable in the internal organs of the birds challenged. Campylobacter invasion 
antigens have a role in internalization (Rivera-Amill and Konkel, 1999) and invasion of 
cell lines (Rivera-Amill et al., 2001), and a deletion mutation of ciaB gene reduces the 
organism’s ability to colonize the ceca of broiler chickens (Ziprin et al., 1999). In this 
study, a challenge dose of 1 X 106 of C. jejuni K2-55 was able to colonize the ceca of 
challenged birds at levels that had no statistically significant difference from the level of 
colonization of the wild-type parent strain (Fig 5.5). The difference in the outcome of 
these experiments could be due to the strain-to-strain variation and experimental design. 
The C. jejuni K2-55 strain used in this study has a different genetic background than the 
strain used by Ziprin et al. (Ziprin et al., 1999). Another important factor is that the 
strains used in this study had an insertion mutation in pflA gene, while the strain used by 
Ziprin and colleagues had a deletion mutation of the ciaB gene. Although both strains had 
no detectable Campylobacter invasion antigens in the culture supernatant, ciaB could 
have functions other than producing the secreted protein that might have affected 
colonization. Also, the deletion mutation might have had another effect that did not affect 
bacterial growth in vitro but was detrimental in vivo. In this study, the lack of 
Campylobacter invasion antigens proteins and motility contributed to the reduced ability 
of C. jejuni K2-55G in  the cecal tissues when compared to the wild-type C. jejuni 81-
176G which was present in all of the ceca examined (Tables 5.2 and 5.3). These finding 
are in agreement with results reported in the literature that loss of motility did not affect 
colonization level (Wassenaar et al., 1993). It is the loss of flagellar structure that impairs 
intestinal colonization (Fernando et al., 2007; Nachamkin et al., 1993). A difference in 
the colonization ability of C. jejuni K2-55 of day-old chicks and 21-days old chickens 
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was observed. The mutant was able to colonize all day-old chickens after one week of 
infection at a dose of 2X108 CFU, while only 81% of 21-days old birds were colonized in 
total. The changes in immune system, gut physiology and microflora might have 
influenced the ability. The difference in experimental design might also had an effect, as 
birds were euthanized daily from the 21-days old chickens challenged with C. jejuni K2-
55, reducing the density of the birds, therefore reducing the chances of bird-to-bird 
transmission.  
 C. jejuni colonization of the ceca did not necessarily extend to the small and large 
intestine for either C. jejuni 81-176 or K2-55. Although 100% of the ceca of birds 
challenged with C. jejuni 81-176 had detectable C. jejuni, only 62% of the large 
intestines and 43% of the small intestines had detectable C. jejuni. C. jejuni K2-55 had 
the same pattern of colonization and was detectable in 81% of the ceca, but only in 43% 
of the large intestine and 25% of the small intestine. These finding are in agreement with 
the results obtained using strains C. jejuni NCTC11168V1 and V26 in Chapter IV, and 
confirms that the ceca is the main colonization site for C. jejuni. These finding are also in 
agreement with the literature where numbers of C. jejuni were found significantly higher 
in the ceca than in other parts of the intestinal tract (Subler et al., 2006; Wallace et al., 
1997). The chicken’s ceca are blind–ended sacs extending from the proximal end of the 
colon at its junction with small intestine. They are the perfect environment for C. jejuni to 
thrive as they are abundant in volatile fatty acids and other nutrients, and they have a very 
limited intestinal motility compared to other parts of the chicken’s intestine which has a 
bi-directional movement and only empty once every 24-48 hours (Clench, 1995).  
In this study, fluorescent C. jejuni was only detected in the lumen and at the 
surface of the intestinal epithelium. Although many bacteria were present, no 
inflammatory reaction was observed when tissue sections were examined using light and 
transmission microscopes, confirming similar findings in the literature (Beery et al., 
1988; Meinersmann et al., 1991; Van Deun et al., 2008). 
 C. jejuni 81-176 and K2-55 colonized the intestinal tract of streptomycin treated 
BALB/c mice, but were not detectable in the spleen or liver of the mice. The absence of 
motility and Campylobacter invasion antigens affected the ability of C. jejuni K2-55 to 
colonize the mice, as only 53.3% of the ceca were colonized compared to 66.6%. 
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Researchers have used a variety of BALB/c mouse models making it difficult to draw a 
direct comparison. C. jejuni spread systemically to spleen and liver in germ-free and 
immuno-deficient mice (Chang and Miller, 2006; Jesudason et al., 1989), but not in this 
study.    
      In conclusion, the presence of flagella was sufficient for C. jejuni to colonize the 
intestine of broiler chickens and BALB/c, while the absence of motility and 
Campylobacter invasion antigens had an impact only on the systemic spread to the liver 
and spleen of broiler chickens.  
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Chapter VI: Vaccination of Broiler Chickens Against Campylobacter jejuni 
 
6.1. Introduction: 
Campylobacter jejuni is the most common cause of human bacterial 
gastroenteritis in North America. Ingestion of few hundred organisms is enough to cause 
the onset of the clinical signs (Robinson, 1981) which includes abdominal cramps, fever, 
and diarrhea (Drake et al., 1981). 
 Consumption or handling of poultry meat that is contaminated with C. jejuni has 
been identified as the main source of infections in humans (Grant et al., 1980; Petersen et 
al., 2001). C. jejuni can be introduced into broiler houses via various sources, including 
flies and other insects (Rosef and Kapperud, 1983), contaminated water (Kazwala et al., 
1990; Pearson et al., 1993), rodents (Annan-Prah and Janc, 1988), and farm workers 
(Annan-Prah and Janc, 1988; Kazwala et al., 1990). Once C. jejuni has been introduced 
into the chicken farm it spreads throughout the flock (Shanker et al., 1988, 1990), and by 
the end of the production cycle almost 100% of the chickens shed the bacteria (Shanker 
et al., 1988). Various studies have shown that fresh poultry meat products are frequently 
contaminated with C. jejuni, and depending on the study and the method of sampling,  up 
to 98% of poultry products tested were positive (Madden et al., 1998; Pearson et al., 
2000).  
 Several methods have been used in an attempt to control C. jejuni levels in the 
poultry products. These methods include on-farm strategies such as water chlorination 
and bacteriophages in feed, and post-harvest strategies such as chemical treatment of 
poultry products. Given the difficulty of controlling the sources of C. jejuni on the farm 
using biosecurity measures only, and public concerns over adding chemicals to poultry 
products, vaccination remains the most feasible alternative approach (de Zoete et al., 
2007; Wagenaar et al., 2006). The exact type of immune response that is protective in 
broiler chickens is not known. Several studies have correlated increased levels in the 
serum of IgG and IgA directed against several C. jejuni antigens with a decrease in 
shedding of C. jejuni (Cawthraw et al., 1994; Myszewski and Stern, 1990). Antibodies 
purified from the bile of chickens colonized by C. jejuni and given to naïve birds have 
increased the infective dose by 50% (Stern et al., 1990). Generally, antibodies are 
generated against C. jejuni flagellin within 2-3 weeks, but it can take up to 8 weeks to 
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generate an immune response to other C. jejuni proteins such as outer membrane proteins 
(OMP) (Cawthraw et al., 1994; Rice et al., 1997). The successful vaccine should also be 
cross protective as the same chicken flock is usually colonized by more than one strain of 
C. jejuni (Denis et al., 2008). 
In this study, the ability of vaccination with a C. jejuni paralyzed flagella mutant 
to reduce the carriage of wild-type in broiler chickens was evaluated in a variety of 
challenge models and in combination with antibiotic treatment.   
6.2. Materials and Methods: 
6.2.1. Bacterial strains and growth conditions: 
 Three C. jejuni strains were used for vaccination studies. These include strain C. 
jejuni 81-176, strain C. jejuni K2-55, which were a generous gift from Dr. P. Guerry 
(Naval Medical Research Institute, Bethesda, Md.) and strain C. jejuni NCTC11168 
variant 1 genetic background (Carrillo et al., 2004). Strain C. jejuni K2-55 shares the 
same genetic background of strain C. jejuni 81-176 but with an insertion mutation in pflA 
gene (Yao et al., 1994). These strains are described in detail in chapter III. 
 C. jejuni strains were cultured on Mueller-Hinton agar (MHA), (Difco), or 
Mueller-Hinton agar supplemented with 5% sheep blood (PML Microbiological, 
Richmond, BC) under microaerophilic conditions (10% carbon dioxide, 5% oxygen, and 
85% nitrogen) at 42̊ C. 
 The spontaneous streptomycin-resistant (SMR) isolates of C. jejuni were 
obtained by plating 109-1010 CFU/ ml on MHA plates amended with 100 µg streptomycin 
(MHA-SM). The colonies that grew were restreaked on MHA-SM plates to confirm their 
resistance. 
6.2.2. Detection of C. jejuni in the ceca of infected chickens: 
Immediately after the birds were euthanized, the ceca were aseptically removed 
and placed in individual, sterile Petri dishes.  To determine the number of colony forming 
units per gram of cecal contents, approximately 0.2-0.4 grams of cecal content were 
aseptically collected from each cecum, and weighed. Contents were diluted 1:10 using 
ice-cold 0.85% NaCl, and were vortexed for 10 seconds each. From each sample, 
dilutions of 10-1 to 10-6 were made, and 25 µl from each dilution were plated on one-third 
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of dry Karmali agar (Oxoid). Plates were incubated under microaerophilic conditions at 
42 °C for 48 hours. Chickens that had no detectable colonies were assigned the value of 
400 CFU/g (level of detection).   
 6.2.3. Collection of serum from blood samples: 
 Blood from each bird was collected from the external jugular vein into blank 
Beckton-Dickinson (BD) Microtainer micro-vacutainer tubes (BD Diagnostics, Oakville, 
ON). Tubes were incubated overnight at room temperature, and centrifuged at 8000 x g in 
a table top centrifuge at room temperature. Serum was collected, stored in cryovials and 
stored at -20 °C. 
6.2.4. Collection of cecal contents for determination of IgA level: 
 Ceca collected for detection of C. jejuni were also used to determine IgA level in 
cecal contents. From each bird, 0.2-0.4 g of feces were diluted 4 times in PBS and 
vortexed for 30 seconds. Samples were centrifuged in a tabletop centrifuge at 12,000 X g 
for 10 minutes, and the supernatant was collected and stored at -20 °C.  
6.2.5. Treatment of birds with streptomycin in drinking water: 
 When appropriate, birds were treated with streptomycin in drinking water (Myhal 
et al., 1983; Wadolkowski et al., 1990). For each treated group, 3g/L streptomycin 
(SIGMA-ALDRICH, Oakville, ON) was added to the drinking water after the birds were 
deprived for two hours of drinking water. Any water left was disposed after two hours of 
adding streptomycin. Birds were treated on days 25, 26, and 27 of the experiment.  
6.2.6. Enzyme Linked Immuno-Sorbent Assay (ELISA): 
 Whole-cell C. jejuni NCTC1168V1 or K2-55 were used to coat ELISA plates. 
Bacteria were grown overnight from frozen stock. A sterile swab was used to restreak 
growing bacteria on MHA agar supplemented with 5% sheep blood. The plates were 
grown for 18 hours at 42 °C to obtain confluent growth. Cells were harvested into 5 ml 
0.85% NaCl and resuspended in Tris-buffered saline (TBS) to an absorbance of 0.25 at 
600 nm wavelength (O.D600). Immunolon HB2 plates (Dynatech) were coated using 
100µl of antigen and incubated for 24 hours at 4 °C. Plates were washed 8 times with 
distilled water. To block the plates, 100 µl of TBS containing 0.05% Tween-20 (Fisher 
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Scientific) and 0.5% gelatin (TBS-T) (Fisher Scientific) were added to each well and 
plates were incubated over night at 4 °C. Plates were washed 8 times with distilled water 
and 100 µl of TBS-T were added to all wells except those in the first row. To each well 
of the first row, 200 µl of serum or feces containing primary antibody diluted 1:20 in 
TBS-T were added and doubling dilutions were made.  Plates were incubated for 1 hour 
at room temperature, and then washed 8 times with distilled water. Alkaline phosphatase-
conjugated goat anti-chicken immunoglobulin (IgG 200 ng/ml or IgA 50 ng/ml; Bethyl 
Laboratories Inc, Montgomery, TX, USA) were used to detect immunoglobulin (Ig) 
captured by the coating antigen. Anti-IgG antibody was used at a 1:7500 dilution in TBS-
T, while anti-IgA was used at a 1:5000 dilution. To each well, 100 µl of secondary 
antibody was added. Plates were incubated for 1 hour at room temperature, and then 
washed 8 times using distilled water. Alkaline phosphatase activity was detected using 
the substrate p-nitrophenyl phosphate (PNPP; Sigma, St. Louis, MO, USA), which was 
prepared immediately prior to use at 3 mg/ml in DE buffer (1M diethanolamine, 0.5 mM 
magnesium chloride, pH 9.5). To each well, 100 µl of PNPP solution was added. The 
absorbance was determined at 405 nm wavelength with a reference of 490 nm 
wavelength in a Bio Rad microplate reader (model # 1350) after 1 hour for serum IgG 
and after an overnight incubation for intestinal IgA. Serum IgG titers were calculated by 
the intersection of least-square regression of absorbance at 405 nm wavelength
 
versus the 
logarithm of dilution, while the absorbance at 405 nm wavelength was used to represent 
IgA activity in cecal contents.  
6.2.7. Animal Experiments: 
All procedures involving animals were carried out using protocols that were approved by 
the University of Saskatchewan Committee on Animal Use and Supply and followed the 
guidelines established by the Canadian Council for Animal Care. 
6.2.8. Statistical analysis:  
One-Way Analysis of Variance (ANOVA), assuming non-parametric data 
distribution, was used for analysis of level of colonization (CFU/g) as well as IgG and 
IgA antibody levels obtained from ELISA readings.    
6.3. Vaccination of Broiler Chickens: 
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 C. jejuni strain K2-55 was used as the vaccine strain. Bacteria were grown, from a 
pure frozen stock, on MHA supplemented with 5% sheep blood for 24 hours under 
microaerophilic conditions in a CO2 incubator at 42 °C. A sterile swab was used to 
restreak growing bacteria on MHA agar supplemented with 5% sheep blood and 
incubated for approximately 18 hours to obtain confluent growth. Cells were harvested 
into 5 ml 0.85%NaCl/plate and diluted in normal saline so that each vaccine dose 
contained 1 x 105 CFU/0.5 ml. The vaccine was delivered orally using a ball taped 
needle. From each batch of prepared vaccine 0.5 ml were used to confirm CFU/ml. The 
viable cell count was determined as previously described.  
6.3.1. Evaluation of C. jejuni K2-55 ability to protect chickens from C. jejuni 81-176 
(homologous) infection: 
 Four groups each consisting of 30 day-old chickens each were housed at the 
VIDO Animal Care Facility. Groups were housed separately for the duration of the 
experiment as illustrated in Fig 6.1. On the day of arrival, 10 cloacal swabs were 
collected from each group to confirm that the birds were C. jejuni free. On day 7, groups 
1, 2, and 3 were vaccinated as described above (Fig 6.1 and Table 6.1). Cloacal swabs for 
bacterial culture and blood samples for determination of serum antibodies were collected 
from 8 birds. From each group, 4 birds were euthanized and the ceca were collected and 
used to determine the level of C. jejuni colonization (CFU/gram counts) as described in 
chapter II. Cecal contents were also used to determine the level of IgA activity. On day 
21, groups 1, 2, and 3 received another vaccination as a booster, and the same sampling 
procedure was repeated (Fig 6.1 and Table 6.1). On days 25, 26, and 27, Groups 2 and 4 
were treated with streptomycin at a dose of 3g/L of drinking water, and on day 28, groups 
1, 2, and 4 received a challenge dose of 1 x 105 of streptomycin-resistant C. jejuni 81-
176. The challenge strain was grown as described for the vaccine strain (C. jejuni K2-55) 
and the same sampling procedure was repeated. On day 35, four birds from each group 
were sampled as described for day 7. Cecal contents from groups 1, 2, and 4 were plated 
on Karmali agar that was supplemented with kanamycin, while contents from group 2 
were plated on unsupplemented Karmali agar. On day 40, all remaining birds were 
euthanized after collecting blood samples, and cecal contents were plated as described 
above to obtain CFU/g for each bird (Fig 6.1 and Table 6.1). 
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6.3.2. Evaluation of the ability of vaccination with C. jejuni K2-55 ability to protect 
chickens from C. jejuni NCTC1168V1 (heterologous) infection: 
 The same experimental design for protection against C. jejuni 81-176 was 
followed as described above (Fig 6.1), with the exception of the challenge strain. 
Additionally, each sample from the cecal contents from groups 2 and 3 were plated on 
media with and without streptomycin. 
 
6.3.3. Evaluation of K2-55 ability to protect chickens from C. jejuni 81-176 
(homologous) infection using a seeder challenge model: 
 
 A seeder model is intended to mimic natural mode of infection and is intended 
mainly to study horizontal transmission of the bacteria (Lowry et al., 1999). In a seeder 
model, a group of chickens are challenged with a precise dose of C. jejuni orally, and 
introduced to a group of uninfected/vaccinated chickens (Fig 6.2). Three groups of 20 
chickens each were housed separately. All birds were numbered. Groups 1 and 3 received 
the first vaccination on day 7 and a booster dose on day 21. Group 2 did not receive any 
vaccination and served as unvaccinated control. These 3 groups were treated with 
streptomycin on days 25, 26, and 27. On day 28 all birds from group 3 were euthanized 
and birds from group 1 and 2 were housed together (Fig 6.2). Blood samples and cecal 
contents were collected from group 3. A fourth group of 10 Campylobacter-free chickens 
received 1x109 CFU/0.5 ml of C. jejuni 81-176 challenge orally on day 28 and housed 
with groups 1 and 2. Blood samples were collected from 6 birds from each group on day 
35. On day 42 all birds were euthanized. Blood samples were collected from all 
remaining birds and serum was collected as described above (Fig 6.2). Cecal contents 
were collected and plated as described above after euthanization.  
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Fig 6.1. Overview of experimental design to evaluate the ability of C. jejuni K2-55 to 
protect broiler chickens against colonization with the wild-type. Four groups of 30 day-
old chickens each were housed separately. Birds were vaccinated using 1 X 105 CFU/0.5 
ml of C. jejuni K2-55 orally on day 7 of age and a booster of the same strain on day 21 of 
age, and challenged with 1 X 105 CFU/0.5 ml on day 28 were applicable. For a complete 
description please refer to section 6.3.1. 
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Day Procedure 
Day 1 
 
• Chickens arrived and screened for C. jejuni 
 
Day 7 
 
• Vaccination of groups 1, 2, and 3. Group 4 
remained C. jejuni free. 
• Cecal contents, blood, and cloacal swabs 
were collected 
 
Day 21 
 
• Vaccination of groups 1, 2, and 3. Group 4 
remained C. jejuni free. 
• Cecal contents, blood, and cloacal swabs 
were collected 
 
Day 28 
 
• Challenge of groups 1, 2, and 4 
• Group 3 was not challenged 
• Cecal contents, blood, and cloacal swabs 
were collected 
Day 35 
 
• Cecal contents, blood, and cloacal swabs 
were collected 
Day 40 
 
• All remaining birds were euthanized. 
• Cecal contents and blood  were collected 
 
Table 6.1. Experimental design used to evaluate the ability of vaccination with C. jejuni 
K2-55 to protect chickens from C. jejuni 81-176 (homologous) infection. Each group 
contained 30 birds in total. Chickens were vaccinated orally using a dose of 1 x 105 
CFU/0.5 ml normal saline and challenged orally with 1 x 105 CFU/0.5 ml C. jejuni 81-
176. Cloacal swabs were used for screening chickens for C. jejuni shedding. The same 
experimental design was followed to evaluate the protection provided by C. jejuni K2-55 
against a heterologous challenge with C. jejuni NCTC11168V1. Full description of the 
experiments is provided in sections 6.3.1 and 6.3.1.  
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Fig 6.2. Experimental design for evaluation of C. jejuni K2-55 (paralyzed flagella 
mutant) ability to protect broiler chickens using a seeder model. Birds in groups 1 and 3 
received two vaccinations orally on day 7 and 21. Each vaccine dose consisted of 1 X 105 
CFU/0.5 ml of normal saline. Groups 2 and 4 received no vaccination. On days 25, 26, 
and 27 birds in groups 1, 2, and 3 received streptomycin in drinking water to eliminate 
the vaccine strain C. jejuni K2-55. On day 28 of the experiment all birds from group 3 
were euthanized, and birds from group 4 received 1 X 109 CFU/0.5 ml C. jejuni 81-176. 
Birds from groups 1, 2, and 4 were housed in the same room thereafter. On day 42 all 
birds were euthanized and cecal contents were collected. Full description of the 
experiment is provided in section 6.3.3. 
 
 
 
 
 
 
 
 
 
Group 1 
 
2 vaccinations 
 
Group 2 
 
No vaccination
Group 3 
 
2 Vaccinations
Group 4 
 
No Vaccinations
Streptomycin StreptomycinStreptomycin No Streptomycin
Day 28 
Group 4 challenged 
with 81-176(SMR) 
Group 1, 2, and 4 
mixed 
Euthanized
Day 42 Euthanized
Days 1-25 
 
Days 25-27 
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6.4. Results: 
6.4.1. Vaccination of broiler chickens with C. jejuni K2-55: 
Motility and proteins secreted via the flagella export apparatus are important in C. 
jejuni pathogenesis of broiler chickens. The vaccine strain C. jejuni K2-55 used in this 
study has paralyzed flagella and does not secret Campylobacter invasion antigens (see 
sections 5.3.3 and 5.3.5). The first step in evaluating the vaccine strain was to study the 
level at which it colonizes the cecum throughout a broiler chicken’s life. Results from 
group 3 in the experiment described in section 6.3.1were used to establish the pattern of 
C. jejuni K2-55 colonization for the duration of the experiment. Chickens that received 
1x105 CFU/0.5 ml of the C. jejuni K2-55 vaccine strain orally on day 7 of age and a 
booster vaccination of the same strain on day 21 of age remained colonized for the 
duration of the experiment as shown in Fig 6.3. No statistically significant change in the 
median of C. jejuni recovered from the cecal contents on days 21, 28, 35, and 40. C. 
jejuni K2-55 CFU counts (Fig 6.3) were 2 logs lower on day 40 than on day 35 (2 X 106 
versus 1.3 X 108 respectively).    
6.4.2. Evaluation of C. jejuni K2-55 ability to protect chickens from C. jejuni 81-176 
(homologous) infection: 
To evaluate the ability of the paralyzed flagella mutant C. jejuni K2-55 to protect 
broiler chickens from subsequent C. jejuni infection, three groups of chickens were 
vaccinated with C. jejuni K2-55 strain and challenged with C. jejuni 81-176 strain. Each 
bird in groups 1 and 2 received 1 X 105 CFU/0.5 ml of C. jejuni K2-55 orally on day 7 of 
age and a booster of the same strain on day 21 of age. Birds in group 2 were treated with 
streptomycin in drinking water on days 25, 26, and 27 of the experiment to clear the 
vaccination strain. Birds in group 4 received no vaccination, and all groups were orally 
challenged with 1 X 105 of streptomycin-resistant C. jejuni 81-176 isolate. Chickens in 
groups 1 and 2 were colonized by vaccination strain C. jejuni K2-55 as shown in Fig 6.4. 
The mean of colonization in both groups was very close as 1.8 X 107 and 1.4 X 107 CFU 
were detected on day 21. No C. jejuni was detectable in the ceca of group 4 chickens on 
day 21, indicating that the chickens remained C. jejuni-free as intended and no 
environmental contamination occurred.  
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Fig 6.3. Colonization of broiler chickens by C. jejuni K2-55 (vaccine strain). Each 
chicken received a vaccination of 1 X 105 CFU/0.5 ml of C. jejuni K2-55 orally on day 7 
of age and a booster of the same strain on day 21 of age. To serve as a vaccinated control, 
this group received no challenge with the wild-type strain. Cecal contents were collected 
on days 7, 21, 28, and 35 from 4 birds and on day 40 from all remaining birds and plated 
on Karmali plates to determine the level of colonization. Full details of the experiment 
are found in section 6.3.1 and Fig 6.1. 
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Fig 6.4. Colonization of broiler chickens by C. jejuni K2-55  on day 21 of the experiment. 
Each chicken received 1 X 105 CFU/0.5 ml orally on day 7 of age. Cecal contents from 4 
birds were collected from each group on day 21 and plated on Karmali agar plates to 
determine C. jejuni colonization level. Full details of the experiment are found in section 
6.3.1 and Fig 6.1. 
G1: Vacc w/o Antibiotic: Group 1 Vaccinated without antibiotic, G2: Vacc + Antibiotic: 
Group 2: Vaccinated and treated with antibiotic, G4: No Vaccination: Group 4: No 
vaccination. 
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No C. jejuni K2-55 was detected in the cecal contents of chickens in group 2 
(vaccinated twice and was not challenged at this point) after three days of treatment with 
streptomycin in drinking water when samples were collected on day 28 (Fig 6.5-A). 
Chickens in group 4 (challenge control, did not receive any vaccination) remained C. 
jejuni-free as no colony forming units were detectable in the cecal contents of birds 
sampled or cloacal swabs collected (Fig 6.5-A). Chickens in group 1 (vaccinated twice, 
was not treated with streptomycin) remained colonized with vaccine strain C. jejuni K2-
55, and the median for the 4 chickens sampled was 1.3 X 107 CFU/g of cecal contents 
(Fig 6.5-A).   
The cecal contents of the 4 birds sampled from each group on Day 35 (one week 
post-challenge) were plated on streptomycin-supplemented Karmali agar plates to 
determine the level of colonization of streptomycin-resistant C. jejuni 81-176. The birds 
in group 1 (vaccinated twice and did not receive any streptomycin) had a median of 1 X 
107 CFU/g of cecal contents of C. jejuni 81-176 (Fig 6.5-B). Birds in group 2 (vaccinated 
twice and received streptomycin treatment) had a median of 0.5 X 102 CFU/g of cecal 
contents as shown in Fig 6.5-B. The median of C. jejuni detected in cecal contents of 
birds in group 4 (was 2 X 108, which is comparable to group 1 (Fig 6.5-B).   
All remaining birds were euthanized on day 40, and cecal contents were plated 
from each bird on Karmali agar plates supplemented with streptomycin to detect C. jejuni 
81-176. Groups 1(vaccinated twice and was not treated with streptomycin) and 4 
(challenge control, did not receive any vaccination) had comparable medians of CFU/g of 
cecal contents, as group 1 had 1 X 108 and group 4 had 2 X 108 (Fig 6.5-C). Birds in 
group 2 (vaccinated twice and treated with streptomycin) had significantly lower (P < 
0.05) median of CFU/g of cecal contents compared to groups 1 and 4 on day 40, as only 
1.3 X 102 CFU/ were detected as shown in Fig 6.5-C.  
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Fig 6.5. Colonization of broiler chickens by C. jejuni K2-55 (vaccination strain) on day  
28 (A), and 81-176 on day 35 (B) and 40 (C) of the experiment. Group 1 (G1: Vacc w/o 
Antibiotic) contained birds that received vaccination but were not treated with 
streptomycin. Group 2 (G2: Vacc + Antibiotic) contained birds that were vaccinated and 
treated with streptomycin. Group 4 (G4: No Vaccination) contained birds that were not 
vaccinated but were challenged with the wild-type strain later in the experiment 
(challenged-unvaccinated control). Each bird in group 1 and 2 received 1 X 105 CFU/0.5 
ml of vaccine strain K2-55 orally on day 7 of age and a booster on day 21 of age. Birds in 
groups 2 and 4 were treated with streptomycin in drinking water on days 25, 26, and 27. 
Cecal contents were collected from groups 1, 2, and 4 on day 28 of the experiment (prior 
to challenge and post streptomycin treatment), day 35 (one week post-challenge), and day 
40 (12 days post-challenge) and plated on Karmali agar plates (A) and Karamali agar 
supplemented with streptomycin (B and C). Chickens sampled from Group 2 had no 
detectable C. jejuni in cecal contents sampled (A). Group 4 remained C. jejuni free until 
day 28 (A). G1: Vacc w/o Antibiotic: Group 1 Vaccinated without antibiotic, G2: Vacc + 
Antibiotic: Group 2: Vaccinated and treated with antibiotic, G4: No Vaccination: Group 
4: No vaccination. Full details of the experiment are found in section 6.3.1 and Fig 6.1. 
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6.4.3. ELISA: 
 Serum was collected from blood samples and ELISA was performed as described 
in the materials and methods section to determine the activity level of IgG antibodies. 
IgA antibody activity in cecal contents was determined using a similar ELISA protocol 
but plates were incubated overnight with the enzyme substrate (DNPP) to allow for the 
proper color intensity to develop. 
 The pre-vaccination IgG titers in the sera of the birds sampled on day 7 were 
comparable (Fig 6.6-A) as the medians were not significantly different when tested using 
one-way ANOVA. When IgG activity in the sera of the birds was tested on day 21, no 
significant difference in titers of groups 1, 2, and 4 was found when they were compared 
to each other. However, the titers of birds in group 3 (birds that were vaccinated but not 
challenged with the wild-type over the duration of the experiment), were significantly 
higher (P < 0.05) than those of group 4 (Fig 6.6-A). IgG titers in group 3 were not 
significantly higher than group 1 or 2. The same trend continued on day 28 (Fig 6.7-A), 
as IgG titers in group 3 remained higher than those of groups 2 and 4 (P < 0.05), but not 
significantly higher than the titers in group 1. On day 35 (Fig 6.7-B), birds in group 3 had 
significantly higher (P < 0.5) IgG titers than the birds sampled in all other groups. No 
significant difference was found among the other groups although the titers of group 4 
(did not receive vaccination, challenged on day 28) were lower.   
IgA activity level in the cecal contents of chickens did not change over the course 
of the experiment and no significant difference among the 4 groups was observed (Fig 
6.9-6.12). The cut-off point for a sample optical density (O.D.) to be considered positive 
was double the O.D. of the negative control.  
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Fig 6.6. IgG antibody activity in the sera of: 7 day old chickens (A) (pre-vaccination) and 
21 day old chickens (B) (two weeks post-vaccination and prior to vaccine boost). From 
each group 8 blood samples were collected and processed to generate serum. Group 1 
(G1), group 2 (G2) and group 3 (G3) were vaccinated twice using 1 X 105 CFU/0.5 ml of 
vaccine strain K2-55 orally on day 7 of age and a booster on day 21 of age. Group 4 (G4) 
did not receive any vaccination. None of the groups received streptomycin treatment up 
to this point. Chickens were found to be C. jejuni free using cloacal swabs (A). G1: Vacc 
w/o Antibiotic: Group 1 Vaccinated without antibiotic, G2: Vacc + Antibiotic: Group 2: 
Vaccinated and treated with antibiotic, G3:Vacc w/o challenge: vaccinated only with no 
challenge, G4: No Vaccination: Group 4: No vaccination. Full details of the experiment 
are found in section 6.3.1 and Fig 6.1. 
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Fig 6.7. IgG antibody activity in the sera of 28 days-old chickens. (A) (one week after a 
vaccine boost and day of challenge with C. jejuni 81-176) and 35 day old chickens (B) 
(one week post challenge with C. jejuni 81-176). From each group 8 blood samples were 
collected and processed to generate serum. Group 1 (G1), group 2 (G2) and group 3 (G3) 
were vaccinated twice using 1 X 105 CFU/0.5 ml of vaccine strain K2-55 orally on day 7 
of age and a booster on day 21 of age. Group 4 (G4) did not receive any vaccination. 
Analysis using one-way ANOVA showed significant difference (P < 0.05) in IgG 
antibody activity in the sera of group 3 compared to group 4 (A). On day 35, group 3 had 
significantly higher (P < 0.05) IgG titers than all other groups (B). Titers among other 
groups were not significantly different.   G1: Vacc w/o Antibiotic: Group 1 Vaccinated 
without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and treated with 
antibiotic, G3:Vacc w/o challenge: vaccinated only with no challenge, G4: No 
Vaccination: Group 4: No vaccination. Full details of the experiment are found in section 
6.3.1 and Fig 6.1. 
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Fig 6.8. IgG antibody activity in the sera of chickens 12 days post-challenge. From all the 
birds remaining in each group blood samples were collected and processed to generate 
serum. Group 1 (G1), group 2 (G2) and group 3 (G3) were vaccinated twice using 1 X 
105 CFU/0.5 ml of vaccine strain K2-55 orally on day 7 of age and a booster on day 21 of 
age. Group 4 (G4) did not receive any vaccination. Analysis using one-way ANOVA 
showed no significant difference among the groups IgG titers. G1: Vacc w/o Antibiotic: 
Group 1 Vaccinated without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and 
treated with antibiotic, G3:Vacc w/o challenge: vaccinated only with no challenge, G4: 
No Vaccination: Group 4: No vaccination. Full details of the experiment are found in 
section 6.3.1 and Fig 6.1. 
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Fig 6.9. IgG antibody activity in the sera from chickens vaccinated with C. jejuni K2-55 
for the duration of the experiment (Group 3, which received two vaccinations and no 
challenge or antibiotic treatment). Blood samples were collected from 8 chickens on each 
time point. Analysis using one-way ANOVA showed no significant difference among the 
time points. Full details of the experiment are found in section 6.3.1 and Fig 6.1. Day 7: 
day of first vaccination, Day 21: day of second vaccination, Day 35: one week post-
challenge, Day 40: twelve days post-challenge.  
 
 
145 
 
Pre-vaccination
G1
: V
ac
c w
/o 
An
tib
iot
ic
G2
: V
ac
c w
ith
 A
nti
bio
tic
G3
: V
ac
c o
nly
G4
: C
ha
lle
ng
e o
nly
0.0
0.1
0.2
0.3
A
Groups
O
.D
.
 
 
Pre-Boost
G1
: V
ac
c w
/o 
An
tib
iot
ic
G2
: V
ac
c w
ith
 A
nti
bio
tic
G3
: V
ac
c o
nly
G4
: C
ha
lle
ng
e o
nly
0.0
0.1
0.2
0.3
B
Groups
O
.D
.
 
Fig 6.10. IgA antibody activity level in cecal content of 7 days-old chickens (pre-
vaccination) (A) and 21 days-old chickens (pre-boost and 14 days post-vaccination) (B). 
Ceca were collected from 4 chickens from each group and processed as described in text. 
Group 1 (G1), group 2 (G2) and group 3 (G3) were vaccinated twice using 1 X 105 
CFU/0.5 ml of vaccine strain C. jejuni K2-55 orally on day 7 of age and a booster on day 
21 of age. Group 4 (G4) did not receive any vaccination. Analysis using one-way 
ANOVA showed no significant difference among groups. G1: Vacc w/o Antibiotic: 
Group 1 Vaccinated without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and 
treated with antibiotic, G3:Vacc only: vaccinated only with no challenge, G4: No 
Vaccination: Group 4: No vaccination. Full details of the experiment are found in section 
6.3.1 and Fig 6.1. 
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Fig 6.11. IgA antibody activity in cecal content of 28 days-old chickens (7 days post-
boost and pre-challenge) (A) and 35 days-old chickens (7 days post-challenge) (B). Ceca 
were collected from 4 chickens from each group and processed as described in text. 
Group 1 (G1), group 2 (G2) and group 3 (G3) were vaccinated twice using 1 X 105 
CFU/0.5 ml of vaccine strain C. jejuni K2-55 orally on day 7 of age and a booster on day 
21 of age. Group 4 (G4) did not receive any vaccination. G1, G2, and G4 were 
challenged on day 28 1 X 105 CFU/0.5 ml. Analysis using one-way ANOVA showed no 
significant difference among groups. G1: Vacc w/o Antibiotic: Group 1 Vaccinated 
without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and treated with 
antibiotic, G3:Vacc only: vaccinated only with no challenge, G4: No Vaccination: Group 
4: No vaccination. 
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Fig 6.12. IgA antibody activity in the cecal contents of 40 day old chickens (12 days post-
challenge). Ceca were collected from all remaining chickens in all groups and processed 
as described in text. Group 1 (G1), group 2 (G2) and group 3 (G3) were vaccinated twice 
using 1 X 105 CFU/0.5 ml of vaccine strain C. jejuni K2-55 orally on day 7 of age and a 
booster on day 21 of age. Group 4 (G4) did not receive any vaccination. G1, G2, and G4 
were challenged on day 28 1 X 105 CFU/0.5 ml. Analysis using one-way ANOVA 
showed no significant difference among groups. G1: Vacc w/o Antibiotic: Group 1 
Vaccinated without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and treated 
with antibiotic, G3:Vacc only: vaccinated only with no challenge, G4: No Vaccination: 
Group 4: No vaccination. 
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6.4.4. Evaluation of  the ability of vaccination with C. jejuni K2-55 to protect 
chickens from C. jejuni NCTC11168V1 (heterologous) infection: 
 C. jejuni NCTC11168V1 has been used in several studies at VIDO as well as 
studies described in Chapters IV and V, making it an ideal strain to evaluate the ability of 
vaccination with C. jejuni K2-55 to protect against a heterologous challenge (Carrillo et 
al., 2004; Fernando et al., 2008; Fernando et al., 2007).  
 Chickens vaccinated with strain C. jejuni K2-55 were colonized throughout the 
experiment, at levels comparable to the challenge strain when groups were sampled on 
day 21 (Fig 6.13-A) with no significant difference among the 4 groups using one-way 
ANOVA. Birds in Groups 2 and 4 received streptomycin treatment in drinking water on 
days 25, 26, and 27 to reduce carriage of the vaccine strain C. jejuni K2-55. Birds 
sampled on day 28 (7 days after the boost) in Groups 1 and 3 remained colonized at the 
same level as day 21 (Fig 6.13-B). Chickens in Group 4 remained C. jejuni-free when 
cecal contents were plated on Karmali agar plates. Only two chickens in Group 2 were 
negative for C. jejuni K2-55, while the other two had an average of 2 X 104 CFU/g of 
cecal contents. On day 35 cecal contents from birds sampled from all groups were plated 
on Karmali-streptomycin agar plates indicated that birds were colonized with strain C. 
jejuni NCTC1168V1 (Fig 6.14-A). Cecal contents from birds sampled from Group 2 
were additionally plated on Karmali agar plates with no streptomycin to test if C. jejuni 
K2-55 would grow. No significant difference in number of colonies growing on media 
with or without streptomycin. The ceca of birds remaining in Groups 1, 2, and 4 were 
colonized with C. jejuni 11168V1 on day 42 (Fig 6.14-B). C. jejuni K2-55 levels in the 
ceca of Group 3 (vaccinated twice and did not receive any challenge) were significantly 
lower (P < 0.05) than C. jejuni 11168V1 levels in ceca of other groups (Fig 6.14-B). No 
significant difference among groups 1, 2, and 4 was found using one-way ANOVA.    
6.4.5. ELISA results of challenge with C. jejuni NCTC11168V1: 
 IgG titer levels in the sera of birds did not change significantly throughout the 
experiment (Fig 6.15-6.17). When birds were sampled one week post-challenge with 
wild-type IgG levels were higher in group 1 but not enough to be significant.  
 IgA levels in the cecal contents did not increase significantly throughout the 
experiment (Fig 6.17-B).  
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Fig 6.13. Colonization of broiler chickens by C. jejuni K2-55 on (A) day 21(Two weeks 
post vaccination, pre-boosting) and (B) on day 28 of the experiment (Day of challenge 
and one week post-boosting). Group 1 (G1), group 2 (G2) and group 3 (G3) were 
vaccinated twice using 1 X 105 CFU/0.5 ml of vaccine strain C. jejuni K2-55 orally on 
day 7 of age and a booster on day 21 of age. Group 4 (G4) did not receive any 
vaccination, and G3 was not challenged with the wild-type. Cecal contents were collected 
from 4 birds from each group. Birds in groups 2 and 4 received streptomycin treatment 
on days 25, 26, and 27 (B). Birds were challenged on day 28 with C. jejuni 
NCTC1168V1. G1: Vacc w/o Antibiotic: Group 1 Vaccinated without antibiotic, G2: 
Vacc + Antibiotic: Group 2: Vaccinated and treated with antibiotic, G3:Vacc only: 
vaccinated only with no challenge, G4: No Vaccination: Group 4: No vaccination. Full 
details of the experiment are found in section 6.3.2 and Fig 6.1. 
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Fig 6.14. Colonization of broiler chickens by streptomycin-resistant C. jejuni 
NCTC1168V1 on (A) day 35 of the experiment (One week post-challenge) and (B) day 
42 of the experiment (Two weeks post-challenge). Group 1 (G1), group 2 (G2) and group 
3 (G3) were vaccinated twice using 1x105 CFU/0.5 ml of vaccine strain C. jejuni K2-55 
orally on day 7 of age and a booster on day 21 of age. Group 4 (G4) did not receive any 
vaccination, and G3 was not challenged with the wild-type. Cecal contents were collected 
from 4 birds on day 35 from each group, and from all remaining birds on day 42 and 
plated on Karmali-SM. In addition, cecal contents from G2 were plated on streptomycin-
free plates to allow for the vaccine strain to grow. No significant difference was found on 
day 35, but G3 had significant difference (P < 0.05) when analyzed using one-way 
ANOVA. G3 was colonized with K2-55 only. G1: Vacc w/o Antibiotic: Group 1 
Vaccinated without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and treated 
with antibiotic plated on Karmali-SM, G2: Vacc + Antibiotic S-: Vaccinated and treated 
with antibiotic plated on Karmali, G3:Vacc w/o challenge: vaccinated only with no 
challenge, G4: No Vaccination: Group 4: No vaccination. 
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Fig 6.15. IgG antibody activity in the sera of (A) 7 days-old chickens (pre-vaccination), 
and (B) of 21 days-old chickens (two weeks post-vaccination, pre-boost). Group 1 (G1), 
group 2 (G2) and group 3 (G3) were vaccinated twice using 1 X 105 CFU/0.5 ml of 
vaccine strain C. jejuni K2-55 orally on day 7 of age and a booster on day 21 of age. 
Group 4 (G4) did not receive any vaccination, and G3 was not challenged with the wild-
type. Blood samples were collected from 8 birds. Analysis using one-way ANOVA 
showed no significant difference among groups. G1: Vacc w/o Antibiotic: Group 1 
Vaccinated without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and treated 
with antibiotic, G3:Vacc only: vaccinated only with no challenge, G4: No Vaccination: 
Group 4: No vaccination. Full details of the experiment are found in section 6.3.2 and Fig 
6.1. 
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Fig 6.16. IgG antibody activity in the sera of (A) 28 days-old chickens (one week post-
boost and day of challenge), and (B) 35 day old chickens (one week post-challenge). 
Group 1 (G1), group 2 (G2) and group 3 (G3) were vaccinated twice using 1 X 105 
CFU/0.5 ml of vaccine strain K2-55 orally on day 7 of age and a booster on day 21 of 
age. Group 4 (G4) did not receive any vaccination, and G3 was not challenged with the 
wild-type. Blood samples were collected from 8 birds. Analysis using one-way ANOVA 
showed no significant difference among groups. G1: Vacc w/o Antibiotic: Group 1 
Vaccinated without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and treated 
with antibiotic, G3:Vacc only: vaccinated only with no challenge, G4: No Vaccination: 
Group 4: No vaccination. Full details of the experiment are found in section 6.3.2 and Fig 
6.1. 
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Fig 6.17. IgG (A) and IgA (B) antibody titers in the sera of 42 days old chickens (two 
weeks post-challenge). Group 1 (G1), group 2 (G2) and group 3 (G3) were vaccinated 
twice using 1 X 105 CFU/0.5 ml of vaccine strain K2-55 orally on day 7 of age and a 
booster on day 21 of age. Group 4 (G4) did not receive any vaccination, and G3 was not 
challenged with the wild-type. Blood samples and ceca were collected from all remaining 
birds in all groups. Analysis using one-way ANOVA showed no significant difference in 
IgG (A) or IgA (B) titers among groups. G1: Vacc w/o Antibiotic: Group 1 Vaccinated 
without antibiotic, G2: Vacc + Antibiotic: Group 2: Vaccinated and treated with 
antibiotic, G3:Vacc only: vaccinated only with no challenge, G4: No Vaccination: Group 
4: No vaccination. Full details of the experiment are found in section 6.3.2 and Fig 6.1. 
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Fig 6.18. Colonization of broiler chickens by C. jejuni 81-176 on day 42 of the 
experiment in a seeder model. Birds in Group 1 (G1: Vaccinated) were vaccinated orally 
on day 7 and day 21 using 1 X 105 CFU of C. jejuni K2-55 suspended in 0.5 ml normal 
saline. Birds in Group 2 (G2: Non-vaccinated) did not receive any vaccination or 
challenge. Birds in Group 4 (G4: Challenged) were challenged orally on day 28 with 1 X 
109 CFU/0.5 ml of normal saline. All birds were euthanized on day 42 and cecal contents 
were plated in Karmali-SM plates. Analysis using one-way ANOVA showed no 
significant difference among groups. Full details of the experiment are found in section 
6.3.3 and Fig 6.2. 
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Fig 6.19. IgG antibody activity in the sera of 28 day old chickens (day of challenge) in a 
seeder model. Birds in group 1 and 3 have received two oral vaccinations. Each vaccine 
dose contained 1 X 105 CFU/ml. Birds in group 2 have received no vaccinations and 
remained C. jejuni free as detected by cloacal swabs. Analysis using one-way ANOVA 
showed no significant difference among groups. Full details of the experiment are found 
in section 6.3.3 and Fig 6.2. 
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Fig 6.20. IgG antibody activity in the sera of 42 day old chickens (two weeks post-
challenge). Group 1 birds have received two vaccinations on day 7 and 21. Group 2 birds 
did not receive any vaccinations or oral challenge. Group 4 birds were challenged on day 
28 with 1 X 109 CFU/0.5 ml C. jejuni 81-176. Chickens were housed in the same room as 
of day 28. Blood samples were collected from all birds. Analysis using one-way ANOVA 
showed no significant difference among groups. Full details of the experiment are found 
in section 6.3.3 and Fig 6.2. 
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6.5. Discussion: 
 Despite C. jejuni being the leading cause of bacterial gastroenteritis in North 
America (Thomas et al., 2008b; WHO, 2001), and handling and consumption of poultry 
being the major source of infection (Stern et al., 2003; Vellinga and Van Loock, 2002), 
no vaccine is yet available for use in humans or chickens. The objective of this study was 
to evaluate the ability of paralyzed flagella mutant C. jejuni K2-55 to protect broiler 
chickens from infection with homologous wild-type C. jejuni 81-176 and heterologous 
strain C. jejuni NCTC11168V1. The data obtained from Chapter IV demonstrated that C. 
jejuni K2-55, which expresses a paralyzed flagellum and cannot produce Campylobacter 
invasion antigens (Cia), colonized chickens mucosal surfaces but failed to spread 
systemically to other organs. This balanced colonization ability made C. jejuni K2-55 an 
ideal candidate for a vaccine. The poor understanding of pathogenesis of C. jejuni in 
broiler chickens makes live attenuated vaccine, at the moment, a better choice than 
subunit vaccines since the protective antigens are not known. 
 The vaccine strain C. jejuni K2-55 was able to persist in broiler chickens’ ceca 
throughout the experiment. However, the bacterial counts started to decline towards the 
end of the experiment, as the median was 2 logs lower on day 40 than on day 35 (2 X 106 
versus 1.3 X 108 respectively), indicating that birds started clearing C. jejuni K2-55 from 
the ceca. Based on the data obtained from these sets of experiments, the specific cause of 
this decline is unknown, but the fact that IgG antibody titers have increased might have 
affected bacterial counts. Also, as birds grew, the physiology and microflora of their 
intestinal tract starts to change, and this might have affected the ability of this motility 
and Cia deficient vaccine strain to persist at a higher number (Rehman et al., 2007; Van 
Immerseel et al., 2005). Vaccine strain C. jejuni K2-55 CFU/g of cecal contents in 
samples collected on day 21 before the challenge were high, indicating persistent 
colonization ability. Boosting with another vaccination dose on day 21 might have 
extended the high levels of C. jejuni K2-55 persistence in the ceca. Future experiments 
are required to determine if this strain is capable of persisting throughout the lifespan of a 
broiler chicken if given once only. This mutant has a much better potential than mutants 
described in literature that failed to colonize chickens’ ceca, as they were attenuated to a 
level that they could not persist (Ziprin et al., 2002b). To date, the only promising 
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vaccine candidate reported is a Salmonella strain expressing CjaA protein (Wyszynska et 
al., 2004). 
 
 To evaluate the ability of C. jejuni K2-55 to protect against homologous and 
heterologous challenge, two different bacterial challenge models were used. In the first 
model, every chicken was orally challenged using a specific dose of the wild-type strain, 
while in the second model, referred to as a seeder model, a small group of birds was 
challenged using the wild-type and then introduced to a larger group of chickens. 
Challenging individual chickens allowed for more accuracy, guaranteeing that every 
single chicken received the same amount of bacteria. The seeder model mimics the 
conditions found on a poultry farm, where the infection is thought to be introduced to a 
small group of birds before spreading throughout the flock (Conlan et al., 2007; Hald et 
al., 2007). A modification to the first challenge model was using streptomycin to 
eliminate the vaccine strain C. jejuni K2-55 (streptomycin sensitive) in one of the 
vaccinated groups. Including this group has allowed for discrimination between the role 
of a possibly protective immune response mounted by the bird, and the niche-filling role 
of C. jejuni K2-55 which might prevent the wild-type from colonization in the first place 
in a manner similar to competitive exclusion. When chickens were challenged with C. 
jejuni 81-176 (as described in section 6.3.1), birds receiving streptomycin treatment in 
drinking water had significantly lower C. jejuni 81-176 in their cecal contents on day 40 
in comparison to the control group that received no vaccination, while birds that did not 
receive streptomycin treatment had no protection. The control group (Group 4), which 
also received streptomycin treatment, was colonized by a high number of CFU/g of cecal 
contents. Birds in Group 1, which received two vaccinations but no streptomycin 
treatment, also had high CFU/g of cecal contents, and were not significantly different 
from Group 4. The combination of vaccination and antibiotic treatment had significantly 
reduced bacterial counts in the cecal contents of Group 2, with 7 birds that had no 
detectable bacterial shedding. Based on the IgG titers observed in challenge with C. 
jejuni 81-176, no significant difference was observed among the median of 4 groups. 
However, the median of IgG titers in Group 1 (2 vaccination with no streptomycin), 
Group 2 (2 vaccination + streptomycin treatment), and Group 4 (received no vaccination 
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but was challenged with wild-type) were constantly lower than Group 3 as of day 21. On 
the other hand, IgA titers in cecal contents did not change throughout the experiment in 
any of the groups. Taken together, although C. jejuni K2-55 persistently colonized broiler 
chickens, it did not increase the levels of secretory IgA, and had a neutralizing effect on 
IgG antibodies, which was lower on day 21 in comparison to day 7 except for Group 3. 
This interference has been reported in studies targeting vaccination at an early age in 
chickens against Salmonella. Maternal antibodies are transferred passively into the egg 
yolk of the breeder chicken, and then absorbed by the growing embryo and deposited into 
the blood circulation (Kramer and Cho, 1970; Schiemann and Montgomery, 1991). 
During the first week of age, these maternal antibodies can still cross the intestinal barrier 
and interact with their target (Dohms et al., 1978; Schiemann and Montgomery, 1991). 
The short lifespan of broiler chickens and the early exposure of chickens to bacterial 
infections require vaccination of the birds as early as possible. The vaccine regime 
followed in this study consisted of an early vaccination on day 7 and a booster dose on 
day 21. The relatively high levels of IgG maternal antibodies in the sera of these birds 
may have reduced the efficacy of the first vaccination by interfering with 
colonization/replication of the vaccine strain (Hassan and Curtiss, 1996). This 
interference was reflected in the inability of the vaccine strain to prevent the colonization 
of the wild-type on day 28. In Group 2, the modification of the microflora caused by 
streptomycin, combined with the immune response to the vaccine strain was protective 
against homologous challenge. When chickens were challenged with C. jejuni 
NCTC11168V1, although the same experimental design was followed, the combination 
of streptomycin treatment and vaccination were not enough to protect. This is not 
unexpected, as live C. jejuni vaccines usually provide protection against homologous 
challenge (Abimiku et al., 1989; Scott, 1997; Widders et al., 1996). 
 Using the seeder model was an important step to evaluate the ability of C. jejuni 
K2-55 to prevent colonization of the homologous wild-type in a poultry industry setting. 
However, no significant difference was detected between vaccinated and non-vaccinated 
groups one week post-challenge. Since antibody titers obtained in this experiment were 
comparable to the ones obtained while chickens were housed separately (section 6.3.1), it 
is possible that streptomycin treatment in the experiment did not produce the same 
160 
 
changes in intestinal microflora that were previously protective. The streptomycin 
treatment regimen was enough to clear C. jejuni K2-55from the intestine of vaccinated 
birds sampled on day 28, indicating how significant the change to the microflora could 
be.  
In summary, vaccination with paralyzed flagella mutant C. jejuni K2-55 
combined with streptomycin treatment protected birds from colonization by wild-type C. 
jejuni 81-176. A modification to the experimental design should mainly apply to seeder 
model challenge, were chickens should be euthanized within 7 days of challenge. This 
might limit the exposure to C. jejuni and allow the protective effect of the vaccine to be 
demonstrated.   
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Chapter VII: Chicken Macrophage Inflammatory Response to Wild-type and 
Paralyzed Flagella Mutant of C. jejuni 
 
7.1. Introduction: 
 
 Campylobacter jejuni is a leading cause of bacterial food-borne diarrheal disease 
throughout the world (Allos, 2001). Ingestion of a small dose of 500 microorganisms is 
enough to cause disease in humans (Black et al., 1988). C. jejuni infections have been 
mainly associated with mishandling of poultry meat (Harris et al., 1986; Istre et al., 
1984). Although C. jejuni frequently colonizes the gastrointestinal tract of chickens with 
up to 1012 colony forming units (CFU) per gram of cecal content (Meade et al., 2009), it 
does not cause any apparent disease (Soerjadi et al., 1982). The reason why C. jejuni 
causes disease in humans but not in chickens is still unknown.      
Macrophages are a group of heterogeneous cells which are found throughout the 
body (Gordon and Taylor, 2005). The earliest description of macrophages was by Elie 
Metchinkoff, who described the process of clearance of foreign bodies (including micro-
organisms) by a group of leukocytes which he named macrophages (Gordon, 2007). 
Today, the macrophage’s vital role in both innate and adaptive immunity is well 
established. Through phagocytosis of invading micro-organisms and clearance of 
apoptotic and necrotic cells, macrophages secrete various signaling molecules that 
orchestrate the immune response (Gordon, 2007). Most of the limited knowledge 
available about chicken macrophages comes from the study of a macrophage-like 
laboratory cell lines available, mainly HD11, and not primary cells isolated from the bird, 
as it is difficult to isolate chicken macrophages due to their circulatory nature (Rose and 
Hesketh, 1974). The use of a laboratory cell line limits the conclusions that research can 
make about the role of chicken macrophages. The limited array of tools available for 
studying chicken’s macrophages also contributes to the lack of information available. 
The HD11 cell line was originally named LSCC-HD (MC/MA1) (Beug et al., 
1979; Leutz et al., 1984). When first discovered, these cells were shown to have several 
macrophage characteristics, including bacterial phagocytosis, expression of antibody Fc 
receptors, and reaction with antiserum direct against avian macrophages (Beug et al., 
1979). Over the years, many phenotypic and functional characteristics of the HD11 cell 
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line have been reported, including expression of several TLR’s (TLR1, TLR2, TLR3, 
TLR4, TLR5, and TLR7 (Iqbal et al., 2005a). HD11 cells also produce a range of 
antimicrobial factors, including nitric oxide production (Sung et al., 1991), and oxidative 
burst (Chadfield and Olsen, 2001). HD11 cells express several cytokines such as IL-1β, 
IL-6, IL-8, and IL-10 (Smith et al., 2005).   
C. jejuni invades, crosses and disrupts the polarized human epithelial cell 
monolayer barrier in vitro (Bras and Ketley, 1999). This invasive process induces the 
production of several immuno-modulatory signals. Human monocytes have been shown 
to produce several cytokines upon infection with C. jejuni, including IL-1β, IL-6, tumor 
necrosis factor alpha (TNF-α), and IL-8 (Jones et al., 2003; Smith et al., 2005; Zilbauer et 
al., 2007). In chickens, C. jejuni has been shown to disseminate to the spleen and liver, 
and generate an antibody response upon infection, therefore interaction with 
macrophages, and stimulation of cytokine production is very likely during systemic 
spread (Meade et al., 2009; Smith et al., 2008). Cytokines are a group of peptides that 
regulate the immune system by acting as a signaling molecule. Cytokines are produced 
by almost all cell types, and they can both elicit and regulate immune response and are a 
means of inter-cellular communication (Eckmann and Kagnoff, 2001). The first cytokine 
discovered was  interferon (IFN), and it was discovered in chickens’ egg injected with 
Influenza A virus (Isaacs and Lindenmann, 1957), but most of the other cytokines were 
discovered first in mammals. Although many of the cytokines identified in mammals are 
found in chickens, they generally share only 25-35% amino acid identity (Asif et al., 
2004; Staeheli et al., 2001). Cytokine classification is based on their activity and/or the 
cell producing or responding to them. Functions of several cytokines produced by 
chicken’s cells are listed in Table 7.1. 
C. jejuni stimulates the production of several cytokines in vitro upon interaction 
with HD11 cells and chicken kidney cells (CKC) (Smith et al., 2005),  human dendritic 
cells (Pulimood et al., 2008), and intestinal epithelium (Johanesen and Dwinell, 2006).  
These studies did not investigate the impact of C. jejuni motility, flagellin, or 
Campylobacter invasion antigens (Cia) on cytokine gene expression. In this study, 
changes HD11 cells in expression of genes coding for IL-1β, IL-2, IL-4, IL-6, IL-8, IL-
10, IL-12β, and TLR5 to C. jejuni wild-type strains and flagellin, motility and Cia 
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mutants were studied using real-time PCR over the period of 8 hours. The main functions 
of these genes’ products are summarized in Table (1).   
7.2. Materials and Methods: 
7.2.1. Bacterial strains and growth conditions: 
Four C. jejuni strains were used in this study. Strain C. jejuni 81-176 which has 
been well characterized and recently its genome sequenced has been published (Pearson 
et al., 2007). Strain C. jejuni K2-55, which was a generous gift from Dr. P. Guerry (Naval 
Medical Research Institute, Bethesda, Md.) shares the same genetic background with C. 
jejuni 81- 176 but has an insertion mutation in the pflA gene that maintains an intact 
flagellar structure although it abolishes the motility (Yao et al., 1994). Strain C. jejuni 
NCTC11168V1 which is a variant of C. jejuni NCTC11168 genetic background which 
has been fully sequenced and is proved to colonize chickens well(Carrillo et al., 2004; 
Parkhill et al., 2000), C. jejuni NCTC11168V1flgK mutant was generated by Dr. U. 
Fernando (VIDO, SK) using an insertion of kanamycin resistance cassette into flgK gene, 
which resulted the expression of the flagellar structure up to the hook level (Fernando et 
al., 2007). The C. jejuni NCTC11168V1flgK mutant also lacks the ability to secrete 
Campylobacter invasion antigens (Fernando et al., 2007). Salmonella enterica serovar 
Typhimurium strain SL1344 (SL1344) (Stocker et al., 1983) was used as a positive 
control for TLR5 gene expression. It is a wild-type Salmonella with no known mutations 
and is ampicillin resistant.  
  C. jejuni strains were cultured on Mueller-Hinton agar (MHA), (Difco), or 
Mueller-Hinton agar supplemented with 5% sheep blood (PML Microbiological, 
Richmond, BC) under microaerophilic conditions (10% carbon dioxide, 5% oxygen, and  
85% nitrogen) at 42 °C. Salmonella strain SL1344 was grown on Luria-Bertani (LB) agar 
at 37 °C under aerophilic conditions. 
Chicken macrophage (HD11) cells were maintained in 25 ml of RPMI 1640 
medium containing 10% fetal bovine serum (FBS) using T-75 flasks (Corning) at 37 °C 
in a CO2 incubator dedicated for tissue culture.  
7.2.2. Incubation of bacteria with HD11 cells: 
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 C. jejuni strains 81-176, NCTC1168V1, NCTC1168V1flgK mutant, and 
C. jejuni K2-55 were grown on MHA-blood as described above. Bacteria were harvested 
and re-suspended in RPMI 1640 medium containing 10% FBS. To obtain heat killed 
cells, C. jejuni 81-176 was harvested in normal saline, and incubated at 65 °C for 15 min. 
From each sample, 25 µl were serially diluted in normal saline and 10-4, 10-5, and 10-6 
dilutions were plated on MHA to determine the actual colony forming unit counts (CFU). 
To prepare HD11 cells for the experiment, cells grown in a T-75 flask were 
harvested using a plastic scraper (VWR) 24-48 hours before incubation with bacteria. 
Cells were transferred to sterile 50 ml centrifuge tubes (Corning) and pelleted at 300x g 
for 5 min. The supernatant was discarded and cells were re-suspended thoroughly using 
30 ml of RPMI 1640 with 10% FBS. To each well of a 6-well plate, 5 ml of cell 
suspension was added and incubated to obtain 1 X 105 cells/well as determined by cell 
count using a hematocytometer. To each well, 1 X 107 CFU of a bacterial strain 
suspended in 200 µl RPMI 1640 with 10% FBS was added to obtain a multiplicity of 
infection (MOI) of 100. A duplicate from each sample was made. Plates were incubated 
under microaerophilic conditions (10% carbon dioxide, 5% oxygen, and 85% nitrogen) at 
42 °C. Cells were harvested as described above at 2, 4, and 8 hours post infection. 
Immediately, RNA was extracted, and processed as described in the following section. 
Two samples were collected  for each strain at each time point. 
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Gene Functions of protein Reference 
β –actin A house keeping gene, it is involved in the actin network and has been previously used as a reference gene for qRT-PCR reactions  1 
IL-1β 
Pro-inflammatory cytokine. Stimulates induction of IL-6 and 
TNF-α, leading to T-cell proliferation and triggering of acute 
phase response 
2 
IL-2 
Involved in Th1immune response, development of T-regulatory 
cells, and immunological memory  3, 4 
IL-4 
Involved in Th2 immune response. Stimulates activated B- and T-
cells proliferation.  3 
IL-6 
Stimulates Th2 responses, B-cell Ig production, and DC to 
macrophage conversion. Inhibits T1 responses.  5 
IL-8 
Renamed CXCL8. Secreted mainly by macrophages. Recruits 
polymorphonuclear cells (PMNs) heterophils and monocytes. 5 
IL-10 
Down-regulates Th1 responses and stimulates Th2 responses by 
affecting APCs, B, T, and NK cells.  2, 5 
IL-12 β 
Involved in Th1 response. Activates NK cells, stimulates IFN-γ 
production, and favors antigen specific Th1 cells proliferation 
while inhibiting Th2 specific cells 
2, 5 
TLR-5 
Member of the Toll-like receptor (TLR) family, which recognize 
pathogen-associated molecular patterns (PAMPs). It mainly 
recognizes bacterial flagellin. It is expressed in a variety of tissues 
and cells including macrophages and HD11 cells 
6 
 
Table 7.1. The main function of the proteins of genes monitered by qRT-PCR. The gene 
β –actin was used as a control gene for qRT-PCR. Main functions of IL-1β, IL-2, IL-4, 
IL-6, IL-8, IL-10, IL-12β listed here are derived from studies conducted human, mouse, 
and chicken. In chicken the Th1-Th2 cytokines exists but the structural and functional 
hallmarks are different than those of human and mouse (Degen et al., 2005).   
References: 
1: (Lambrechts et al., 2004), 2:(Giansanti et al., 2006), 3: (Degen et al., 2005) 4: (Malek, 
2003), 5: (Staeheli et al., 2001), 6: (Iqbal et al., 2005a; Iqbal et al., 2005b) 
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7.2.3. RNA extraction: 
 RNA was extracted using an RNeasy mini kit (Qiagen). After cells were pelleted, 
the supernatant was removed completely and 350 µl of RNeasy Lysis Buffer (RLT) 
buffer were added and the pellet was disrupted by flicking the test tube. Cells were 
homogenized by passing them 5 times through 20-gauge needle. A volume of 350µl of 
70% ethanol was added and mixed by pipetting. The sample was transferred to an 
RNeasy spin column and centrifuged for 15s at 9000 x g. DNase digestion was performed 
on column using Qiagen DNase kit (Qiagen). To each sample, a total of 30U of DNase 
suspended in RNase- and DNase-free water was added to the column and incubated at 
room temperature for 15 minutes. The column was washed twice to remove the DNase 
using 350µl washing buffer (RW1). Another 2 washes to remove any remaining DNA 
were done using 500µl of buffer RPE were performed. To elute RNA, a 100 µl RNase-
free water was added to the column and centrifuged at 9000 x g for 1 minute. Samples 
were stored immediately at -20 °C. Concentration and purity of RNA was determined 
using an Agilent 2100 Bioanalyzer (Agilent Tech, Mississauga, ON).   
7.2.4. Real-time reverse transcription polymerase chain reaction: 
  To produce cDNA, one µg of RNA was reverse transcribed using SuperScript III 
Platinum Two-Step qRT-PCR kit with SYPR GreenER (Invitrogen). The kit reaction mix 
contains both random hexamers and oligo dT primers. To obtain cDNA, 1µg of RNA 
from each sample was mixed with 10 µl of 2X RT reaction mix, 2 µl RT enzyme mix, 
and water was added according to RNA volume to bring the total reaction volume to 20 
µl. Reaction mixture was mixed gently. The reverse transcription reaction was carried out 
in PCR machine using the following set of parameters: 25 °C for 10 minutes, 42 °C for 
50 minutes, and finally 85 °C for 5 minutes. Reaction tubes were immediately chilled on 
ice. To each tube, 5 µl of deionized, diethylpyrocarbonate (DEPC)-treated water was 
added to bring the total volume to 25 µl. Reactions were stored at -20 °C until used.  
  All qRT-PCR reactions contained 1µl target cDNA, 0.2 µM each of forward and 
reverse primers, and 9 µl of qRT-PCR SuperMix (Invitrogen). Deionized, 
diethylpyrocarbonate-treated double distilled water was added to a final volume to 15 µl. 
Reactions were run in duplicate in 96-well RT-plates covered with optical quality tape 
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(Bio-Rad) using the iCycler iQ Real-Time PCR detection system (Bio-Rad). 
Amplification was performed using the following protocol: initial denaturation at 95 °C 
for 3 minutes (cycle one), followed by cycle two (95 °C, 15 seconds; 60 °C for 30 
seconds; 76 °C for 30 seconds) which was repeated for 45 times. Cycle 3 ran at 95 °C for 
1 minute. Cycle 4 was preset at 45 °C ramping to 95 °C with 1 °C increase each 30 
seconds. The final hold temperature was 22 °C. Each plate had a negative template 
control that contained all the reagents except cDNA.       
7.2.5. Real time RT-PCR primers: 
Table 2 lists primers used for each gene and the size of expected cDNA product. 
Each primer spanned an intron to differentiate cDNA from genomic DNA by the product 
size. To confirm cDNA synthesis and to validate the primers in one step, 2 µl of the final 
cDNA reaction mixture were added to a PCR reaction as described in the general 
materials and methods section, with a pair of primers from Table 2 to amplify sequences 
corresponding to β-actin, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12β, and TLR5. For 
confirmation of the product size and the absence of genomic DNA contamination, two µl 
from the final PCR reaction were tested using 1% agarose gel and the product size was 
confirmed based on comparison to a molecular marker. Primers were adapted from Patel 
et al and Iqbal et al (Iqbal et al., 2005b; Patel et al., 2008) and were manufactured by 
Invitrogen (Burlington, ON). Before initial usage, primers were resuspended to a 
concentration of 10 µM/µl. A working solution of 1 µM/µl was made and used in PCR 
and qRT-PCR reactions. All resuspended primers were stored at -20 °C after each use. 
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Target 
gene Primer 
Primer sequence 
(5’→ 3’) 
cDNA 
product 
(bp) 
Genomic 
product 
(bp) 
Acc. No. 
β-actin 
F 
 
R 
GTACCCTGGCATTGCTAC 
 
CGGATTCATCGTACTCCTGC 
 
182 465 X00182 
IL-1 β 
F 
 
R 
GGCATCAAGGGCTACAAGC 
 
GTTGGAGCGGGCAGTCAG 
 
296 386 AJ245728  
IL-2 
F 
 
R 
GGAGCATCTCTATCATCAGC 
AAGTTGGTCAGTTCATGGAG 
 
347 2468 AJ224516 
IL-4 
F 
 
R 
GGCTGTGCCCACGCTGT 
 
TGGCAGTGCTGGCTCTC 
 
192 1283 AJ621249 
IL-6 
F 
 
R 
GTGCGAGAACAGCATGGAGA 
GACTTCAGATTGGCGAGGA 
 
312 1785 AJ250838 
IL-8 
F 
 
R 
CAGCTGCTCTGTCGCAAG 
 
GGGGTCATCAGAATTGAGCT 
 
264 2248 AJ009800 
IL-10 
F 
 
R 
AGCACCAGTCATCAGCAGA 
 
GGCTCACTTCCTCCTCCT 
 
240 818 NM_00100 4414 
IL-12 β 
F 
 
R 
CCGACTGAGATGTTCCTGGA 
 
CCTGCACAGAGATCTTGTC 
 
292 2346 AJ564201 
TLR-5 
F 
 
R 
TGCACATGTTTTCTCCTAGGT 
 
CCACATCTGACTTCTGCCTTT 
262 2815 AJ626848 
  
Table 7.2. List of real time qRT-PCR primers, their corresponding cDNA and DNA 
product size, and GenBank accession number. Each primer spanned an intron to 
differentiate cDNA from genomic DNA by product size. F = Forward. R = Reverse. 
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7.2.6. Gene expression data and statistical analysis: 
 For each qRT-PCR reaction a cycle threshold value (Ct value) was determined. 
The Ct value was determined based on the cycle number at which there was an increase 
in detection of the fluorescence signal above base line as the PCR reaction reaches the 
exponential phase of amplification. The Ct values were expressed as the mean of 
duplicates ± standard deviation (SD). The relative difference in gene expression (ΔCt) 
was calculated by subtracting the mean Ct value for each gene from the corresponding 
endogenous control’s mean Ct value (ΔCt = Ct(sample) – Ct(β-actin). The difference between 
the average ΔCt(sample) and the average ΔCt(control) was expressed as ΔΔCt and was used to 
calculate fold changes in gene expression using the following formula:    
Fold change = 2-(ΔΔCt).  
Statistical significance among the different treatments for each gene at a given 
time point was confirmed using pairwise fixed reallocation randomization test (Pfaffl et 
al., 2002). Data was analyzed using the BioRad iQ5, Microsoft Excel and GraphPad 
prism software. 
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7.3. Results: 
7.3.1. Purity and amounts of mRNA extracted: 
 To determine the amount and the purity of mRNA extracted from each sample, 
two μl of the mRNA were analyzed using an automated Bioanalyzer. All samples 
extracted were pure and no contamination was observed (Fig 7.1B). On average, each 
purification attempt produced 709 ng/μl of final elution volume.  
 7.3.2. Primer optimization: 
 Primer sequences were adapted from Patel et al (Patel et al., 2008) and Iqbal et al 
(Iqbal et al., 2005b). To validate primer sequences, two μl of cDNA synthesized from 
mRNA extracted from untreated HD11 cells were used as a template in PCR reactions. A 
separate reaction for each primer listed in Table 7.2 was carried and the primers 
amplified the selected gene product of the expected size. After each qRT-PCR reaction 
melt curve analysis was carried out to examine the specificity of amplification as all PCR 
products for each primer pair are expected to have the same melting temperature, unless 
there is contamination, mispriming, or primer-dimer artifact (Fig 7.3). None of the 
samples examined had any genomic DNA contamination. 
 7.3.3. Gene normalization: 
 The β-actin gene was selected as an internal standard (loading control) as it is 
expressed in HD11 cells. The Ct value (mean ±SD) for β-actin from all samples at 0 
hours was 18.9 ±0.6, at 2 hours Ct value was 18.3±0.6, at 4 hours 17.3±1.1, and at 8 
hours 16.9±1.3. No significant difference (P < 0.5) in β-actin gene expression was found 
between 2, 4, and 8 hours when cells were either stimulated or unstimulated. However, 
these values varied significantly (P < 0.05) when 0 hours the Ct values from unstimulated 
cells are compared with the Ct values after 4 and 8 hours stimulation with C. jejuni and 
Salmonella SL1344 (Fig 7.2).  
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Fig 7.1. Analysis of purity of mRNA samples extracted from HD11 cells either incubated 
or non-incubated with C. jejuni wild-type strains or mutants. In (A) samples are loaded 
separately; mRNA samples in lanes 1-7 are from cells incubated for 2 hours, while 
samples from 8-12 were incubated for 8 hours. Samples represented in the figure are: 1: 
untreated HD11 cells (control), 2: C. jejuni 81-176, 3: HK C. jejuni 81-176, 4: K2-55, 5: 
C. jejuni NCTC11168V1, 6: C. jejuni NCTC11168V1flgK mutant, 7: SL1344, 8: 
untreated HD11 cells, 9: C. jejuni 81-176, 10: HK C. jejuni 81-176, 11: C. jejuni 
NCTC11168, and 12: Salmonella SL1344. (B) Purity of mRNA extracted is determined 
by the presence of only 3 spikes, a small spike at 23 seconds for positive control, spike at 
43 seconds detects 18s ribosomal subunit, and at 49 seconds detects the presence of 28s 
ribosomal subunit. If any extra spikes are present mRNA is considered contaminated or 
degraded. Abbreviations: haitham-CTRL: mRNA extracted form unstimulated HD11 
cells, 55: cells stimulated with C. jejuni K2-55, 69: cells stimulated with C. jejuni 81-176.  
  
A 
B
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7.3.4. Gene expression levels of HD11 cells after incubation with C. jejuni 81-176, 
Heat-killed C. jejuni 81-76, and C. jejuni K2-55: 
 To determine if C. jejuni affects the level of expression of HD11 cytokine genes, 
HD11 cells were incubated with C. jejuni 81-176, C. jejuni K2-55. Heat-killed C. jejuni 
81-176 was used as a control. Each strain was incubated with HD11 cells in duplicate. 
The expression of each gene from each sample at 0, 2, 4, and 8 hours was measured in 
duplicate, leading to a total of 4 wells/sample. Expression of IL-1β, IL-6, and IL- 8 genes 
showed increased levels indicating that living C. jejuni cells are not required to induce 
these cytokines (Table 7.3 and Fig 7.4, 7.5, and 7.6). Interlukin-4 was measured in all 
samples, and was not detected in any. Interleukin-2 was not expressed in any cells treated 
with the strains. 
Expression level of IL-10  remained unchanged at the various time points (Fig 
7.7), while IL-12β increased approximately 5, 4, and 3 fold in HD11 cells incubated with 
C. jejuni 81-176, heat-killed C. jejuni 81-176, and C. jejuni K2-55 respectively (Fig 7.8). 
Expression of TLR5 was detected in all samples and remained almost constant after 8 
hours of exposure to the three strains (Fig 7.9).  
7.3.5. Gene expression levels of HD11 cells after incubation with C. jejuni 
NCTC11168V1 and an isogenic C. jejuni NCTC11168V1flgK mutant: 
 A significant difference in HD11 cell gene expression of cytokines IL-1β, IL-6, 
and IL-8 in response to the presence of C. jejuni NCTC11168V1 or the isogenic flgK 
mutant was observed, as NCTC11168V1 increased expression of IL-1β, IL-6, and IL-8 
by 17-, 20-, and 27-fold respectively, while the C. jejuni NCTC11168V1flgK mutant 
increased the expression by 6-, 3-, and 8- fold after 8 hours of incubation (Fig 7.4, 7.5, 
and 7.6). Levels of IL-10 gene expression remained unchanged for both strains (Fig 7.7), 
while IL-12β was upregulated slightly (Fig 7.8). As expected, the level of TLR5 gene 
expression did not change in the presence of either of the strains (Fig 7.9) 
7.3.6. Gene expression levels of HD11 cells after incubation with Salmonella SL1344: 
 HD11 cell mRNA levels of IL-1β, IL-6, IL-8, and IL-10 increased after 
incubation with SalmonellaSL1344 (Table 7.4) while IL-12β gene expression level was 
downregulated by 15 fold (Fig 7.8). Levels of TLR5 gene expression increased after 8 
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hours of incubation of HD11 cells with Salmonella SL1344 (Fig 7.9). Level of IL-2 
expression was at a very low copy number (high Ct value) when levels of expression 
were measured at 8 hours after challenge with no significant fold changes. 
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Fig 7.2. Mean Ct values ± SD for β-actin gene level of expression from all samples at 0, 
2, 4, and 8 hours. Ct values were significantly (P < 0.05) lower after 4 and 8 hours of 
incubation with any of the C. jejuni strains and Salmonella SL1344 strain. Beta-actin 
gene level of expression in unstimulated HD11 cells remained unchanged (Control).      
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Fig 7.3. Real-time melting curves acquired after amplification of cDNA samples with IL-
6 mRNA used as a template. For cDNA synthesis was extracted from HD11 samples 
treated with C. jejuni 81-176, heat killed C. jejuni 81-176, C. jejuni K2-55, C. jejuni 
NCTC11168V1, C. jejuni NCTC11168V1flgK mutant, and Salmonella SL1344 for 8 
hours.   
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Fold change in gene expression over time 
Gene 0 hr  2 hrs  4 hrs  8 hrs 
 81-176 K2-55 HK  81-176 K2-55 HK  81-176 K2-55 HK  81-176 K2-55 HK 
β-actin 1 1 1  1 1 1  1 1 1  1 1 1 
IL-1β 1 1 1  0.7 3.5 2  3.4 4.3* 4.3*  16.7** 16.0** 15.5**
IL-6 1 1 1  1.5 1.3 0.8  29.7** 22.9** 22.9**  22.6** 17.8** 24.9**
IL-8 1 1 1  4.37* 5.5* 4.05*  19.97** 21.55** 21.55**  32.89** 30.27** 32** 
IL-10 1 1 1  0.9 1 0.8  0.7 0.6 0.6  0.6 0.8 0.9 
IL-12β 1 1 1  1.1 1.1 0.3  2.8 1.4 1.4  5.2* 3.6* 4.1* 
TLR5 1 1 1  0.8 1.0 0.9  0.8 1.0 0.8  0.7 1.3 1.0 
                
 
Table 7.3. Fold change in HD11 cell gene expression after incubation with C. jejuni 81-176, K2-55, and heat-killed C. jejuni 81-176. 
Untreated HD11 cells were used as controls. Gene expression values were normalized using β-actin gene expression value (reference 
gene) to obtain relative gene difference value (ΔCt). The difference between the average ΔCt(sample) and the average ΔCt(control) was 
expressed as ΔΔCt and was used to calculate fold changes in gene expression  Fold change was calculated using the formula: fold 
change = 2-(ΔΔCt). Fold change values of samples significantly different from control using pairwise fixed rellocation randomization 
test (P < 0.05) are marked with (*), while (P <0.01) are marked with (**). The three treatments had induced a strong increase in IL-1, 
IL-6, and IL-8 expression, and a moderate IL-12β expression increase, but did not affect the expression of IL-10 or TLR5.  
 
81-176: C. jejuni 81-176, K2-55: C. jejuni K2-55, HK: Heat-killed C. jejuni 81-176 
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Fold change in gene expression over time 
Gene 0 hr 2 hrs 4 hrs 8 hrs 
 11168 flgK SL1344 11168 flgK SL1344 11168 flgK SL1344 11168 flgK SL1344 
β-actin 1 1 1 1 1 1 1 1 1 1 1 1 
IL-1β 1 1 1 0.8 1.3 1.3 3.8* 3.5* 4.2* 17.3** 5.7* 8.9** 
IL-6 1 1 1 1.4 0.8 2 21** 2.3* 20.1** 20.3** 2.5* 15.3** 
IL-8 1 1 1 4.4* 3.1* 1.13* 20.3** 8.57** 3.83* 26.90** 8.28** 23.75** 
IL-10 1 1 1 0.6 0.6 1.7 0.8 1.4 1.1 0.8 0.9 4.3* 
IL-12β 1 1 1 0.8 1 0.3 1.1 3.1* 0.08** 4.6* 2.8* 0.1** 
TLR5 1 1 1 0.8 0.5 1.4 1.2 1.2 1.3 0.8 0.8 5.2* 
             
 
Table 7.4. Fold change in HD11 cell gene expression after incubation with C. jejuni NCTC11168V1, flgK mutant, and Salmonella 
SL1344. Untreated HD11 cells were used as controls. Gene expression values were normalized using β-actin gene expression value 
(reference gene) to obtain relative gene difference value (ΔCt). The difference between the average ΔCt(sample) and the average 
ΔCt(control) was expressed as ΔΔCt and was used to calculate fold changes in gene expression  Fold change was calculated using the 
formula: fold change = 2-(ΔΔCt). Fold change values of samples significantly different from control using Turkey’s test (P < 0.05) are 
marked with (*), while (P <0.01) are marked with (**).C. jejuni NCTC11168 induced a strong expression of IL-1β, IL-6, and IL-8 
cytokines genes, and a moderate increase in IL-12β gene expression, but did not affect the expression of IL-10 and TLR5. flgK mutant 
induced a moderate cytokine gene expression and did not affect TLR5 expression. Salmonella SL1344 induced a strong expression of 
IL-1β, IL-6, and IL-8 cytokines genes, a moderate expression of IL-10 and TLR5, and down-regulated the expression of IL-12β.  
11168: C. jejuni NCTC11168V1, flgK: C. jejuni NCTC11168V1flgK, SL1344: Salmonella SL1344  
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Fig 7.4. Fold changes in expression of IL-1β in HD11 cells at 0, 2, 4, and 8 hours post-
exposure to: (A) C. jejuni 81-176, (B) heat killed (HK) C. jejuni 81-176, (C) C. jejuni 
K2-55, (D) C. jejuni 11168, (E) flgK mutant, and (F) Salmonella SL1344. Fold changes 
represented are calculated using mean Ct value of duplicate biological samples. The solid 
line represents samples and the dotted line represents the expression of IL-1β in control 
tissue culture. The NCTC11168flgK mutant induced a moderate increase in gene 
expression compared to other C. jejuni strains.  
81-176: C. jejuni 81-176, heat-killed 81-176: heat-killed C. jejuni 81-176,   
K2-55: C. jejuni K2-55, NCTC11168: C. jejuni NCTC11168V1, NCTC11168flgK: C. 
jejuni NCTC11168V1flgK, SL1344: Salmonella SL1344. 
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Fig 7.5. Fold changes in expression of IL-6 in HD11 cells at 0, 2, 4, and 8 hours post-
exposure to: (A) C. jejuni 81-176, (B) heat killed (HK) C. jejuni 81-176, (C) C. jejuni 
K2-55, (D) C. jejuni 11168, (E) flgK mutant, and (F) Salmonella SL1344. The solid line 
represents samples and the dotted line represents the expression IL-6 in control tissue 
culture. C. jejuni NCTC11168flgK mutant induced a limited increase (2.5 fold) in IL-6 
expression compared to other C. jejuni strains which induced more than 20 fold increase 
in expression. 81-176: C. jejuni 81-176, heat-killed 81-176: heat-killed C. jejuni 81-176, 
K2-55: C. jejuni K2-55, NCTC11168: C. jejuni NCTC11168V1, NCTC11168flgK: C. 
jejuni NCTC11168V1flgK, SL1344: Salmonella SL1344. 
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Fig 7.6. Fold changes in expression of IL-8 in HD11 cells at 0, 2, 4, and 8 hours post-
exposure to: (A) C. jejuni 81-176, (B) heat killed (HK) C. jejuni 81-176, (C) C. jejuni 
K2-55, (D) C. jejuni 11168, (E) flgK mutant, and (F) Salmonella SL1344. The solid line 
represents samples and the dotted line represents the expression of IL-8 in control tissue 
culture. The flgK mutant induced a moderate 10 fold increase in IL-8 expression after 8 
hours of incubation. Other C. jejuni strains induced more than 25 fold in expression of 
IL-8. Salmonella SL1344 induced a 4 fold increase in expression at 4 hours, and 24 fold 
increase by 8 hours. 81-176: C. jejuni 81-176, heat-killed 81-176: heat-killed C. jejuni 
81-176, K2-55: C. jejuni K2-55, NCTC11168: C. jejuni NCTC11168V1, 
NCTC11168V1flgK: C. jejuni NCTC11168V1flgK, SL1344: Salmonella SL1344. 
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Fig 7.7. Fold changes in expression of IL-10 in HD11 cells at 0, 2, 4, and 8 hours post-
exposure to: (A) C. jejuni 81-176, (B) heat killed (HK) C. jejuni 81-176, (C) C. jejuni 
K2-55, (D) C. jejuni 11168, (E) flgK mutant, and (F) Salmonella SL1344. The solid line 
represents samples and the dotted line represents the expression of IL-10 in control tissue 
culture.  None of C. jejuni strains induced the expression of IL-10, while SL1344 induced 
a moderate increase by 4.3 fold after 8 hours of infection. 81-176: C. jejuni 81-176, heat-
killed 81-176: heat-killed C. jejuni 81-176, K2-55: C. jejuni K2-55, NCTC11168: C. 
jejuni NCTC11168V1, NCTC11168V1flgK: C. jejuni NCTC11168flgK, SL1344: 
Salmonella SL1344. 
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Fig 7.8. Fold changes in expression of IL-12β in HD11 cells at 0, 2, 4, and 8 hours post-
exposure to: (A) C. jejuni 81-176, (B) heat killed (HK) C. jejuni 81-176, (C) C. jejuni 
K2-55, (D) C. jejuni 11168, (E) flgK mutant, and (F) Salmonella SL1344. The solid line 
represents samples and the dotted line represents the expression IL-2β in control tissue 
culture. C. jejuni strains induced a moderate (3-5 fold) increase in expression of IL-12β 
while Salmonella SL1344 down-regulated the expression by 15 fold after 8 hours of 
infection. 81-176: C. jejuni 81-176, heat-killed 81-176: heat-killed C. jejuni 81-176, K2-
55: C. jejuni K2-55, NCTC11168: C. jejuni NCTC11168V1, NCTC11168flgK: C. jejuni 
NCTC11168V1flgK, SL1344: Salmonella SL1344. 
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Fig 7.9. Fold changes in expression of TLR5 in HD11 cells at 0, 2, 4, and 8 hours post-
exposure to: (A) C. jejuni 81-176, (B) heat killed (HK) C. jejuni 81-176, (C) C. jejuni 
K2-55, (D) C. jejuni 11168, (E) flgK mutant, and (F) SL1344. The solid line represents 
samples and the dotted line represents the expression of TLR5 in control tissue culture.  
C. jejuni strains did not affect the expression of TLR5 while SL1344 caused a moderate 5 
fold increase after 8 hours of infection. 81-176: C. jejuni 81-176, heat-killed 81-176: 
heat-killed C. jejuni 81-176, K2-55: C. jejuni K2-55, NCTC11168: C. jejuni 
NCTC11168V1, NCTC11168V1flgK: C. jejuni NCTC11168flgK, SL1344: Salmonella 
SL1344. 
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7.4. Discussion: 
The asymptomatic nature of C. jejuni infection in broiler chickens, despite the 
high level of colonization of the ceca (up to 1010 CFU/g) remains a major challenge for 
controlling the spread of infection to humans. The difference in the clinical outcome 
between chickens and humans is probably multi-factorial as no single factor has been 
identified to be solely responsible for the difference in outcome. Cytokines play a major 
role in orchestrating the immune response by either promoting or suppressing 
inflammation. A role for the pro-inflammatory cytokines in causing disease symptoms 
during gastro-intestinal disease has also been suggested (Enocksson et al., 2004). 
Cytokine induction by C. jejuni has been mainly studied in human cell lines (Al-Salloom 
et al., 2003; Bakhiet et al., 2004; Hickey et al., 2000; Jones et al., 2003),  while only a 
few studies have investigated avian cytokine profiles (Smith et al., 2008; Smith et al., 
2005; Watson and Galan, 2008). The development of an antibody response by chickens 
infected with C. jejuni indicates that inter-cellular signaling among the immune cells 
following the host-pathogen interaction has occurred, and C. jejuni presumably is 
exposed to the innate immune system during the infection (Meade et al., 2009; Smith et 
al., 2008). Macrophages are an integral part of the innate immune system, and may play a 
role in clearing systemic C. jejuni infection, as a macrophage-like HD11 cell kills C. 
jejuni within 24 hours of incubation in vitro (Watson and Galan, 2008). Several cytokines 
are induced during this process (Smith et al., 2005), and thus broiler chickens exposed to 
C. jejuni will have increased cytokine expression upon the colonization by C. jejuni 
(Smith et al., 2008).  
One of the main antigenic components of C. jejuni is the flagellum, which is 
recognized by antibodies of chickens infected with C. jejuni (de Zoete et al., 2007). This 
study investigated the role that C. jejuni flagellum and Cia secreted proteins have in 
inducing an HD11 cytokine response. The results demonstrated that wild-type C. jejuni 
that has intact flagella induced a strong increase in expression of IL-1β, IL-6, and IL-8 in 
HD11 cells. These results are in agreement with the data previously reported (Smith et 
al., 2008; Smith et al., 2005; Watson and Galan, 2008). The response was moderate at 2 
hours postinfection, and increased significantly (P < 0.01) after 4 and 8 hours of 
incubation as C. jejuni 81-176 and NCTC11168V1 caused an increase by more than 30 
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fold for IL-8, 16 fold for IL-1, and as much as 22 fold for IL-6 in comparison to control 
cells after 8 hours of incubation.  
The absence of motility and Campylobacter invasion antigens secretion did not 
affect C. jejuni interaction with HD11 cells. C. jejuni K2-55, which has a paralyzed 
flagellum that is structurally intact and does not secrete Cia, had the same cytokine 
expression profile of wild-type C. jejuni 81-176. A moderate difference of IL-6 
expression of 5 fold between the mutant and the wild-type, which might not be 
biologically significant as the response profile for both strains followed a similar trend. 
These findings are further confirmed by the fact that a similar response was induced by 
heat-killed C. jejuni 81-176, C. jejuni. This suggests that stimulatory antigens are not 
actively produced upon contact with the HD11 cells, but have already been synthesized 
by C. jejuni. These stimulatory antigens are probably classic innate immune system 
stimulators, such as lipooligosaccharides, DNA, and flagellin. When the flagellin-lacking 
C. jejuni NCTC11168V1flgK mutant, which expresses the flagellar structure up to the 
hook (Fernando et al., 2007), infected HD11 cells it stimulated only a moderate (though 
significant) increase in the expression of IL-1β and IL-8 (6 and 8 fold respectively), and 
approximately three-fold increase in IL-6 and IL-12β expression. The C. jejuni flgK 
mutant has a reduced ability to adhere to and invade HeLa cells in vitro and colonize day-
old chickens (Fernando et al., 2007), which might have contributed to the limited 
response in gene expression. The increase in expression of IL-1β, a pro-inflammatory 
cytokine that stimulates T-cell proliferation, and IL-8, a chemokine that recruits 
heterophils, is an indicator that C. jejuni promotes an inflammatory response through 
recruitment of cells and promoting their replication. A similar response to the presence of 
C. jejuni by human epithelial cells and clinical samples has been observed (Enocksson et 
al., 2004; Hickey et al., 2000; Jones et al., 2003; Zheng et al., 2008), but the clinical 
outcome and the pathological findings are different than those found in chickens upon C. 
jejuni infection.  Zheng and colleagues found that T84 human colonic epithelial cells 
produced IL-8 upon infection with any of  11 C. jejuni strains that varied in their 
adherence and invasion abilities (Zheng et al., 2008). Heterophils, which are equivalent to 
neutrophils in mammals, were recruited when two-week-old chickens were challenged 
with C. jejuni (Smith et al., 2008), but no lesions were found. The lack of lesion 
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formation is not unique to C. jejuni, as some Salmonella strains cause PMNs recruitment 
in pigs without any lesion formation (Foster et al., 2003).  
 C. jejuni did not affect the expression of IL-10, which is involved mainly in 
down-regulating Th1 response and stimulating B, T, and NK cells; while Salmonella 
caused a moderate 5 fold increase in HD11 cells. IL-10 expression was not detected when 
day-old and 2-weeks old chickens were challenged with C. jejuni (Smith et al., 2008), but 
was detected and remained unchanged in HD11 cells (Smith et al., 2005). These findings 
indicate a Th1-biased immune response. However, the presence of the Th1-Th2 biased 
response in chickens is still debatable as some of the hallmarks of Th2 response are 
absent in chickens. Interlukin-4, which induces proliferation of various cell types, was 
not expressed in HD11 cells before or after the challenge, supporting a Th1 biased 
response by HD11 cells infected with C. jejuni. 
 The absence of flagellin in C. jejuni flgK mutant clearly produced a lower 
expression of several cytokine by HD11 cells compared to wild-type C. jejuni, while the 
absence of motility and Cia secreted proteins had no effect on HD11 cells response to C. 
jejuni K2-55, indicating that the presence of flagellin has an immunomodulating effect, 
while Cia proteins did not affect cytokine gene expression in HD11 cells      
 
 The lack of pathology in birds infected with C. jejuni does not indicate a lack of 
pro-inflammatory response. The various C. jejuni strains used in this study were capable 
of inducing cytokine gene expression. The absence of motility or Cia did not alter 
cytokine expression in HD11 cell, but the lack of flagellin had a major impact on 
cytokine induction. It could be concluded that the presence of flagella itself is more 
detrimental to cytokine induction than motility or Campylobacter invasion antigens.  
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Chapter VIII: General Discussion and Conclusions 
 
 Despite the importance of C. jejuni as a leading cause of bacterial gastroenteritis 
in humans, the pathogenesis of C. jejuni is poorly understood. When compared to the 
other two major bacterial pathogens, E. coli and Salmonella, several aspects of C. jejuni’s 
pathogenesis remain unknown. The study of C. jejuni pathogenesis in poultry has been 
hindered by the lack of tools that help to track the bacteria in vivo. This research is 
another step to understand the pathogenesis of C. jejuni in broiler chickens and the role 
that the flagella, Campylobacter invasion antigens, and motility play in mucosal and 
systemic spread of the bacteria. 
By establishing a system using green fluorescent protein as a marker, we were 
able to track C. jejuni mucosally and systemically in broiler chickens. The plasmid 
pHG101was stable in vitro when subcultured several times in the absence or the presence 
of selective antibiotic pressure. Similar plasmid stability has been reported previously in 
C. jejuni, both in vitro and in vivo (Miller et al., 2000; Mixter et al., 2003). Miller and 
colleagues were unable to transform all the strains they tested with the plasmid they 
developed (Miller et al., 2000), while in our study all the variants we used were 
transformed. After transformation, no visible morphological changes were noticed in any 
of the C. jejuni strains when visualized using electron microscopy, and no significant 
changes, in the growth rate or morphology, were noticed when the bacteria were cultured 
or used to challenge poultry or mice. These findings are in agreement with the literature, 
as Salmonella expressing GFP constitutively, with a kanamycin marker similar to the one 
used in this study, had the same invasiveness in canine kidney cells as the wild-type 
(Clark et al., 2009). Mixter and colleagues detected GFP-expressing C. jejuni in mouse 
macrophages, neutrophils, spleenocytes, and hepatocytes after intraperitoneal challenge 
(Mixter et al., 2003). In our experiments, C. jejuni NCTC11168V1G remained 
fluorescent in the ceca of broiler chickens after 7 days of oral challenge, as detected by 
culture and fluorescence microscopy. The colonization level of C. jejuni 
NCTC11168V1G was similar to that of C. jejuni NCTC11168V1 (Biswas et al., 2007a; 
Carrillo et al., 2004), indicating that the ability to colonize the cecum was not affected by 
the expression of GFP. C. jejuni NCTC11168V1G and C. jejuni 81-176G remained 
fluorescent both mucosally and systemically, despite the different surrounding 
194 
 
environment in the host, which allowed for its detection in liver and spleen of broiler 
chickens. To date, there are no literature reports in about systemic detection of GFP-
expressing bacteria delivered via an oral challenge. There are, however, reports of GFP-
expressing Lactobacillus detected on mucosal surfaces and cecal contents (Yu et al., 
2007). The use of confocal microscopy and immunohistochemistry allowed for 
confirmation of the presence of C. jejuni in positive tissues, and its absence in negative 
tissues. The GFP-based detection system developed in this study will be useful in 
studying the effect of mutations on colonization at mucosal surfaces and systemic 
spreading. When plasmid pHG101 was transformed into C. jejuni 81-176 and K2-55, the 
same plasmid stability was observed in vitro and in vivo. C. jejuni K2-55G colonized 
day-old chicks despite the absence of both motility and Campylobacter invasion antigens 
secretion, indicating that the presence of full-length flagella was the minimal requirement 
for mucosal colonization. The absence of motility and Campylobacter invasion antigens 
affected the ability of C. jejuni K2-55 to spread systemically in 21-day old broiler 
chickens, indicating that they are required for invasion/systemic spread, which is in 
agreement with our hypothesis that the flagella and flagella secreted proteins are 
important for C. jejuni colonization of broiler chickens. 
 C. jejuni 11168V1G, C. jejuni 81-176G, and C. jejuni K2-55G colonized the 
gastrointestinal tract of BALB/c mice, but were not detected in any of the spleens or 
livers examined. C. jejuni K2-55 was not as efficient as the wild-type C. jejuni 81-176 in 
colonizing the gastrointestinal tract of BALB/c mice, as it was detected in only 53.3% of 
mice challenged, compared to 66.6% of mice challenged with C. jejuni 81-176. 
The lack of systemic spreading and Campylobacter invasion antigens secretion by 
C. jejuni K2-55 made this strain a potential live vaccine candidate. We investigated the 
vaccine potential of C. jejuni K2-55, and the difference the absence of Campylobacter 
invasion antigens and/or flagella may have on macrophage-like HD11 cell expression of 
cytokines.   
 Oral vaccination with C. jejuni K2-55 on days 7 and 21 of age resulted in a 
moderate antibody response, which was protective when combined with antibiotic 
treatment before the challenge with the homologous strain C. jejuni 81-176 when 
compared to non-vaccinated group. Vaccination was not protective against the challenge 
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with the homologous strain without the antibiotic treatment. The reason for the different 
outcome is not related to antibody response, as there was no significant difference 
between the median of antibody titers of these groups, but it could be due to the changes 
in the intestinal microflora after antibiotic treatment (Pedroso et al., 2006; Smirnov et al., 
2005). C. jejuni K2-55 did not protect against a heterologous C. jejuni NCTC11168 
challenge as well, as there was no significant difference between the colonization level 
(CFU/g) of the vaccinated and non-vaccinated groups. This limits the future applications 
of this vaccine (in its current form) to homologous protection only. The same vaccine 
failed to protect broiler chickens from colonization with C. jejuni 81-176 in a seeder 
model challenge despite the antibiotic treatment. The reason for the difference in the 
outcome remains unknown, but the dynamics of C. jejuni in a room that contains 
vaccinated and non-vaccinated birds that are shedding may be different than its dynamics 
in a room that contains vaccinated chickens only. The homologous protection and the 
lasting colonization of the paralyzed flagella C. jejuni K2-55 is a promising initial step 
that is still in early development.  
 The absence of motility and Campylobacter invasion antigens did not affect 
macrophage-like HD11 cell cytokine expression, while the absence of flagellin had a 
significant impact on cytokine expression levels under the same conditions. The absence 
of flagellin subunits in the C. jejuni NCTC11168flgK mutant resulted in a moderate (5-8 
fold) stimulation of pro-inflammatory cytokines IL-1β, IL-6, and IL-8, compared to wild-
type C. jejuni, heat-killed C. jejuni, and the C. jejuni K2-55 paralyzed flagella mutant 
which had a significant increase in expression of these cytokines (15-32 fold). None of 
the C. jejuni strains tested stimulated IL-10 or TLR5 expression, which is not a surprising 
finding (Iqbal et al., 2005b; Watson and Galan, 2005). There was no significant 
difference in stimulation of IL-12β expression among the different C. jejuni strains, 
indicating that the absence of flagellin or Campylobacter invasion antigens had no impact 
on IL-12β production. These results confirm our hypothesis that the flagella have a 
significant impact on cytokine expression, but indicate a limited role for either motility or 
secretion of Campylobacter invasion antigens in stimulation of cytokines by chicken 
macrophages. These findings do not rule out any impact motility or Campylobacter 
invasion antigens may have on expression of cytokines by intestinal cells.  
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 The information obtained from the experiments described in this study, along with 
the current literature, were used to formulate a description of the major pathogenesis 
steps occuring during mucosal and systemic spread of C. jejuni in broiler chickens (Fig 
8.1 and 8.2). After oral infection, C. jejuni passes through the gastrointestinal tract, and 
establishes its population mainly in the ceca of the chicken (Beery et al., 1988). The exact 
reason for preferential colonization of the cecum remains unknown, but it is probably a 
combination of abundant nutrients and the limited motility of the ceca (Rehman et al., 
2007; Udayamputhoor et al., 2003). C. jejuni colonizes the large intestine as a second 
stage of infection, and subsequently establish infection in the small intestine. C. jejuni 
resides mainly in the mucus layer and in close proximity with the intestinal epithelium 
(Beery et al., 1988; Smith et al., 2008). C. jejuni was not observed in any of the 
submucosal layers in the intestinal tract, but it has to cross the intestinal epithelium to 
spread systemically. It is unclear if C. jejuni is internalized into intestinal epithelial cells 
or if it crosses the mucosal barrier by disrupting the intestinal tight junctions, but C. 
jejuni survives in intestinal cells (Watson and Galan, 2008), making intracellular route 
more probable than crossing between cells, as no lesions are observed in chickens 
colonized with C. jejuni (Smith et al., 2008). Immunomodulation by C. jejuni has two 
major indicators. Firstly, cecal cells produce a variety of cytokines in chickens colonized 
by C. jejuni (Smith et al., 2008). Secondly, expression of antimicrobial peptides is 
significantly reduced in C. jejuni infected chickens (Meade et al., 2009). Secreted 
cytokines, including pro-inflammatory cytokines, cause an influx of innate immune cells, 
mainly heterophils (Smith et al., 2008) and macrophages (Meade et al., 2009). C. jejuni 
probably uses macrophages to spread systemically, as the number of macrophages in 
chickens’ blood increases after a challenge with C. jejuni (Meade et al., 2009). Once C. 
jejuni resides in the spleen or liver, it will survive for at least 3 days.  
 The adaptive immune response plays an important role in clearing C. jejuni 
infection in broiler chickens, as antibodies against C. jejuni help prevent or clear the cecal 
colonization (Sahin et al., 2003). In our vaccination study, chickens remained colonized 
as vaccinated groups did not develop a significant increase in antibody response when 
compared to an unvaccinated group.  
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 The major finding from this study was that motility and Campylobacter invasion 
antigens mutations affected the ability of C. jejuni to colonize broiler chickens’ mucosal 
surfaces, but their effect had a greater impact on systemic spread. Future experiments 
should investigate in depth the exact role of these two important characteristics in 
colonization of broiler chickens, as the exact role Campylobacter invasion antigens play 
at mucosal surfaces remains unknown. As well, the impact these antigens may have on 
immune system cells other than macrophages needs to be determined. Answering these 
questions will shed some light on pathogenesis of C. jejuni in broiler chickens, and lead 
to development of a protective vaccine that will reduce the C. jejuni carriage of broiler 
chickens, maybe to understanding the pathogenesis of these bacteria in humans. 
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Fig 8.1. Colonization of broiler chickens by C. jejuni. The initial infection step for C. 
jejuni is to colonize the gastrointestinal tract of broiler chickens. The bacteria were not 
detected in the crop or the gizzard (1), but the initial and main sites for colonization were 
the ceca of the chicken (2), which provide abundant nutrients and a relatively reduced 
intestinal motility compared to other parts of the intestine. C. jejuni then spread to the 
large intestine (3), and then spread to the small intestine shortly after (3). After 72 hours 
of infection, C. jejuni was detected in the liver and spleen. The absence of 
Campylobacter invasion antigens prevented C. jejuni K2-55 from systemic spread. 
(Fig 8.1. is modified from an image courtesy of Dr. Bruce Hunter, University of Guelph). 
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Fig 8.2. Mucosal and systemic dynamics of C. jejuni in broiler chickens. After 
establishing itself in the cecum, C. jejuni is associated mainly with the mucus layer (1), 
but it must cross the intestinal epithelium barrier as it spreads systemically (2). Crossing 
the epithelium will induce a cytokine response by epithelial cells regardless of the path 
followed by C. jejuni; i.e. para-cellular or intracellular (3). Once cytokines are secreted, 
innate immune system cells will be recruited to the site, mainly macrophage and/or 
heterophils. At this stage C. jejuni is internalized, as there is no record of bacteremia in 
chickens. During the internalization process, C. jejuni immunomodulates the immune 
system, resulting in a delayed antibody response against the infection (4). C. jejuni is 
transported to liver and/or spleen, where it colonizes benignly without any detectable 
lesion formation (5). More details are provided in the text above.    
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